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Abstract 
Somatic hypermutation of antibodies during humoral immune responses depends on 
expression of Activation Induced Deaminase (AID) in antibody-producing B cells. AID 
initiates somatic hypermutation by converting cytosine (C) residues in antibody genes 
into uracil (U) residues, by deamination. Alone, conversion of cytosine into uracil can 
only produce C:G to T:A transition mutations, by replication across U (phase 1A 
mutation). Processing of C deaminations by base excision repair (BER) or mismatch 
repair (MMR) diversifies mutation, predominantly at C:G (phase 1B mutation) and A:T 
(phase 2 mutation), respectively.  
 
Mutations at C along the Ig variable region are not equally distributed.  AID de-
aminates C more often if they occur as part of WRCY motif (A/T,A/G,C,C/T). WRCY 
sequences are concentrated in hypervariable regions of Ig genes, where nucleotide 
substitutions are likely to be effective at generating useful amino acid substitutions to 
optimize affinity maturation. Of all WRCY motifs, AGCT and AACT are the most 
mutated hotspots. AGCT is also enriched in switch regions and facilitates CSR. 
 
In Chapter three, using large datasets of a transgenic mouse model, I compared Igh 
hypermutation between SWHEL B cells, SWHEL B cells deficient for UNG2 via retroviral 
expression of the uracil glycosylase inhibitor (ugi), SWHEL B cells deficient for MutSα by 
crossing Msh2ko alleles into SWHEL mice and SWHEL B cells deficient for both UNG2 and 
MutSα.  
 
 xvii 
I found that phase 1B mutations occur by distinct MMR-independent or MMR 
dependent pathways. At or in proximity to AGCW motifs, phase 1B mutations were 
driven by UNG2 without requirement for mismatch repair. Deaminations in AGCW 
were refractive both to processing by UNG2 and to high-ﬁdelity base excision repair 
(BER) downstream of UNG2, regardless of mismatch repair activity. Outside AGCW 
motifs, transversions at C:G are co-dependent on UNG2 and MMR.    
 
Classically, MMR mediates high fidelity repair of mismatches introduced during 
replication. The reasons for the profound differences in repair accuracy between 
classical and AID-induced MMR have not been elicited.  During S-phase of the cell 
replication cycle, when classical post-replication MMR occurs, nucleotide 
triphosphate (dNTP) levels are optimal for DNA replication, while in G1-phase dNTP 
levels are lower. Since there is evidence that AID is active in G1-phase, we 
hypothesized that low dNTP levels may be the cause of low fidelity MMR.  
 
Two enzymes are the major determinant of dNTP pools: ribonucleotide reductase 
(RNR), which converts ribonucleotides into deoxyribonucleotides predominantly 
during S-phase, and SAMHD1, which degrades dNTPs predominantly outside of S-
phase. 
 
In Chapters four and five, I quantified antibody hypermutation in B cells lacking 
SAMHD1 and/or over-expressing RNR. I observed a 2-fold decrease in mutations at 
A:T bases in cells lacking SAMHD1. This decrease was comparable to the decrease 
induced by RNR over-expression and was consistent with our hypothesis. 
 xviii 
Unexpectedly, loss of SAMHD1 also decreased transversion mutations at C:G by about 
70%, and almost doubled transition mutations at C:G bases. RNR over-expression had 
no obvious impact on transversion mutations at C:G, but increased transition 
mutations at C:G bases similarly to loss of SAMHD1. Furthermore, loss of SAMHD1 
decreased AID/BER-dependent antibody class switch recombination, while RNR over-
expression did not.  
 
These findings indicate that dNTPs play a role in MMR-mediated antibody mutation, 
as predicted by our hypothesis, but they also indicate a major role for SAMHD1 in AID-
induced BER that was not predicted by our hypothesis or by current models of 
antibody hypermutation. This important finding warrants further investigation to 
identify the mechanism.   
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1. Introduction 
In 1957, Frank Macfarlane Burnet published the “clonal selection hypothesis”, a 
theory to account for the body’s ability to produce antibodies to virtually all foreign 
antigens, with the absence of an immunological response to self (Burnet, 1957). He 
postulated that embryonic stage lymphocytes would “have a randomization of the 
coding responsible for part of the specification of gamma globulin molecules”, and 
subsequently during antigen exposure, lymphocytes that bind antigen would 
proliferate. The clones with highest affinity to antigen would be selected and 
“inherited changes will occur as a result of somatic mutation”. It would take another 
19 years before molecular biology would identify the process of antigen receptor VDJ 
recombination and later somatic hypermutation of VDJ-rearranged immunoglobulin 
genes (Jung & Alt, 2004). 
Overview of the immune system 
It was Claude Bernard who, in 1865, pioneered the understanding of the human body 
as “simple phenomena, which could be associated together to form a common final 
purpose”. It is these processes which allow for la vie constant ou libre: “where life is 
liberated from the external environment and succeeds in maintaining constant 
conditions within its own internal environment” (Cooper, 2008). It was later, in 1929, 
that Walter Cannon would coin the term homeostasis to refer to the “constancy of 
the internal environment after distortion by external stresses” (Cannon, 1929).  
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As such, the immune system can be conceptualised as a set of individual components 
to maintain homeostasis of the body in an environment of pathogenic microbes. 
Components of the immune system 
The immune system is complex. For simplicity, it can broadly be divided into three 
major components, which include constitutive innate immunity, reactive innate 
immunity and adaptive immunity. 
 
As part of constitutive innate immunity, the skin and mucosal surfaces form physical 
barriers against infection. These surfaces prevent the passage of pathogens from the 
external environment into the internal tissues. The most superficial layer of the skin, 
the stratum corneum, mediates the barrier function of the epidermis (Baroni et al., 
2012).  
  
The strength of the physical barrier in the stratum corneum is provided by its cellular 
structure of flat, anucleated squamous cells with an internal structure of keratin 
filaments. These keratin filaments assemble into a web-like structure originating from 
a ring around the nucleus. This structure terminates at desmosomes, located on the 
cell membrane, which interconnect adjacent keratinocytes and provide intercellular 
cohesion. The keratinocyte is also surrounded by a cell envelope consisting of cross-
linked proteins (Elias, 2007). The intercellular space is composed of lipids, which 
counteract the loss of water and salts from the skin and prevent the penetration of 
water soluble substances into the skin (Baroni et al., 2012).  
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Similarly, the cells forming the lining of the gastrointestinal tract, the intestinal 
epithelial cells, form a physical barrier. In contrast to the skin, however, the physical 
barrier is selectively permeable, allowing absorption of nutrients (Pitman & Blumberg, 
2000). Intestinal epithelial cells maintain their structural integrity through a complex 
cytoskeletal network of microfilaments. These include actin filaments, which form 
rings at both the apical (luminal) and basolateral poles of the cell, and intermediate 
filaments which spread through the cytoplasm and, similarly to keratinocytes, 
terminate at the cell membrane. Tight junctions on the apical (luminal) surface 
separate the lumen of the gastrointestinal tract from the paracellular space.  
 
Also contributing to physical barrier function is the secretion of mucins onto the 
luminal surface by goblet cells. Mucins, which are a group of glycoproteins, provide a 
hydrated viscous layer to prevent trauma to the epithelial surface. Bacteria also 
adhere to mucins, preventing bacterial contact to intestinal epithelial cells. Mucus is 
also propelled down the intestinal tract, facilitating removal of bound bacteria. 
Specifically, in the stomach, a low pH contributes to pathogen elimination (Pitman & 
Blumberg, 2000).  
 
At these physical barriers, including skin and gastrointestinal tract, certain 
antimicrobial peptides are produced, including lysozyme and defensins. Lysozyme is a 
1,4-β-N-acetylmuramidase that cleaves the glycosidic bond between the C-1 of N-
acetylmuramic acid and the C-4 of N-acetylglucosamine. This bond occurs in 
peptidoglycan, which is an important component of the gram-positive bacterial cell 
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wall. Lysozyme in humans is most abundant in tears, gastric fluid and also breastmilk 
(Jolles & Jolles, 1984).  
 
Defensins are antimicrobial peptides with a characteristic β-sheet-rich fold and a 
framework of six disulfide-linked cysteines (Ganz, 2003). Defensins permeabilise 
target bacterial, fungal and encapsulated viral membranes (McCormick & Weinberg, 
2010). Defensins contain clusters of amino acids with positively charged side chains 
and clusters of amino acids with hydrophobic side chains. Due to this property, they 
interact with microbial membranes. When defensins congregate on microbial cell 
membranes they form pores, and this leads to permeabilisation. Although defensins 
are secreted by epithelial cells, they are in much higher concentration in granulocytes 
(Ganz, 2003). Cathlecidin, produced by the stratum corneum and gastrointestinal 
tract, also functions by interaction with microbial cell membranes, leading to 
permeabilisation (Kosciuczuk et al., 2012). Like defensins, cathlecidins are also present 
in higher concentration in granulocytes. 
 
Other antimicrobial peptides include RNase 7, produced by the stratum corneum, 
which has potent ribonuclease activity (Harder & Schroder, 2002), and calprotectin, a 
manganese and zinc chelator, which deprives pathogens of essential metals. 
Calprotectin comprises as much as 60% of the soluble protein content of the cytosol 
of neutrophils (Striz & Trebichavsky, 2004). Other metal binding antimicrobial 
peptides include psoriasin, produced by the stratum corneum, that likely functions by 
sequestration of zinc (Glaser et al., 2005) and neutrophil gelatinase-associated 
lipocalin, which sequesters iron (Miethke & Skerra, 2010).  
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The reactive innate immune system 
Should pathogens penetrate the physical barriers of the body, the reactive innate 
immune system and adaptive immune system detect the presence of invading 
organisms. One key difference between the innate and adaptive immune systems is 
that the innate immune system has a rather limited repertoire of receptors to detect 
invading pathogens. Innate immune system receptors are inherited on a germline 
basis. In contrast, the adaptive immune system has an extremely diverse, semi-
randomly generated repertoire of receptors (Turvey & Broide, 2010). 
 
The innate immune system has three different recognition strategies for infection. Not 
only does it recognize foreign pathogens, also called ‘microbial non-self’ or pathogen-
associated molecular patterns (PAMP), but it is able to detect metabolic consequences 
of cell injury, also called damage-associated molecular patterns (DAMP). The innate 
immune system is also able to recognise “missing self” molecules only expressed in 
normal healthy cells, and not in damaged or infected cells. These pattern recognition 
receptors (PRR) are expressed on antigen presenting cells such as dendritic cells and 
macrophages, other immune cells such as fibroblasts, mast cells, monocytes and 
neutrophils, and on non-immune cells such as epithelial cells. 
 
Pattern recognition receptors include toll-like receptors (TLR), nucleotide 
oligomerization domain (NOD)-like receptors, collectin (collagen-containing C-type 
lectin) family receptors, retinoic-acid-inducible gene (RIG-1)-like receptors and absent 
in melanoma-2 (AIM2)-like receptors (Takeuchi & Akira, 2010; Turvey & Broide, 2010). 
TLR can detect a limited but highly conserved number of foreign antigens in the 
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extracellular space or in the lumen of endocytic vesicles. The human TLR family 
consists of 10 receptors. Examples include TLR 4, which recognizes lipopolysaccharide, 
TLR 5, which recognizes flagellin and TLRs 1,2 and 6, which recognise lipoproteins. 
 
The collectin family of receptors are soluble pattern recognition receptors that bind 
to oligosaccharides or lipids on microorganism surfaces. An example of this is 
mannose binding lectin, which binds to microbial terminal mannose residues. 
 
NOD-like receptors on the other hand recognise foreign antigen in the intracellular 
environment. There are 23 members of the NOD family. Examples include NOD2, that 
recognises muramyl dipeptide and Ipaf, that recognises flagellin. RIG-1-like receptors 
also recognise foreign antigens in the cytoplasm, in the form of double stranded RNA. 
 
During cell lysis from infection, DAMPs are released and recognised through NOD-like 
receptors. Examples of DAMPs include high mobility group box 1, heat shock proteins 
and uric acid. On the other hand, recognition of normal cells, through expression of 
MHC Class I molecules by MHC class I-specific inhibitory receptors, inhibits activation 
of the immune response against uninfected tissue. 
 
Activation of PRR upregulates transcription of multiple inflammatory response genes 
(Takeuchi & Akira, 2010). These genes encode enzymes, chemokines and pro-
inflammatory cytokines. These include tumour necrosis factor, interleukin-1 and 
interleukin-6, type I interferons, adhesion molecules, regulators of the extracellular 
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matrix and antimicrobial proteins. Signaling pathways involved for each PRR are 
different and are reviewed in reference (Takeuchi & Akira, 2010). 
 
Production of these substances leads to recruitment and activation of innate immune 
system leucocytes including natural killer cells, mast cells, eosinophils, basophils, 
macrophages and neutrophils. This process is assisted by vascular alteration by 
mediators including histamine, prostaglandins and nitric oxide, which cause 
vasodilation and increase vascular permeability. Tumour necrosis factor and 
interleukin-1 promote leucocyte extravasation by increasing leukocyte adhesion 
molecules on endothelial cells (Newton & Dixit, 2012).  
 
Activated immune cells at the site of infection include dendritic cells, macrophages 
and neutrophils. These immune cells remove foreign particles and host debris by 
phagocytosis and subsequent digestion by production of reactive oxygen species, 
release of antimicrobial peptides as described previously and in the case of 
neutrophils, expulsion of nuclear contents to form neutrophil extracellular traps 
(Mayadas et al., 2014). Further specialized roles of tissue macrophages outside of 
inflammation are discussed in reference (Epelman et al., 2014). Inflammation also 
activates the complement cascade. For further information see (Dunkelberger & Song, 
2010).  
 
In summary, the reactive innate immune system consists of sentinel cells that express 
PRR and detect infection. Activation of these sentinel PRR induces the production of 
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inflammatory molecules, leading to recruitment of effector immune cells, which is 
facilitated by vascular changes.  
 
The reactive innate immune system functions intimately with the adaptive immune 
system to provide a comprehensive system that can react with the speed inherent to 
the innate system, following-up with the specificity of the adaptive immune system.  
Although dendritic cells are part of the innate response, they serve a critical role in 
linking the innate immune system with the adaptive immune system. 
The adaptive immune system 
Although the innate immune system rapidly senses and eliminates pathogens, it is 
only able to recognise a limited set of PAMPs and DAMPs. As a result, pathogens have 
evolved mechanisms to avoid detection by the innate immune system. 
 
With constant evolutionary drive between vertebrates and pathogenic microbes, an 
adaptive immune system provides an extra layer of protection with a broader and 
more finely tuned repertoire of recognition for self and non-self-antigens (Bonilla & 
Oettgen, 2010). The adaptive immune system also provides immunological memory, 
whereby on subsequent encounters with the same pathogen, a more rapid, robust 
and protective response is elicited (Bonilla & Oettgen, 2010). 
 
The innate immune response makes crucial contributions to adaptive immunity by 
presenting antigen to the cells of the adaptive immune system, and activating 
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lymphocytes (cells that are part of the adaptive immune system) with complement 
fragments on microbial surfaces (Janeway et al., 2001). 
Antigen presentation by dendritic cells 
Induction of the adaptive immune system occurs when an immature dendritic cell 
phagocytoses a pathogen after binding and activation of a PRR. Micropinocytosis, 
whereby immature dendritic cells also continually take up extracellular material, can 
also lead to uptake of virus and bacteria and activate PRR. After activation of PRR, 
dendritic cells travel to a nearby lymph node and mature into a highly effective antigen 
presenting cell. At this stage, they are able to activate pathogen-specific lymphocytes 
(Janeway et al., 2001).  
 
Antigens that are presented to lymphocytes have been processed by dendritic cells. 
Cytosolic and nuclear antigens are degraded in the cytosol by proteasomes to 
peptides. These peptides are then transported to the endoplasmic reticulum and 
stabilize newly synthesized MHC Class I heavy chain and B2 microglobulin and move 
to the cell surface. Interaction of the T cell receptor with antigenic peptides complexed 
with MHC Class I molecules activates naïve CD8 T cells. Activated CD8 T cells are then 
able to kill infected cells that present the same antigenic peptide/MHC Class I complex. 
 
Antigens from the extracellular space are enclosed into endosomes in dendritic cells 
and are degraded into peptides. MHC Class II molecules in conjunction with invariant 
chain interact with these peptides. CLIP, a peptide place holder of invariant chain, 
dissociates by digestion once in the endosome, allowing peptides in the endosome to 
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bind to MHC Class II. The complex is then transported to the cell surface and can 
activate CD4 T cells expressing cognate antigen receptors. Different PRR control CD4 
T cell function by determining the origin of the antigens recognised by the antigen 
receptors expressed on T cells. Different classes of dendritic cells produce different 
cytokines and, in doing so, instruct lymphocytes to induce the appropriate effector 
immune response (Iwasaki & Medzhitov, 2015). CD4 T cell subsets have distinct 
functions, including activation of other lymphocytes to kill microbes (TH1), production 
of antibody and expulsion of helminths (TH2), induction of inflammatory responses 
(TH17), and dampening of immune activation (regulatory T cells). See (Bonilla & 
Oettgen, 2010; Iwasaki & Medzhitov, 2015) for further information. 
 
T cell receptors are immensely diverse. Generation of T cell receptor diversity is similar 
to generation of antibody diversity in B cells and is discussed below. See (Dudley et 
al., 2005) for further information. 
B cells provide humoral immunity by production of antibodies 
While T cell functions include killing of infected target cells, provision of signals to 
enhance B cell and T cell responses, activation of mononuclear phagocytes and also 
regulation of immune responses, B cells primarily produce defensive antibodies 
(Bonilla & Oettgen, 2010), although they play important antigen-presenting and 
regulatory functions as well (LeBien & Tedder, 2008).  
 
Antibodies are initially expressed as membrane-bound B cell receptors, but are 
secreted into blood plasma following activation of antigen-specific clones. Antibodies 
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function to neutralize toxins, prevent organisms adhering to mucosal surfaces, 
activate complement, opsonize bacteria for phagocytosis, and sensitise cells for 
antibody dependent cytotoxic attack (Parkin & Cohen, 2001). Antibody structure is 
critical for these properties. Each antibody consists of two types of polypeptide chains; 
two identical heavy chains and two identical light chains are linked together with 
disulfide bonds. This forms a Y shaped structure (see Figure 1.1 (Loureiro et al., 2015)).  
 
Each antibody chain consists of variable (V) and constant (C) regions. Antigen binds to 
paired heavy and light chain V regions of the Y shaped structure. As the heavy and 
light chains are duplicated, each antibody bears two identical antigen binding sites. 
The base of the Y shape structure consists of the paired heavy chain C regions, forming 
part of the F(ab) region and the Fc region. It is the Fc region that interacts with effector 
cells by binding to the Fc receptor on effector cells or binding to other molecules such 
as complement (Schroeder & Cavacini, 2010). There are 5 classes of Ig: IgM, IgD, IgG, 
IgA and IgE. See (Schroeder & Cavacini, 2010) for further information. 
 
The structure of the antigen binding site is determined by the unique amino acid 
sequence of the three complementary determining regions located inside the V region 
(see Figure 1.1) (Jung et al., 2006). While there are a very limited number of PRR 
involved in innate immunity, humans are capable of producing antibodies with about 
5x1013 different antigen binding sites (Pieper et al., 2013). 
 
Each B cell produces one type of antibody only, as a consequence of allelic exclusion, 
which will be explained later. Each B cell’s unique antigen binding site is brought about 
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by somatic “V(D)J recombination” of genomic DNA within the Ig loci during B cell 
development to create heavy chain and light V regions unique to each B cell clone. 
V(D)J recombination is a semi-random process that recombines separate VH, DH and 
JH germline gene segments to produce the heavy chain VDJH variable region encoded 
by the Igh locus (IgH heavy chain), then VL and JL germline gene segments recombine 
to encode the light chain variable region using either the Igk locus (Igκ light chain) or 
the Igl locus (Igλ light chain). V(D)J recombination is a process of precise double 
stranded break (DSB) formation, followed by imprecise non-homologous end joining 
(NHEJ) that permanently deletes large segments of genomic DNA up to a megabase in 
length (Fugmann et al., 2000). 
V(D)J recombination creates antibody diversity 
The heavy chain locus (Igh) is located on Chromosome 12 or 14 in mouse or human, 
respectively. The light chain Igκ and Igλ loci are located on chromosomes 6 and 16, 
respectively, in mice and on chromosomes 2 and 22, respectively, in humans (Honjo, 
1983). In mice, the Igh locus includes 141 of VH  (in strain C57/BL6 (de Bono et al., 
2004)), 13 of DH  and 4 of JH. In humans, there are about 65 of VH, 27 of DH and 6 of JH; 
exact numbers of germline V gene segments vary between mouse strains and 
between human haplotypes. As the light chain sequence can be derived from either 
the Igκ or Igλ light chain loci, the possible VJ-rearrangements can include 
combinations in mice of any one of 100-300 of Vκ with any one of 5 of Jκ, or 2 of Vλ with 2 of Jλ (see Figure 1.2) and 40 of Vκ with 5 of Jκ or 30 of Vλ with 4 of Jλ in humans. 
Functional V, D and J gene segments are flanked by non-coding recombination signal 
sequences (RSS). Recombination signal sequences consist of a highly conserved 
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heptamer (consensus 5’-CACAGTG) followed by a poorly conserved spacer usually 12 
or 23 bases long, followed by a conserved nonamer (consensus 5’-ACAAAAACC) 
(Fugmann et al., 2000). There is variation between heptamer and nonamer of 
individual RSS, with those most closely resembling the consensus sequences being the 
most efficiently re-arranged (Dudley et al., 2005). 
 
In mice and humans, VH segments are 3’-flanked by RSS with 23-bp spacers, while the 
DH segments are flanked at both the 3’ and 5’ ends by RSS with 12-bp spacers. Like the 
3’ end of VH, the 5’ end of JH is also flanked by RSS with 23-bp spacers. Vκ segments are 
3’-flanked by RSS with 12-bp spacers. Jκ are flanked at their 5’ ends by RSS with 23-bp 
spacers. Vλ segments are flanked by RSS with 23-bp spacers at their 3’ ends and Jλ are 
5’-flanked by RSS with 12-bp spacers (see Figure 1.2). 
 
The initiator of V(D)J recombination is the RAG endonuclease. The genes that produce 
RAG endonuclease are recombination-activating genes 1 and 2 (RAG1 and RAG2) 
(Jung et al., 2006), which are only expressed in developing lymphocytes. A null 
deficiency for either RAG 1 or 2 leads to a complete block in B and T lymphocyte 
development at progenitor stages and null mutations in RAG 1 or 2 are amongst the 
causes of severe combined immune deficiency in humans and mice (Dudley et al., 
2005; Tasher & Dalal, 2012). RAG endonuclease introduces DNA double stranded 
breaks specifically between RSS and their associated V, D or J segments (Fugmann et 
al., 2000). Efficient recombination occurs between gene segments with a 12-base 
spacer RSS to gene segments with a 23-base spacer RSS, which is known as the 12/23 
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rule (Fugmann et al., 2000). Enforcement of the 12/23 rule appears to occur at the 
level of binding and assembly of RAGs 1 and 2 to paired RSS and at the subsequent 
cleavage step. The 12/23 rule prevents non-productive V to V or J to J joining and 
ensures the incorporation of DH segments into the heavy chain variable region (Dudley 
et al., 2005).  
 
The process of cleavage begins with bringing RAGs 1 and 2 to a single 12-bp RSS, 
followed by integration of the companion 23-bp RSS. The DNA bending proteins HMG1 
and HMG2 facilitate the binding of both the 12-bp and 23-bp RSS and promote RAG-
mediated cleavage (Dudley et al., 2005). RAGs introduce a single strand nick in the 
DNA between the border of the RSS heptamer and the gene-coding segment creating 
a 3’-OH on one DNA strand of the gene-coding segment and a 5’ phosphate on the RSS 
strand. The 3’-OH then acts as a nucleophile and attacks the opposite DNA strand in a 
transesterification reaction, and forms a covalently sealed hairpin on the coding 
strand and a blunt 5’-phosphorylated RSS end (Dudley et al., 2005). 
 
RAG-mediated DSBs are joined by non-homologous end joining (NHEJ). NHEJ proteins 
include Ku70, Ku86, XRCC4, XLF, ligase IV, DNA-PKcs and Artemis. Initially Ku70 and 
Ku86 form a heterodimer that binds to RAG generated breaks. The Ku heterodimer 
then recruits DNA-PKcs that bridges gene segment junctions (Malu et al., 2012). 
Artemis, in conjunction with DNA-PKcs, mediates hairpin opening within four or five 
nucleotides of the apex of the hairpin, and this results in short 5’ or 3’ overhangs 
(Dudley et al., 2005). This ultimately increases junctional diversity, and, in doing so, 
increases the repertoire of antibodies generated. Polymerase µ is able to promote 
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NHEJ of ends with non-complementary 3’ overhangs, by priming synthesis from a 3’ 
overhang from one DNA end, and using a noncomplementary overhang from a second 
end as a template (Davis et al., 2008). Polymerase µ performs this by adding 
nucleotides in a template-independent manner and generates microhomology 
between junctions for pairing and ligation (Chang et al., 2017). Nucleases are able to 
chew back 3’ overhangs, and this causes deletion of sequences at the junction. 
Terminal deoxynucleotidyl transferase, a lymphoid specific protein, also adds non-
templated nucleotides to the heavy chain junctions, further increasing junctional 
diversity. Finally, ligation is catalyzed by ligase IV, XRCC4 and XLF. XLF and XRCC4 
interact to form filaments that bridge DNA ends and stimulate ligase IV recruitment 
to perform ligation (Andres et al., 2012; Roy et al., 2015). 
 
Like all blood cells, B lymphocytes are derived from haematopoietic stem cells (HSC) 
resident in the liver during embryogenesis and in the bone marrow after birth. HSC 
originate from the aorta-gonad mesonephros, formed from the mesoderm (Pieper et 
al., 2013). DH to JH V(D)J-recombination initially occurs in the Igh locus in liver pro-B 
cells in the foetus or in bone marrow pro-B cells post-partum. This is followed 
by VH to DJH V(D)J-recombination. Once an IgH polypeptide is produced, the Igh loci in 
both chromosomes become inaccessible to RAG-endonuclease; a brief burst of 
proliferation occurs to “amplify” the successful VDJH-recombination, then V to J 
recombination commences in one allele of either the IgN or IgO loci in the resulting 
pre-B cells. If V(D)J-recombination fails to produce an IgL chain, it will continue in the 
same allele or in another IgN or IgO allele until all alleles are unable to undergo further 
recombination. Pre-B cells that fail to produce IgH and IgL chains will die by apoptosis, 
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but cells that have produced IgH and IgL chains differentiate into immature B 
lymphocytes expressing surface IgM and IgD. Immature B cells undergo negative 
selection to minimize export of self-reactive cells from the fetal liver or bone marrow. 
Most immature B cells with autoreactive receptors undergo apoptosis or overcome 
auto-reactivity via receptor editing driven by further V(D)J-recombination or by 
somatic mutation, but “central tolerance” is not perfect, and potentially auto-reactive 
B cells are exported. For further information see (Nemazee, 2006). B cells that survive 
negative selection leave the bone marrow as transitional B cells, and mature into 
follicular B cells (Cambier et al., 2007). 
Somatic mutation creates high affinity antibodies in response 
to antigen challenge  
Prior to activation by antigen, B cells circulate through the body through the 
vasculature. B cells then enter secondary lymphoid organs and will filter through 
lymphoid follicles for approximately 24 hours. If activation does not occur, then the B 
cell re-enters the circulation.  
 
B cell activation occurs in lymphoid B-cell follicles, which occur adjacent to T cell zones 
(see (Hamel et al., 2012) for review). Here, naïve B cells encounter T-dependent 
antigens that enter the lymph node through lymphatics. Binding of the B cells’ antigen 
receptor (BCR, formed from CD79a + CD79b + membrane Ig produced by alternative 
splicing of the ultimate CH exon) by antigen activates B cells via signaling from the BCR 
to the nucleus (Healy et al., 1997). Activated B cells migrate to the T cell/B cell border, 
where they can be rescued from programmed cell death by TH cell-derived secondary 
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signals as long as they successfully present peptides derived from internalization of 
BCR-bound antigen as peptide/MHC class II complexes to cognate TH cells (Shulman et 
al., 2014). This dependence on a second signal from antigen-specific TH cells inhibits 
inappropriate activation of auto-immune B cells that escaped central tolerance. 
 
Following secondary activation by cognate T cells, some B cells migrate to the central 
region of the B cell follicle and proliferate rapidly to form germinal centres (GC) (see 
Figure 1.3). In the GC, proliferating B cells are called centroblasts (Z. Li et al., 2004). 
Proliferating centroblasts undergo somatic hypermutation, a process which 
introduces nucleotide substitutions (and less commonly, insertions and deletions) in 
the V(D)J and 3’ flanking regions of the rearranged antibody genes, leaving the C 
regions unmutated. Somatic hypermutation introduces mutations at a rate 106 times 
higher than the rest of the genome (Bardwell et al., 2004). This leads to production of 
daughter clones with antibody variants that bind antigen with differing affinities. B 
cells producing antibody with maintained or increased affinity are positively selected 
and undergo a proliferative burst (Neuberger & Milstein, 1995); the extent of the burst 
being proportional to the amount of antigen that the daughter cell has been able to 
capture from follicular dendritic cells and re-present to follicular TH cells (Gitlin et al., 
2015; Gitlin et al., 2014). Selection occurs when centroblasts drop out of cell cycle to 
become centrocytes, and is provided by both follicular dendritic cells and T-follicular 
helper cells (Hamel et al., 2012) (see Figure 1.3 (Heesters et al., 2014)). Proliferation 
and somatic hypermutation occur in the dark zone of the germinal centre, while 
selection occurs in the light zone (Gitlin et al., 2015; Gitlin et al., 2014). 
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Two processes are therefore involved in creating high affinity antibodies. Firstly, high 
levels of nucleotide substitutions in the variable region, termed somatic 
hypermutation, is combined with secondly, clonal selection. Daughter lymphocytes 
with higher affinity antibodies continue to proliferate, while lymphocytes with lower 
affinity undergo apoptosis (Z. Li et al., 2004). B cells with the highest affinity are rapidly 
selected into the antibody secreting pool (Krautler et al., 2017). 
Class Switch Recombination alters production of antibody 
isotype 
While somatic hypermutation is involved in creating high affinity antibodies, class 
switch recombination (CSR) is a process that alters the isotypes of antibodies 
produced from the IgM and IgD (predominantly IgM) isotypes produced by all naïve B 
cells to IgG, IgE or IgA isotypes following B cell activation. Switching from pentameric 
IgM to the much smaller IgG, E and A isotypes allows antibodies to diffuse out of the 
blood into other tissues, and also changes antibody effector functions; both 
potentially improve the ability of antibodies to eliminate target pathogens (Chaudhuri 
et al., 2003; Stavnezer & Schrader, 2014). In the germline, exons encoding IgM (CP) 
and IgD (CG) occur 3’ to the JH gene segments, separated from the JH by the J-CH intron. 
Either CP or CG exons are spliced to the VDJH exon during transcription in naïve B cells, 
such that mature naïve B cells express both IgM and IgD. Downstream (i.e. 3’) of CG 
are additional constant region exons that are not used by naïve B cells which encode 
Fc distinct from IgM and IgD. In humans, the order (5’ to 3’) of these additional 
constant region gene segments are CJCJCDCJCJCHandCD, which encode 
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the Fc of IgG3, IgG1, IgA1, IgG2, IgG4, IgE and IgA2, respectively. Located upstream (i.e. 
5’) of every constant region gene lies a non-coding switch (S) region sequence.  
  
Class switch recombination is the process of deletional recombination between the 
SP switch region and one of the 3’ SJ, SH or SD regions (see Figure 1.4). Combination 
between SP and a downstream S region changes the constant region exons placed 
immediately 3’ to the splice acceptor in the J-H intron, leading to the production of a 
different antibody isotype without changing antigen specificity. Switch (S) regions are 
typically 1-10kb in length, G-rich in the top strand and are highly repetitive, consisting 
of G4-5 tracts, which can form G-quadruplexes when single-stranded, interspersed with 
WGCW (W = A or T) motifs. The non-canonical switch region lying upstream of 
CG(known as σδ) has residual function and switching to IgD is a rare event (Choi et al., 
2017). (see Figure 1.4). 
Somatic hypermutation and Class Switch Recombination are initiated by 
Activation Induced Cytidine Deaminase (AID) 
Activation induced cytidine deaminase (AID, gene Aicda) is essential for both somatic 
hypermutation and class switch recombination. AID deficiency causes a complete 
defect in class switching and somatic hypermutation (Muramatsu et al., 2000), and is 
the cause of the human disorder Hyper-IgM syndrome 2 (HIGM2) (Revy et al., 2000). 
  
AID initiates somatic hypermutation and class switch recombination by de-aminating 
genomic cytosine residues, converting them into uracil residues (see Figure 1.5) 
(Frieder et al., 2009). In the absence of further processing, replication uracils produces 
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transition C:G to T:A mutations, because replicative DNA polymerases incorporate A 
opposite U in DNA (Frieder et al., 2009). 
 
The sequence homology between AID and Apobec-1, which is the catalytic component 
of the complex that deaminates cytidine to uracil in Apolipoprotein B mRNA, initially 
suggested that the mechanism of AID mutation might be deamination of cytidine to 
uracil in a specific unknown RNA target (Muramatsu et al., 1999). However, the first 
evidence that AID functions by directly mutating cytosine bases in genomic DNA was 
produced when AID was overexpressed in E.coli. Subsequent sequencing of E.coli DNA 
sequences revealed that 80% of AID-induced mutations in E. coli were C:G to T:A 
transitions and that these mutations were enhanced when the E. coli ung gene was 
inactivated; the UNG protein removes uracils from DNA, but not from RNA (Petersen-
Mahrt et al., 2002). Direct evidence that AID converts genomic cytosines into uracils 
in vivo was produced by quantifying uracil residues in immunoglobulin variable 
regions in genomic DNA from murine germinal centre B cells (Maul et al., 2011). In-
vitro, DNA deamination by AID in the absence of cofactor proteins was observed in 
single stranded DNA and not in double stranded DNA, DNA/RNA hybrids or RNA 
(Bransteitter et al., 2003; Dickerson et al., 2003). Transcription exposes single 
stranded DNA (ssDNA) and enhances AID mediated cytidine deamination; this initially 
supported the concept that AID requires ssDNA as a substrate (Ramiro et al., 2003). In 
the presence of co-factors, however, AID deaminates both ssDNA and dsDNA 
templates in vitro (Basu et al., 2011).  
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Nucleotide substitutions are not randomly distributed along the variable region of Ig 
genes. Mutation hotspots occur where nucleotide substitutions are likely to be 
effective at generating useful amino acid substitutions to optimize affinity maturation 
of the immune response (Jolly et al., 1996; Neuberger, 2008). AID deaminates C 
residues more often if they occur as part of a WRCY motif (W=A/T; R=A/G; Y=C/T) in 
either DNA strand  (Rogozin & Diaz, 2004; Wang et al., 2010). AGCT is a palindromic 
variant of WRCY that encodes apposed hotspots on both strands; that is, the C on both 
strands is favoured by AID at AGCT sites. Of all WRCY motifs, AGCT, and outside Ig 
genes AACT, are the most mutated hotspots (Alvarez-Prado et al., 2018). WRCY motifs 
are enriched in the CDRs of Ig V genes and depleted from the framework regions (Jolly 
et al., 1996; Neuberger, 2008), and as mentioned earlier, AGCT motifs are very dense 
in switch regions (Zarrin et al., 2004), which facilitates CSR (Han et al., 2011; Yeap et 
al., 2015). Substitution of AID’s DNA-binding site with the DNA binding sites from AID 
homologues (APOBEC proteins) that target motifs distinct from WRCY skewed 
mutation during IgO mutation in chicken DT40 cells away from WRCY motifs and 
towards the motifs preferred by the donor APOBEC proteins (Wang et al., 2010). This 
elegantly proved that the mutator function of AID was determined by AID's acting 
directly on genomic DNA in vivo. 
The action of AID is tightly regulated in vivo 
As AID is a potent mutator (58), its expression is tightly controlled. In B cells, AID is 
expressed after activation (Muramatsu et al., 1999). AID is also expressed in the ovary, 
where its function may lie in epigenetic programming (Orthwein & Di Noia, 2012). The 
mechanism for controlled expression of AID includes a combination of binding sites 
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for factors such as NF-κB, Stat 6, Hox C4 and Pax5 in Aicda’s promoter (Maul & 
Gearhart, 2010a) and also enhancers and silencers located within four upstream 
regulatory regions (Tran et al., 2010). Aicda transcription in B cells is induced by 
engagement of B cell CD40 by CD40 ligand (CD154) and by cytokines such as 
interleukin-4 (IL-4) (Dedeoglu et al., 2004), both of which are provided by T cells during 
immune synapse formation with activated B cells (Orthwein & Di Noia, 2012). 
 
Given the preference of AID for single stranded DNA in vitro, and, given that single 
stranded DNA is exposed during transcription, it is thought the immunoglobulin gene 
is targeted when it is actively transcribed. This is indirectly supported by the 
observation that immunoglobulin transgenes undergo somatic hypermutation at 
levels that correlate with their transcription rates (Bachl et al., 2001). An analysis of 
the 118 most expressed genes in germinal centre B lymphocytes revealed 43% of 
these genes were also mutated by AID. The rates of mutation in these genes, however, 
were at least 100-fold lower than the variable region (Liu et al., 2008). Active 
transcription, therefore, is not the sole reason that AID targets Ig genes.  
 
Recruitment of AID is more closely correlated to sites of RNA polymerase II (RNA Pol 
II) stalling than to sites of transcription. In chromatin immunoprecipitation analyses, 
AID was associated with the 5’ ends of many transcription domains, along with RNA 
Pol II, but the AID co-factor RPA, which is required for AID activity on dsDNA in vitro 
was predominantly associated with Ig loci (Yamane et al., 2011). A spike in RNA Pol II 
density was seen in immunoglobulin switch regions in activated B lymphocytes and is 
thought to be due to elongation stalling (Rajagopal et al., 2009). Elongation stalling is 
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an intrinsic feature of immunoglobulin locus transcription (Pavri & Nussenzweig, 
2011). Spt5 is a factor that is recruited to sites of stalling and is required for CSR. Spt5 
was found to facilitate the association between RNA Pol II and AID and their 
recruitment to immunoglobulin targets (Pavri et al., 2010).  
 
Interacting with RNA Pol II is the RNA exosome, which disassociates stalled RNA Pol II 
from DNA (Andrulis et al., 2002). The RNA exosome is involved in 3’ processing of 
various stable RNA species. Its function is crucial for RNA quality control in the nucleus 
(Kilchert et al., 2016). It degrades many types of cryptic transcripts formed by 
pervasive transcription and removes aberrant RNA molecules that fail to mature 
correctly. In-vitro and in-vivo experiments found that the RNA exosome bound to AID 
and stimulated AID activity on both template and non-template strands in-vitro (Basu 
et al., 2011). This suggested that stalled RNA Pol II recruited the RNA exosome to the 
Igh locus and in doing so recruited AID. Supporting this theory is the presence of DNA 
sequences within the immunoglobulin loci that express non-coding RNAs that are 
substrates for the RNA exosome (Laffleur et al., 2017). 
During somatic mutation, processing downstream of UNG2 introduces 
transversions at G and C bases 
On its own, conversion of cytosine into uracil can only produce C:G to T:A transition 
mutations, by subsequent replication across U. Although these are the most common 
mutations in Ig genes that have not undergone antigen selection, mutations at A:T 
base pairs and transversion mutations at C:G are also abundant in hypermutated B 
cells (Methot & Di Noia, 2017). Uracil is directly recognized as DNA damage by DNA 
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base excision repair (BER) factors UNG2, SMUG1, TDG and MBD4; furthermore U:G 
base pairs are recognized as DNA mismatches by the DNA mismatch repair factor 
MutSα, which is a heterodimer of MSH2 and MSH6 (Jacobs & Schar, 2012). B cells 
deficient in both the BER factor uracil N-glycosylase (UNG2) and MutSα accumulate 
only C:G to T:A transition mutations in their Ig loci, at elevated frequencies compared 
to wild-type B cells (Rada et al., 2004; Shen et al., 2005), while somatic hypermutation 
of Ig genes in wild type mice includes all possible nucleotide substitutions. Processing 
of U:G base pairs by these two proteins are therefore required for transversions at G 
and C bases and for mutations at A and T bases (see Figure 1.6 (Petersen-Mahrt et al., 
2002)).  
 
When UNG2 is inactivated; transversions at C and G bases are reduced by greater than 
80% (Rada et al., 2002; Storb & Stavnezer, 2002). This is distinct to the high-fidelity 
function of UNG2 in the canonical base excision repair (BER) pathway. In canonical 
BER, UNG2 cleaves the N-glycosylic bond of genomic uracils, creating an apyrimidinic 
(AP) site (Krijger et al., 2009). Subsequently, two different pathways can process the 
apyrimidinic site. Short-patch BER recognizes the site by APE1, which creates a nick in 
the DNA immediately 5’ to the AP site. The AP-lyase activity of APE1 or of DNA 
polymerase β then removes the AP base. The original base is then restored by DNA 
polymerase β and XRCC1/DNA ligase III (Krokan & Bjoras, 2013). DNA polymerase O 
can substitute for Pol E. Long-patch BER excises at least two nucleotides and up to 20 
nucleotides, with DNA synthesis via polymerase β or polymerase δ/ε (Sattler et al., 
2003; Woodrick et al., 2017). Unlike single-nucleotide BER, long-patch BER requires 
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Proliferating cell nuclear antigen (PCNA), the trimeric sliding clamp that tethers DNA 
polymerases to the template during replication (Krokan & Bjoras, 2013). 
 
More specifically, when the activity of UNG2 is restricted to G1-phase by cell cycle 
restricted overexpression of a uracil glycosylase inhibitor polypeptide (ugi), it was 
found that UNG2 excision in G1-phase was responsible for mutagenic processing of 
AID induced uracils, and surprisingly also for most of the faithful repair (Sharbeen et 
al., 2012). 
 
Current unresolved questions involve the mechanisms downstream of uracil excision 
to achieve this result. It is highly likely that replication across AP sites with a low fidelity 
polymerase is the major mechanism. Supporting this theory is that mice deficient for 
Rev1 DNA polymerase, a translesion synthase that adds dC opposite AP sites, have an 
almost complete loss of C:G to G:C transversions, while the frequencies of C:G to A:T 
transversions are unaffected (Jansen et al., 2006; Maul & Gearhart, 2010b). B cells 
double-deficient for Rev1 and the translesion polymerase Pol η, which can 
accommodate several DNA lesions in its active site (Parijs et al., 1999), or double-
deficient for REV1 and MSH2 have almost no Ig C:G to G:C transversions at all, but 
again C:G to A:T transversions are unaffected (Kano et al., 2012; Krijger et al., 2013). 
Thus, REV1 and Pol K activity downstream of UNG2 and MutSD, respectively, are 
responsible for C/G to G/C transversions, but the source of C:G to A:T transversions 
remains unknown. It is also unknown when in the cell cycle bypass of AP sites by REV1, 
Pol K or other translesion polymerases might occur. It was proposed that lesion bypass 
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occurs in S-phase, when unrepaired AP sites persist from G1-phase (Sharbeen et al., 
2012), but this is far from certain.
The mismatch repair pathway introduces mutations at A and T bases 
through recruitment of DNA polymerase η 
In conventional post-replicative mismatch repair (MMR), which occurs in S-phase 
(Hombauer et al., 2011), the MutSα protein (a heterodimer  of MSH2 and MSH6) binds 
to single base mismatches, most of which have been produced by occasional mis-
incorporation during replication fork progression. Activation of MutSD by mismatches 
leads to MutSD translocation and recruitment by MutSD of MutLα (a heterodimer of 
PMS2 and MLH1). The DNA is then nicked distal to the mismatch site by PMS2. 
Exonuclease 1 (Exo1) binds MSH2 and MLH1 and creates an excision patch greater 
than 100bp long starting from the nicked site; DNA Polymerase δ (one of the two DNA 
polymerases used for conventional high-fidelity replication) then fills in the excision 
patch. This process repeats until the mismatch driving MutSα activation is repaired 
(Jiricny, 2013). AID-induced MMR, on the other hand is distinct from this pathway, 
because it is highly mutagenic and because it involves factors that are not involved in 
canonical post-replicative MMR (see below). 
 
Low fidelity MMR is the main contributor of mutations at A and T bases. More 
specifically, deficiency in MSH2, MSH6 or Exo1 is associated with an 80-95% loss of Ig 
mutations at A and T bases. A complete loss in mutations at A and T bases, however, 
is observed in UNG/Msh2 and UNG/Msh6 double-deficient GC B cells and, therefore, 
UNG2 is able to generate some mutations at A:T independent of MSH2, perhaps via 
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error-prone long patch BER (Krijger et al., 2009; Rada et al., 2004; Shen et al., 2008). 
A deficiency in UNG2 alone is associated with a modest and insignificant reduction of 
mutations at A:T bases (Rada et al., 2002).  
 
While B cells deficient in PMS2 and MLH1 display unchanged mutation frequencies 
(Maul & Gearhart, 2010b), a deficiency in both UNG and PMS2 leads to a 50% 
reduction in mutations at A:T bases. Reduction in mutation at A:T bases is also seen in 
a Ungko/ko background with additional deficiencies in other enzymes with uracil-DNA 
glycosylase activity; these are TDG and SMUG1 (Girelli Zubani et al., 2017). Double-
deficiency for the BER factors APE1 and APE2 also impacts A:T mutation significantly 
(Stavnezer & Schrader, 2014). Overall, the data suggest that uracil BER and MutLD 
create nicks from deamination sites redundantly, to then allow DNA entry by Exo1 
during AID-induced MMR (Girelli Zubani et al., 2017). 
 
The mutagenic phase of AID-induced MMR has been associated with polymerase η, 
the same translesional DNA polymerase (TLS) responsible for C:G to G:C transversions 
downstream of MMR. Pol K can bypass DNA lesions at replication fork stall sites; TLS 
are also error-prone (Weill & Reynaud, 2008). In-vitro, MSH2 was shown to bind to 
polymerase η and the MSH2-MSH6 heteroduplex stimulated the catalytic activity of 
polymerase η (Wilson et al., 2005). In humans with xeroderma pigmentosum variant 
(XPV), a condition with defective polymerase η, analysis of DNA from lymphocytes 
showed reduced mutation at A and T bases (Masuda et al., 2008; Mayorov et al., 2005; 
Yavuz et al., 2002; Zeng et al., 2004). There was also an increase in mutations at C 
bases, especially transversions (Zeng et al., 2004). In mice, inactivation of POLH (the 
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gene for polymerase η) also leads to decreased mutation at A and T bases (Delbos et 
al., 2005; Weill & Reynaud, 2008), and an increase in transition mutations at C and G 
bases (Weill & Reynaud, 2008). In the absence of polymerase η, it appears that 
polymerase κ contributes to residual mutations at A and T bases. Mice deficient for 
both polymerase η and polymerase κ show a further reduced mutation frequency at 
A and T bases compared to polymerase η deficiency alone (Faili et al., 2009).  
 
Interestingly, studies using MSH2, polymerase η and combined MSH2 and polymerase 
η deficient mice showed that mutations at A and T bases as a percentage of total 
mutations in mouse Ig somatic hypermutation to be 10, 16 and 1% respectively 
(Delbos et al., 2007). This reinforced the theory that polymerase κ contributes to 
residual mutations in the absence of polymerase η, but also that mutations at A and T 
bases due to polymerase η are not entirely downstream of MSH2; some are 
presumably downstream of UNG2 and are introduced during long-patch BER (Delbos 
et al., 2007). 
 
Of the other TLSs, it is uncertain if polymerase θ contributes to somatic hypermutation 
downstream of MMR (Masuda et al., 2007; Masuda et al., 2006). It does not appear 
that polymerase ι contributes to mutations downstream of MMR (Weill & Reynaud, 
2008). 
Mechanisms for polymerase eta recruitment 
Proliferating cell nuclear antigen (PCNA) is a homo-trimeric sliding clamp that tethers 
DNA polymerases to the DNA template during replication (Weill & Reynaud, 2008). 
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Ubiquitination of PCNA occurs during replication fork stall, which recruits TLS 
polymerases (Weill & Reynaud, 2008). Specifically, monoubiquitination at lysine 164 
is responsible for recruitment of polymerase η (Hoege et al., 2002). It has been shown 
that after UV damage, PCNA becomes ubiquitinated, and it is the monoubiquitinated 
form of PCNA that interacts with polymerase η (Kannouche et al., 2004). Studies in 
mice revealed that B cells with PCNA resistant to ubiquitination at lysine 164 showed 
a large reduction of mutations at A and T bases in Ig genes (Roa et al., 2008). In G1-
phase human B cells, PCNA ubiquitination is dependent on MMR; furthermore PCNA 
ubiquitination recruits polymerase K (Pena-Diaz et al., 2012). 
Class Switch Recombination requires double strand break formation 
Class switch recombination is an event that recombines double strand DNA breaks 
between the donor µ switch region (Sµ) and a downstream acceptor switch region. 
This process begins with cytosine deamination by AID. Further processing by BER 
alone, or together with MMR produces the vast majority of double strand breaks. Ung-
knockout (producing uracil-BER deficiency) results in a 95-99% reduction in CSR 
(Stavnezer & Schrader, 2014). Another uracil DNA glycosylase: SMUG1, is able to 
partially substitute for UNG in CSR when over-expressed (Di Noia et al., 2006), and 
Smug1-knockout five-fold further reduced CSR in UNG deficient mice from its already 
very low base. No effect on CSR was seen in Smug1-knockout, UNG competent mice, 
however (Dingler et al., 2014). Msh2ko/ko cells switch at a rate of 15-50% of wild type 
cells and, in general, deficiencies in MMR factors including MSH2, MSH6, MLH1, PMS2 
and EXO1 have reduced CSR by two to seven-fold. A combination of UNG and MSH2 
deficiency ablates CSR (Stavnezer & Schrader, 2006).  
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A simple model for DSB generation in CSR has emerged. Most deamination sites are 
detected by UNG and are converted into AP sites in G1-phase (Sharbeen et al., 2012). 
APE1 and/or APE2 then cuts at these AP sites, creating ssDNA nicks (Stavnezer & 
Schrader, 2014). When two ssDNA nicks occur in close proximity on opposite strands, 
this creates a double strand break. When ssDNA nicks are too far apart to generate a 
double strand break, MMR can convert the single strand nicks to double strand breaks 
provided some U:G mismatches able to activate MutSD are left in place by UNG2 
(Schrader et al., 2007; Stavnezer & Schrader, 2014) (see Figure 1.7). 
 
Usually, BER is a highly active and error free pathway (Stavnezer & Schrader, 2014), 
however given the large numbers of deaminations at switch regions, it appears to be 
overwhelmed before repair can be completed (Stavnezer & Schrader, 2014). Indeed, 
germinal centre B cells express very low levels of APE1 compared to other cells 
(Stavnezer & Schrader, 2014). APE2 is a much less efficient endonuclease compared 
to APE1 with around 1000-fold lower activity that may impair efficient BER. Thus, APE2 
actvity may promote DSB formation by reducing faithful BER of uracils. 
Non-homologous end joining recombines S region double strand breaks 
Two major DSB repair pathways have been elucidated: homologous recombination 
(HR) and non-homologous end joining (NHEJ) (Davis & Chen, 2013). NHEJ is the DSB 
repair pathway that leads to CSR.  
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In NHEJ, after DSB formation, the Ku heterodimer (composed of Ku70 and Ku86) binds 
to both DNA ends flanking the DSB. Ku can also interact with various DNA fragments 
that contain nicks (Yang et al., 2016). Ku serves as a scaffold to bind other NHEJ factors; 
after binding to DNA sequences, the conformation of Ku is modified. Ku is then able 
to bind other NHEJ factors. DNA-dependent protein kinase catalytic subunit (DNA-
PKcs) binds to the Ku heterodimer and forms the DNA-PK complex (Chang et al., 2017). 
The binding of DNA-PKcs is assisted by scaffolding of Ku and DNA-PKcs by the long 
noncoding RNA LINP1 (Y. Zhang et al., 2016). DNA-PKcs is thought to function to co-
ordinate processing and ligation of DSBs (Yang et al., 2016). 
 
Processing of ends are required if they are incompatible; this is to achieve short 
regions of microhomology (less than four nucleotides) for end recombination (Chang 
et al., 2017). DNA-PKcs recruits Artemis, which has intrinsic 5’ exonuclease activity, and 
when in complex with DNA-PKcs, has endonuclease activity on both 5’ and 3’ 
overhangs (Chang et al., 2017).  Artemis also functions to bridge DNA ligases to the 
DSBs. The Ku-DNA complex also recruits polymerases µ and λ. Pol µ adds nucleotides 
in a template independent manner at 3’ incompatible overhangs to achieve 
microhomology, while Pol λ promotes ligation of terminally compatible overhangs 
that require fill-in activity (Chang et al., 2017).  
 
Proteins belonging to the XRCC4-like family include XRCC4 and XLF. These proteins 
function to co-stabilise DSB ends to enable bridging and ligation. Ligation is then 
performed by the XRCC4-XLF-Lig4 complex (Yang et al., 2016).  
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The effect of cell cycle on Class Switch Recombination 
AID dependent DSBs are predominantly detected in the G1-phase of the cell cycle. 
This was found in-vitro by activating mouse splenic B cells with lipopolysaccharide and 
IL-4 and then sorting for G1-phase vs S/G2/M-phase fractions (Schrader et al., 2007). 
This showed that AID-dependent DSBs were more abundant in the G1-phase fraction. 
Independent experiments showed that AID activity is restricted to early G1-phase 
(Wang et al., 2017); AID (as an AID-EGFP fusion protein) was transiently localised in 
the nucleus from prometaphase until early G1-phase. AID deamination of the S region 
was also seen to be restricted to early G1-phase. Supporting this, experiments that 
enforced nuclear localization of AID to G1-phase accelerated CSR and somatic 
hypermutation, while enforced nuclear localization of AID to S/G2/M compromised 
cell viability (Le & Maizels, 2015).  
 
It is also G1-phase UNG that leads to DSB formation during CSR (Sharbeen et al., 2012).  
Although the cell cycle phase of MMR involved in CSR is not known, mouse B cells with 
PCNA-K164 mutation (which makes PCNA resistant to ubiquitination) displayed a 
decrease in CSR as well as a reduction in mutation at A:T, with a reduction in switching 
to IgG3 by 50% and IgG1 by 25% (Roa et al., 2008).  
 
The ligation step in CSR occurs in S-phase. It was shown that activation of DNA 
replication origins in the Igh locus is required for CSR (Wiedemann et al., 2016).  
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Current unresolved questions 
It is clear that AID hotspots exist because AID more often targets C in WRCY motifs 
than outside these motifs. Interestingly, MMR deficiency increases focusing of 
mutation in AID hotspots in mice with normal levels of UNG (Bardwell et al., 2004; 
Frey et al., 1998; Jacobs et al., 1998; Li et al., 2006; Phung et al., 1998; Rada et al., 
1998; Wiesendanger et al., 2000). We do not know why this occurs but possible 
explanations include MMR-induced AID targeting (Li et al., 2006), or that C 
deaminations at AID hotspots are resistant to UNG processing compared to non-
hotspot C deaminations (Delbos et al., 2007). 
 
As previously stated, AID-induced MMR processing leads to mutation at A:T and 
involves mono-ubiquitination of PCNA and recruitment of polymerase η. We do not 
know why PCNA becomes mono-ubiquitinated, however, given that G1-phase MMR 
leads to PCNA mono-ubiquitination, then differences in cellular environments during 
G1 versus post G1-phase, such as dNTP pools may be responsible. We previously 
hypothesised that dNTP paucity in G1 is the cause of polymerase G stalling and 
recruitment of polymerase K during AID-induced MMR (Sharbeen et al., 2010). 
dNTP concentrations vary across the cell cycle 
An optimal concentration of dNTPs is crucial for the fidelity of DNA synthesis during 
replication and repair (Rampazzo et al., 2010), but the supply of dNTPs is not constant 
through the cell cycle. Uncontrolled and high dNTP concentrations are known to be 
mutagenic for genome replication (Stillman, 2013). A limited pool of dNTPs also limits 
viral reverse transcription (Lahouassa et al., 2012). dNTP production and turnover are 
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regulated to increase dNTP levels in cycling cells and restrict levels in non-cycling cells 
(Ayinde et al., 2012). In S-phase, when replication of DNA occurs, dNTP pools are in 
the range of 10-100pmol for each dNTP per 106 cells, while in G0/G1-phase, dNTPs are 
about 10-fold lower (Rampazzo et al., 2010) (see Figure 1.8). 
dNTP pools are determined by ribonucleotide reductase and 
SAMHD1 
dNTP synthesis occurs via de-novo synthesis and salvage pathways. The de-novo 
pathway is responsible for the bulk of dNTP synthesis and is regulated by the activity 
of ribonucleotide reductase (RNR) (Nordlund & Reichard, 2006). RNR is a 
heterotetramer containing two copies of a large subunit, R1 and two small subunits, 
R2 or p53R2. While R1 is abundant through the cell cycle, R2 is restricted to S-phase. 
This restriction to S-phase translates to the much higher levels of dNTPs during S-
phase. p53R2 is much less abundant than R2 but is expressed throughout the cell cycle 
to allow for mitochondrial DNA synthesis (Rampazzo et al., 2010). p53R2 is also 
transcriptionally activated by p53 after DNA damage, and is required for optimal dNTP 
pools for DNA repair in quiescent cells (Pontarin et al., 2012). RNR is recruited to sites 
of DNA damage via interaction of the R1 subunit with the histone acetyl transferase 
TiP60. This interaction is essential for G1-phase DSB repair, but is redundant in S-phase 
cells (Niida et al., 2010), and presumably overcomes local dNTP deficiency to enable 
G1-phase DNA synthesis during DSB end-processing. 
 
The salvage pathway is dependent of the activity of thymidine kinase 1 and 
deoxycytidine kinase (Kunos et al., 2011). These enzymes phosphorylate 
 35 
deoxyribonucleosides to produce deoxyribonucleoside monophosphates. Like 
ribonucleotide reductase, thymidine kinase 1 is restricted to S-phase (Kunos et al., 
2011). Deoxycytidine kinase is constitutively expressed through the cell cycle (Kunos 
et al., 2011). 
SAMHD1 is a cellular enzyme with deoxynucleoside triphosphate 
triphosphohydrolase (dNTPase) activity 
On top of the regulation of dNTP pools by RNR and thymidine kinase 1, sterile alpha 
motif domain and histidine-aspartic domain containing protein 1 (SAMHD1) also 
contributes to the lower dNTP pools in G0/G1-phase. SAMHD1 was initially identified 
in 2000 as a novel cDNA expressed in human peripheral blood monocyte derived 
macrophages and was designated as dendritic cell-derived IFN- γ (DCIP) (Li et al., 
2000) . However, its function was not identified until 2009, when mutations in the 
gene were found in patients with Aicardi-Goutières syndrome (Rice et al., 2009).  
 
SAMHD1 is a metal dependent deoxynucleotide-triphosphohydrolase (dNTPase) 
which degrades dNTPs to deoxynucleosides and triphosphate products (Powell et al., 
2011). In-vitro studies show the recombinant human and mouse enzymes to cleave all 
dNTPs: dGTP, dATP, dTTP and dCTP (Goldstone et al., 2011; Powell et al., 2011). 
Studies in THP-1 human monocytic cell lines showed that shRNA-mediated 
knockdown of SAMHD1 led to increased dNTP levels (Amie et al., 2013b; Lahouassa et 
al., 2012). Knockdown of SAMHD1 by siRNA also showed increased dNTP levels 
compared to controls in lung and skin fibroblasts. Samhd1 knockout mice (produced 
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by gene-trapping in embryonic stem cells) have 40-fold elevated dNTP levels 
(Behrendt et al., 2013). 
 
SAMHD1 is a protein of 626 amino acids in human and 658 amino acids in mice.  
In-vitro studies on SAMHD1 mutants reveal residues 110-599 are responsible for 
dNTPase activity and these correspond to the HD1-like domain (Goldstone et al., 2011; 
Powell et al., 2011; Sze et al., 2013; White et al., 2013a). The HD1-like domain is 
sufficient to achieve dNTPase activity without the rest of the protein (Goldstone et al., 
2011). This structure of SAMHD1 is a predicted phosphohydrolase HD (His---His-Asp--
-Asp) domain (Powell et al., 2011; Rice et al., 2009) with conserved doublet of histidine 
and aspartate (Franzolin et al., 2013). Similar enzymes that share the conserved 
doublets exist in Escherichia coli, which hydrolyses dGTP to deoxyguanosine and 
triphosphate, Enterococcus faecalis which hydrolyses all canonical dNTPs and also in 
Thermus thermophilus, which is also able to hydrolyse all canonical dNTPs (Franzolin 
et al., 2013).  
 
Initial studies showed that SAMHD1 dNTPase activity is activated in the presence of 
dGTP. SAMHD1 is able to hydrolyse dGTP alone. However, to hydrolyse dATP, dUTP, 
dTTP and dCTP, dGTP has to be present as well (Goldstone et al., 2011). dNTPase 
activity was found to be twenty-fold higher in the presence of dGTP (Powell et al., 
2011). Further studies have shown that GTP is also able to activate dNTPase activity, 
and rather than dGTP, is the likely activator of SAMHD1, as GTP levels are 1000-fold 
higher than dGTP levels (Amie et al., 2013a).  
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It is likely that SAMHD1 is regulated by GTP/dGTP binding to an allosteric site. 
Comparison of SAMHD1 protein to the related HD proteins from Enterococcus faecalis 
and Aquifex aeolicus suggested allosteric activation of the enzyme by dGTP. 
Examination of the HD domain and residues that interact with guanosine show that 
Asp 137, Gln 142 and Arg 145 recognize the activating guanosine edge, with identical 
hydrogen bonding with Watson-Crick and Hoogsteen (N7) sites of the guanine base 
(Koharudin et al., 2014). Base substitutions at Arg 145 and Asp 137 abolish dNTPase 
activity (Goldstone et al., 2011). Base substitution at Gln 142 reduces the dNTPase 
activity five-fold.  
 
Examination of the catalytic site shows binding of dNTPs via the triphosphates with a 
metal ion, coordinated through two histidine residues and two aspartate residues 
(Ahn, 2016). H167, H206, D207 and D311 coordinate the metal ion binding in the 
active site and R164, H233, K321 and Y315 form hydrogen bonds with the 
triphosphate (Arnold et al., 2015). 
 
Subsequent research has elicited the crystal structure of SAMHD1 as a tetramer in its 
active state, while usually existing in a monomer and dimer form in a non-active state. 
In the presence of dGTP/GTP binding to the activator site (A1), monomers and dimers 
assemble into the tetramer form. Subsequent formation of the tetramer form induces 
a conformational change in the dNTP binding pocket (A2) to yield the catalytically 
active enzyme that can bind all dNTPs (Ji et al., 2013; Koharudin et al., 2014). Out of 
all dNTPs binding to the A2 site, dATP is the most potent cofactor for inducing 
SAMHD1 tetramerisation (Ballana & Este, 2015) (see Figure 1.9 (Seamon et al., 2014)). 
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Further in-vitro studies have found that when the activator site, A1, was bound by GTP 
and the catalytic site, A2, bound by dNTP, this led to a long lived activated state that 
remained even after dNTP levels were depleted (Hansen et al., 2014). To summarise, 
SAMHD1 is a tetramer in its active state, and this is controlled by levels of GTP and 
dNTPs. However once in tetramer form, SAMHD1 remains in a long lived active state 
despite dNTP depletion and is still active, even when there is a very low level of dNTPs 
later on.  
 
The rest of the SAMHD1 protein consists of the following features: 
• An N-terminus extended loop with nuclear localization signal (amino acids 1-
39); in humans this corresponds to residues 11KRPR14(Brandariz-Nunez et al., 
2012). Mutagenesis of these residues change SAMHD1’s nuclear distribution 
to the cytoplasm (Wu, 2013a). Patients with SAMHD1 nuclear localization 
signal mutations have a cytosolic distribution of SAMHD1 (Goncalves et al., 
2012). 
• Putative protein-protein interaction sterile motif (SAM) domain (amino acids 
40-109) consisting of four alpha helices (Powell et al., 2011). SAMs are 65–70 
residues in length and can serve as protein-interaction modules mediating 
interactions with other SAM domain and non-SAM domain–containing 
proteins. In SAMHD1, however, a function of the SAM domain has not been 
yet elucidated (Rice et al., 2009). The SAM domain may possibly contribute to 
binding of ssDNA and ssRNA (Beloglazova et al., 2013). 
• C terminus tetramerisation site (amino acids 600-626). Tetramerisation relies 
on interactions at these residues (Ahn, 2016). Deletion of the C-terminal region 
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of SAMHD1 prevents tetramerisation and ablates HIV restriction activity 
(Arnold et al., 2015). 
Regulation of SAMHD1 deoxynucleotide-triphosphohydrolase activity 
SAMHD1 levels have been shown to remain unchanged throughout the cell cycle in 
primary T lymphocytes and the monocyte cell line THP-1 (Yan et al., 2015). Initial 
reports showed that the T592 residue was phosphorylated in cycling THP-1 cells and 
in U937 cells transduced to express SAMHD1-FLAG (U937 cells do not express 
SAMHD1), but not in resting cells (White et al., 2013b). Initial in-vivo and in-vitro 
experiments however showed that T592 phosphomimetic mutants still had dNTPase 
activity, and that dNTP levels were comparable (White et al., 2013b). These early in-
vitro assays, however, provided a level of dNTPs far in excess of intracellular levels.  
 
Subsequent experiments showed, via size exclusion chromatography and multi-angle 
light scattering (SEC-MALLS), that T592 phosphorylated SAMHD1 (pSAMHD1) 
inhibited stable tetramer formation. This leads to disordered protein formation and 
loss of tetramer stabilizing interactions (Arnold et al., 2015). Experiments showed that 
SAMHD1 was able to hydrolyse dNTPs at much lower concentrations compared to 
T592 phosphorylated SAMHD1. This suggested that phosphorylation impaired 
SAMHD1 tetramerisation in a long lived active state. 
 
It has been shown that T592 phosphorylated SAMHD1 was detectable by western blot 
in extracts from S/G2/M-phase but not G1-phase cells (Yan et al., 2015). In-vitro 
experiments with recombinant proteins demonstrated T592 phosphorylation by 
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Cyclin A2/CDK1 (Pauls et al., 2014b). Cyclin A2/CDK1 associates with the c-terminus of 
SAMHD1 and phosphorylates it at T592 (Cribier et al., 2013; St Gelais et al., 2014; Yan 
et al., 2015). When the cyclin A2/CDK binding site in the c-terminus was abolished, 
SAMHD1 was not phosphorylated at T592 (Yan et al., 2015). As Cyclin A2 is synthesized 
at the onset of S-phase, this suggests that the in-vivo phosphorylation of SAMHD1 
occurs at entry into S-phase. Studies reveal the equivalent phosphorylation site to be 
T603 in mice (Wittmann et al., 2015). Similar to human SAMHD1, activity in mice is 
regulated by T603 phosphorylation.  Given that SAMHD1 activity is regulated to G1-
phase cells, while RNR is regulated to post-G1-phase, SAMHD1 activity has a greater 
effect on dNTP pools in G1. 
 
CDK2 and p21 have also been shown to be regulators of SAMHD1 phosphorylation, 
with CDK2 expression triggering S-phase (Pauls et al., 2014c), while CDK6 is an 
upstream regulator of CDK2 (Pauls et al., 2014a; Pauls et al., 2014b). siRNA mediated 
knockdown of CDK2 and CDK6 were shown to decrease SAMHD1 phosphorylation 
(Pauls et al., 2014b). Pan-CDK inhibitors have been shown to decrease dNTP 
concentrations in monocyte-derived macrophages (Pauls et al., 2014b).  
SAMHD1 has nuclease activity in addition to dNTPase activity 
SAMHD1 can bind to single stranded nucleic acids. Using fluorescence cross 
correlation spectroscopy, SAMHD1 was shown to interact with ssDNA and ssRNA 
(Tungler et al., 2013). Also, incubating immobilized nucleic acids with cell extracts also 
showed that SAMHD1 binds these substances (Goncalves et al., 2012). It was noted 
also that while tetrameric SAMHD1 is a dNTPase, monomeric SAMHD1 binds ssRNA 
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(Seamon et al., 2015), while other data suggests the phosphomimetic mutant of 
SAMHD1 T592E has decreased RNAse activity (Koharudin et al., 2014). 
 
Studies showed in-vitro 3’ -> 5’ exonuclease activity against ssDNA, ssRNA and RNA in 
DNA/RNA duplexes using full length recombinant SAMHD1 and 32P-ssRNA and ssRNA 
as substrates with the addition of magnesium (Beloglazova et al., 2013). Other studies 
confirm the degradation of ssRNAs, however without activity on ssDNA or RNA in 
RNA:DNA hybrids (Ryoo et al., 2014). 
SAMHD1 is an HIV restriction factor 
SAMHD1 was found to be an HIV restriction factor while looking for a binding partner 
to the HIV-2 accessory protein Vpx (Laguette et al., 2011). Vpx was initially discovered 
in 1989 as an open reading frame in HIV-2 and SIV, which was not present in HIV-1. 
This accessory protein was dispensable when infecting lymphocyte cell lines, as Vpx 
mutants were still infectious. These viruses, however, had a severe defect of infectivity 
in peripheral blood lymphocytes, macrophages and dendritic cells (Goujon et al., 
2007; Guyader et al., 1989; Yu et al., 1991). Vpx, which is not usually expressed in HIV-
1, was also found to enhance HIV-1 infection in dendritic and myeloid cells (Goujon et 
al., 2007). Vpx was later found to load human SAMHD1 (but not mouse SAMHD1) onto 
CRL4DCAF1 E3 ubiquitin ligase (Ahn et al., 2012; Hrecka et al., 2011), leading to highly 
efficient proteasome-dependent degradation of SAMHD1. 
 
It was also found that SAMHD1 was expressed in cells resistant to HIV-1 infection, 
which included THP-1 cells, primary monocytes, monocyte derived macrophages, 
 42 
dendritic cells and resting CD4+ T cells. Active CD4+ T cells and U937 cells, which are 
susceptible to HIV-1, did not express SAMHD1 (St Gelais & Wu, 2011). Subsequent 
experiments showed that SAMHD1 knockdown by shRNAs in THP-1 cell lines and 
resting CD4+ T cells significantly increased susceptibility HIV-1 infection. SAMHD1 was 
subsequently labelled as an HIV-1 restriction factor (Baldauf et al., 2012; Laguette et 
al., 2011). 
 
Multiple HIV restriction factors exist in addition to SAMHD1, and include 
apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G), 
which is related to AID, Tripatite Motif 5 alpha (TRIM5a) and BST-2/Tetherin (Cribier 
et al., 2013; St Gelais & Wu, 2011). These cellular factors “mediate a cell intrinsic 
resistance that arrest the viral life cycle at a specific step”. The following table 
demonstrates the characteristics of various HIV-1 restriction factors (Sze et al., 2013): 
 
Restriction factor Function Retroviral countermeasure 
APOBEC-3G Deaminates cytidine to uracil, leading to G-to-A 
hypermutations 
HIV-1: Vif HTVL-1: nuclear capsid 
TRIM5α Targets retroviral capsids for proteasomal 
degradation 
Capsid proteins cannot be bound by 
human TRIM5α 
Tetherin  Cross-links new HIV-1 particles to the cell surface, 
preventing release 
HIV-1: Vpu HTLV-1: cell-to-cell 
transmission strategy 
SAMHD1 Hydrolyzes host dNTPs that are required for 
reverse transcription 
HIV-2: Vpx 
Table 1.1: Known HIV restriction factors, function in HIV restriction and retroviral 
countermeasures. 
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 The defining characteristics of a restriction factor are the following (Ballana & Este, 
2015): 
1. A restriction factor must directly and dominantly cause a significant decrease 
in virus infectivity. 
2. If a restriction factor is a true threat to viral replication, then the predecessors 
of HIV invariably evolved an equally potent counter-restriction mechanism 
that still exists in the present-day virus. 
3. Because the interactions between restriction and counter-restriction factors 
occur through direct protein-protein interactions, the restriction factor often 
shows signatures of rapid evolution. 
4. The expression of each restriction factor is often hard wired to the innate 
immune response.  
 
SAMHD1 fulfills all these requirements. 
 
As stated previously, the resistance mechanism of Vpx is to load SAMHD1 onto 
CRL4DCAF1 E3 ubiquitin ligase (Ahn et al., 2012; Hrecka et al., 2011), and this leads to 
highly efficient proteasome-dependent degradation. This mechanism of ubiquitin 
ligase recruitment is similar to other non-structural accessory proteins. Vif promotes 
degradation of APOBEC3G by interacting with E3 ubiquitin ligase complex consisting 
of cullin 5, elongin B and elongin C. Vpu and Nef degrade Tetherin by recruiting 
another ubiquitin ligase, the SKP-cullin 1-βTRCP complex (Ayinde et al., 2012). 
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SAMHD1 has been shown to restrict multiple retroviruses, not just HIV-1 in non-
cycling cells. Alpha, beta and gamma retroviruses are also restricted by SAMHD1 in 
myeloid cells (Gramberg et al., 2013), as is Hepatitis B virus in hepatocytes (Chen et 
al., 2014), Herpes Simplex virus 1 in macrophages (Kim et al., 2013) and vaccinia 
(Hollenbaugh et al., 2013). 
Mutations in SAMHD1 are responsible for AGS5, a subset of Aicardi 
Goutières syndrome. 
Aicardi Goutières syndrome (AGS) is a rare disease with the clinical manifestations of 
congenital encephalopathy, which leads to severe intellectual disability and motor 
deficits including tetraplegia, pyramidal and extrapyramidal signs, abnormal eye 
movements, nystagmus and poor visual performance (Crow, 1993; Orcesi et al., 2009). 
AGS also manifests with clinical signs consistent with systemic lupus erythematosus 
(SLE), including recurrent fevers, inflammatory arthropathy and chilblains (Kretschmer 
et al., 2015; Ramesh et al., 2010). Mutations in multiple genes have been found in 
AGS, including SAMHD1. Patients with SAMHD1 mutation also manifest with cerebral 
arteriopathy on top AGS manifestations, and present with both cerebral vascular 
occlusion and haemorrhage and also peripheral vascular disease. As expected, resting 
CD4+ T cells from AGS patients are permissive to HIV-1 infection (Berger et al., 2011). 
 
AGS patients have increased IFN-D levels regardless of the mutation conferring AGS 
(Dussaix et al., 1985; Goldstone et al., 2011). The manifestations of AGS mimic 
congenital viral infection and also SLE (Rice et al., 2009) as these diseases all display 
increased production of interferon alpha (IFN-D) (Dussaix et al., 1985). In viral 
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infection, IFN-D is produced to elicit antiviral activity from target cells and induce 
apoptosis in virus-infected cells (Taniguchi & Takaoka, 2002). This involves nucleic 
acid-binding PRR including toll-like receptors, RNA and DNA receptors (Crow & Manel, 
2015). In SLE, IFN-D production is also characteristic of the disease (Niewold et al., 
2010). Double stranded DNA, RNA and DNA/RNA hybrids are the primary autoimmune 
targets in SLE and activate PRR. This induces production of IFN-D, which activates the 
adaptive immune system by promoting dendritic cell activation of T cells, and also 
enhances proliferation of primary B cells. 
 
AGS is associated with autosomal recessive mutations in nuclease genes including 
TREX1 and RNASEH2. Mutations in these genes lead to failure to clear nucleic acid 
debris and subsequent activation of the innate immune system (Rice et al., 2009).  
 
This table summarizes the known mutations associated with AGS (Crow & Rehwinkel, 
2009; Leshinsky-Silver et al., 2011): 
AGS variant Gene Locus Proportion  of AGS  Protein Function 
AGS1 TREX1/DNaseIII 3p21 35 3’ -> 5’ exonuclease 
AGS2 RNASEH2B 13q14 45 Cleaves RNA of RNA/DNA hybrids 
AGS3 RNASEH2C 11q13 15 Cleaves RNA of RNA/DNA hybrids 
AGS4 RNASEH2A 19p13 <5 Cleaves RNA of RNA/DNA hybrids 
AGS5 SAMHD1 20q11 10 dNTPase/single stranded ribonuclease 
Table 1.2: Aicardi Goutières Syndrome variants, genetic aetiology and protein function. 
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The role of SAMHD1 in malignancy 
The most substantial research in the role of SAMHD1 in malignancy has been in 
chronic lymphocytic leukaemia (CLL). SAMHD1 mutation frequency was found to be 
5% of CLL patients (Clifford et al., 2014). A higher proportion of patients with 
relapsed/refractory CLL have SAMHD1 mutations (11% vs 3%). Other cancers 
implicated with SAMHD1 mutation include pancreatic, lung, glioblastoma multiforme, 
breast and colorectal cancers (Kohnken et al., 2015). 
 
One study showed that SAMHD1 deficiency causes genomic instability in fibroblasts 
of patients with AGS (Kretschmer et al., 2015), with increased comet tail length in the 
absence of exogenous genotoxic stress. It is now clear that SAMHD1 is involved in the 
DNA damage response, especially DNA double strand break repair (Clifford et al., 
2014). SAMHD1 has been found to reside in a high molecular weight complex in 
untreated cells and a low molecular weight complex after treatment with etoposide. 
SAMHD1 also co-localises with 53BP1 foci in camptothecin treated and untreated 
cells. CtIP is an endonuclease which processes the 5’ ends of DSBs during the initial 
stages of HR. Independent experiments showed that SAMHD1 complexes with CtIP to 
facilitate HR (Daddacha et al., 2017).  
SAMHD1 in mouse 
Phenotypically, SAMHD1 knockout mice (produced by gene-trapping in embryonic 
stem cells) are fertile, have no macroscopic abnormalities and were also healthy 
beyond the age of 96 weeks. Their cells have 40-fold elevated dNTP levels (Behrendt 
et al., 2013). 
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Compared to human, murine SAMHD1 has some similarities and differences. 
Similarities in human and mouse SAMHD1 include (Behrendt et al., 2013; Rehwinkel 
et al., 2013): 
1. Murine SAMHD1 also restricts HIV replication in-vitro, however SAMHD1 
competent mouse cells have a higher concentration of dNTPs than human 
cells. dNTP concentrations in mice are higher than the KM of HIV reverse 
transcriptase, and so in-vivo HIV restriction is not present in wild type mice, 
except for HIV mutants with reverse transcriptase that has a lower affinity for 
dNTPs. 
2. SAMHD1 knockout mice also have activation of IFN-D. 
3. SAMHD1 knockout mice also have elevated dNTP concentrations in bone 
marrow derived dendritic cells and macrophages, splenic B and T cells and 
mouse embryonic fibroblasts (Behrendt et al., 2013; Wu, 2013b).  
Differences in human and mouse SAMHD1 include: 
1. Vpx does not lead to murine SAMHD1 degradation (Lahouassa et al., 2012). 
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Aims: 
The first aim of this research project is to understand why a deficiency in MMR leads 
to an increase in focusing of mutation in AID hotspots. 
 
Specifically, this involves: 
1. Generation of large mutation datasets using the SWHEL adoptive transfer model 
(Sharbeen et al., 2010; Sharbeen et al., 2012) in the following groups:  
i. SWHEL B cells. 
ii. SWHEL B cells deficient for UNG2 via retroviral expression of the uracil 
glycosylase inhibitor (ugi). 
iii. SWHEL B cells deficient for MutSα by crossing Msh2ko alleles into SWHEL 
mice. 
iv. SWHEL B cells deficient for both UNG2 and MutSα. 
2. Analysis of the mutation spectrum by sequence context by comparing the  
above groups. 
  
Hypothesis: 
Downstream processing of AID-induced deamination by UNG2 BER along the Ig gene 
is dependent on sequence context of surrounding bases. 
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The second aim of this research project is to determine the effect of increasing dNTP 
pools on somatic hypermutation by knockdown and knockout of Samhd1, in 
combination with retroviral manipulation of R2 levels.  
 
Specifically, this involves: 
Samhd1 knockdown by retroviral expression of shRNAs against Samhd1 and 
measurement of effect on somatic hypermutation: 
1. Development of shRNA to inhibit Samhd1 expression.  
2. Creation of retroviral reagents containing these sequences. 
3. Determination of efficacy of knock-down of each shRNA by western blot 
analysis of transduced mouse fibroblast cell line 3T3 cells. 
4. Measurement of the effects of Samhd1 knockdown on somatic hypermutation 
by the SWHEL adoptive transfer model. 
5. Analysis of the mutation spectrum compared to controls. 
Creation of homozygous Samhd1 knockout mice and measurement of the effect on 
somatic hypermutation (CRISPR/Cas9 frameshift deletions in Samhd1 were created by 
Robert Brink, Garvan Institute, Sydney): 
1. Breeding of founder mice to achieve homozygous Samhd1 frameshift deleted 
mice. 
2. Measurement of the expression of SAMHD1 in homozygous Samhd1 mutants 
by western blot. 
3. Measurement of effect on somatic hypermutation by adoptive transfer model. 
4. Analysis of mutation spectrum compared to controls. 
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Hypothesis: 
Polymerase K recruitment during somatic hypermutation is caused by nucleotide 
paucity during G1 cell cycle phase, due to stalling of DNA replication complexes during 
AID-induced MMR. 
Figure 1.1: Schematic representation of an antibody. Each antibody consists of !
two types of polypeptide chains: two identical heavy (H) chains (blue) and two !
identical light (L) chains (orange) linked together by disulfide bonds (SS). The !
heavy chain is composed of three to four constant domains (CH1-CH3) and one !
variable domain (VH). The light chain is composed of one constant domain (CL) and !
one variable domain (VL). The Fab consists of VL, CL, VH and CH1, while Fc consists !
of CH2 to CH4. Complementary determing regions (CDRs) are located within !
the V regions (from Loureiro et al. 2015).     
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Figure 1.2: Genomic structures of the antigen receptors of IgH and IgL  
loci in mice. Functional V, D, and J gene segments are flanked by non-coding  
recombination signal sequences (RSS). VH segments are 3’-flanked by RSS with  
23-bp spacers, while the DH segments are flanked at both the 3’ and 5’ ends  
by RSS with 12-bp spacers. Like the 3’ end of VH, the 5’ end of JH is also  
flanked by RSS with 23-bp spacers. Vκ segments are 3’-flanked by RSS  
with 12-bp spacers. Jκ are flanked at their 5’ ends by RSS with 23-bp  
spacers. Vλ segments are flanked by RSS with 23-bp spacers at their 3’ ends  
and Jλ are 5’-flanked by RSS with 12-bp spacers (from Jung et al. 2004).
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Figure 1.3:  Visual representation of the germinal centre in the lymph node. !
Following secondary activation by cognate T cells, B cells proliferate rapidly !
to form germinal centres (large circle). Germinal centres have two different zones. !
In the Dark zone, B cells undergo proliferation and somatic hypermutation, !
producing daughter clones with antibody variants that bind with different affinities. !
B cells migrate into the Light zone to undergo affinity selection, provided by !
survival signals from follicular dendritic cells (FDC) and T-folliculr helper cells !
(TFH) (from Heesters et al. 2014). 
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Figure 1.4: Structure of the mouse immunoglobulin heavy chain gene and Class  
Switch Recombination. In the germline, exons encoding IgM (Cµ) and IgD (C∂) occur 3’  
to the JH gene segments. Either Cµ or C∂ exons are spliced to the VDJH exon during 
transcription in naïve B cells, such that mature naïve B cells express both IgM and IgD. 
Downstream of C∂ are additional constant region exons which encode Fc distinct from 
IgM and IgD that are not used by naïve B cells. Located upstream (i.e. 5’) of every 
constant region gene lies a non-coding switch (S) region sequence. Class switch 
recombination is a process of deletional recombination between the Sµ switch region 
and a downstream S region, the example here is to IgG2b (from Stavnezer et al. 2014).
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Cytosine Uracil
H20 NH3
Figure 1.5: Diagram of the deamination of cytosine to uracil by Activation induced  
cytidine deaminase (AID).  
AID
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Figure 1.6: The Neuberger model of Somatic Hypermutation. Activation induced cytidine !
deaminase (AID) initiates somatic hypermutation by de-aminating genomic C residues to U. !
Without further processing, replication leads to transition mutations (Phase one A). !
Processing of U:G mismatches by the mismatch repair pathway (Msh2/Msh6) introduces !
mutations at surrounding A and T bases (Phase two). Processing of U:G mismatches by the !
base excision repair protein Uracil-DNA glycosylase (UNG2) can repair the initial C to U !
mutation but also introduces transversion mutations (Phase one B) (from Petersen-Mahrt !
et al. 2002). 56
Figure 1.7: The model of double strand break formation (DSB) in Class Switch !
Recombination. A) Mismatch repair independent (MMR) DSB formation occurs when !
Uracil-DNA glycosylase (UNG) converts Activation induced cytidine deaminase !
(AID) induced deaminations into apyrimidinic (AP) sites. AP endonuclease 1 and/or !
2 (APE) cut these AP sites 5', creating a single stranded DNA (ssDNA) nick. When !
two ssDNA nicks occur in close proximity on opposite strands, this creates a DSB. !
B) MMR dependent DSB formation occurs when ssDNA nicks are too far apart !
to generate a DSB. MMR can convert the ssDNA nick to a DSB, provided!
some U:G mismatches able to activate Msh2/Msh6 and Mlh1/Pms2 are left in place!
by UNG (from Stavnezer 2014). 57
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Figure 1.8: Diagram of the regulation of dNTP pools in different phases of the cell cycle.!
The synthesis of dNTPs is dependent on ribonucleotide reductase (RNR) while !
degradation is dependent on the dNTPas activity of SAMHD1. During S phase, RNR levels !
are high, while SAMHD1's dNTPase is inactive. In G1 phase, RNR is low, while SAMHD1's !
dNTPase is active. This leads to higher dNTP levels in S phase versus G1 phase.  !
!
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Figure 1.9: Diagram of SAMHD1 tetramer formation. SAMHD1's dNTPase is active !
in a tetramer state and inactive in a monomer or dimer state. dGTP/GTP (red) and !
dNTPS (blue) bind to activator sites, leading to formation of the SAMHD1 tetramer. This 
induces a conformational change int the dNTP binding pocket to yield the catalytically 
active enzyme that cleaves dNTPs into nucleosides (dN) plus triphosphate (PPPi) (from 
Seamon et al. 2014). 
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2. Materials and methods 
Mice 
SWHEL rag1ko/ko mice carry a gene-targeted VDJH-rearrangement (SW3) and a 
transgenic IgK gene, both from the HyHEL-10 hybridoma, together conferring Ig 
specificity for hen egg lysozyme (HEL). Inactivation of rag1 or rag2 in SWHEL mice 
prevents V(D)J receptor editing, ensuring that all B cells express identical HEL-specific 
receptors (Cook et al., 2003; Phan et al., 2003). 
 
Samhd1/// SWHEL rag1ko/ko mice were constructed by Australian BioResources by 
targeting frameshift deletion to exon 1 of Samhd1 by CRISPR/Cas9 in mouse embryos 
on a SWHEL background. 25, 41, 55 and 74 base pair deletions in Exon 1 were obtained 
and confirmed by PCR. Mutant alleles were bred to homozygosity after back-crossing 
founders to congenic SWHEL mice. 
 
Male C57BL/6 adoptive transfer experiment host mice were purchased from Animal 
Resources Centre (Canning Vale, Western Australia) and Australian BioResources 
(Moss Vale, New South Wales) and were used in experiments when 8–12 weeks old.  
 
SWHEL rag1ko/ko msh2ko/ko mice were created by inter-crossing msh2ko/ko and 
SWHEL rag1ko/ko mice (de Wind et al., 1995; Sharbeen et al., 2010). 
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Fucci transgenic mice have fused red and green-emitting fluorescent protein to E3 
ligase substrates. mKO is fused to the post G1 degron portion of cdt (amino acids 30-
120) and therefore labels cells in G1. mAG is fused to the G1 degron portion of geminin 
(last 100 amino acids) and therefore labels cells in post G1 (Sakaue-Sawano et al., 
2008) 
 
Mice were bred and maintained under SPF conditions in the Centenary Animal Facility. 
Mouse experiments were approved and monitored by the University of Sydney Animal 
Ethics committee in accordance with the New South Wales Animal Research Act 
(1985). 
Materials 
Cell lines 
Cell line Source Culture medium 
NIH/3T3 ATCC HEK 
Platinum E Cell Biolabs, Inc. HEK 
A20 ATCC 10FR 
HEK293 ATCC HEK 
Table 2.1: Cell lines used in experiments. 
Plasmids 
Name Gene Vector Source 
GS015 ugi-GFP pMiG George Sharbeen 
DB04 R2-IRES-GFP pMiG Daniel Bosnjak 
DB05 R2AAN-IRES-GFP pMiG Daniel Bosnjak 
mCherryLuc mCherry-Luciferase pHIV Michelle Van Geldermalsen 
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V057 GFP pMiG commercial 
GS026 mKO2 pMiG George Sharbeen 
Samhd1 shRNA 1-15 mIR30-shRNA pLMP created 
Table 2.2: Plasmids used in experiments. 
Recipes 
B cell medium: 
Constituent concentration 
L-glutamine 2mM 
Streptomycin 100ug/mL 
Penicillin 100U/mL 
Non-essential amino acids 0.1mM 
2-mercaptoethanol 50uM 
Sodium pyruvate 1mM 
Heat inactivated FCS 10% 
in IMDM  
 
HEK-293 medium: 
Constituent concentration 
L-glutamine 2mM 
Streptomycin 100ug/mL 
Penicillin 100U/mL 
Heat inactivated FCS 10% 
Sodium pyruvate 1mM 
in DMEM  
 
10FR medium: 
Constituent concentration 
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L-glutamine 2mM 
Streptomycin 100ug/mL 
Penicillin 100U/mL 
Heat inactivated FCS 10% 
in RPMI  
 
Lysogeny Broth/Luria Bertani medium (LB): 
Constituent concentration 
Tryptone 1% (w/v) 
Yeast extract 0.5% (w/v) 
Sodium chloride 0.1M 
in distilled water  
 
TBST: 
Constituent concentration 
Tris pH 7.4 10mM 
Sodium chloride 0.9% (w/v) 
Tween 20 0.05% (v/v) 
in distilled water  
 
Single cell sort buffer: 
Constituent concentration 
Proteinase K 0.5mg/mL 
EDTA 0.1mM 
Taq buffer 1x 
Tween 20 0.1% 
in MilliQ water  
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Tris-acetate-EDTA electrophoresis buffer (TAE): 
Constituent concentration 
Tris pH 7.4 0.04M 
Acetic acid 20mM 
in distilled water  
 
Laemmli sample buffer: 
Constituent concentration 
SDS 2% (w/v) 
Glycerol 10% (v/v) 
Tris pH 7.4 60mM 
Bromophenol blue 0.01% (w/v) 
in distilled water  
 
Bjerrum Schafer-Nielsen buffer: 
Constituent concentration 
Tris pH 7.4 48mM 
Glycine 39mM 
Ethanol 15% v/v 
in distilled water  
 
Conjugation buffer:  
Constituent concentration 
Mannitol 0.35M 
Sodium chloride 0.001M 
in distilled water  
passed through 0.22um filter. 
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Cell cycle staining solution 
Constituent concentration 
DAPI 1Pg/mL 
NP-40 0.1% (v/v) 
BSA 20Pg/mL 
EDTA 2mM 
in PBS  
 
Methods: 
Production of retroviral supernatants 
Ecotropic viral supernatants were produced by calcium phosphate transfection of the 
Platinum-E retroviral packaging cell line (Cell Biolabs, Inc.). Culture medium (DMEM, 
10% fetal calf serum, 1mM sodium pyruvate, 2mM L-alanyl-L-glutamine dipeptide, 
penicillin/streptomycin) was replaced at 12 hours, then retroviral supernatants were 
harvested at 60 hours, 0.45 Pm filtered, snap frozen in liquid nitrogen and stored at -
70 °C. 
Transduction of NIH-3T3 cells 
Log phase mouse immortalized NIH-3T3 fibroblasts were transduced by adding 
thawed retroviral supernatants supplemented with 8Pg/mL polybrene to HEK 
medium.  
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Adoptive Transfer of splenocytes: 
Mouse spleens were harvested from C02 euthanased mice into 5mL B cell medium, 
passed through 70Pm sieve and washed with a further 5mL B cell medium. These 
samples were centrifuged at 500g 4 degrees Celcius 5 minutes. The supernatant was 
removed, and the cells were resuspended in 4mL B cell medium. Splenocytes were 
isolated from red blood cells by using Histopaque 1083 (Sigma Aldrich). Cells were 
then suspended in B cell medium with recombinant CD40L-FLAG fusion protein and 
anti-FLAG antibody (4Pg/mL clone M2) (Invitrogen) for 24 hours and then transduced 
by centrifugation with viral supernatant with 16Pg/mL polybrene (1100g, 60min, 32 
°C). Splenocytes were then washed and incubated for 48 hours. 104 GFP+ cells were 
sorted using BD FACS Aria II or BD influx, combined with 108 sheep red blood cells 
(SRBC) (Applied Biological Products) conjugated to HEL in B cell medium and tail vein 
injected into 8-12-week hosts previously intraperitonally injected with 108 SRBC in PBS 
7 days prior. 6 days later host spleens were harvested, splenocytes isolated by 
Histopaque 1083 and sorted on BD FACS Aria II or BD influx for GFP+ and HEL+ one cell 
per well in 96 well plate containing 15 µl/well of ice-cold single cell sort buffer. 
Collection of mutation data followed the methods from (Sharbeen et al., 2010) and 
statistical analysis of mutation data followed methods from (Sharbeen et al., 2012). 
Conjugation of hen egg lysozyme to sheep red blood cells 
5mL of SRBC in Alsever’s solution was transferred to 50mL centrifuge tube, and 4qC 
sterile PBS was added to 50ml. This was spun at 2300 rpm (1111 g) for 5 minutes at 
4qC without brakes. and repeated twice. This was resuspended with 20 ml of 4qC 
conjugation buffer and centrifuged at 2200 rpm for 5 min at 4qC without brakes. This 
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was resuspended in 5.0 ml 4qC conjugation buffer and split SRBC into two 50ml 
centifuge tubes: 3mL for normal conjugation, 2mL for mock. 100ug of HEL was added 
to normal conjugation tube and incubated on the rocker on ice for 10 minutes. 0.05g 
of EDCI was added to both tubes and incubated on rocker for 30 minutes. 
 
After this 4qC sterile PBS was added to a total of 50mL in both tubes and centrifuged 
at 2200 rpm for 5 min at 4qC without brakes. This was repeated thrice. 
 
To confirm successful conjugation, 10ul of mock & conjugated SRBC were combined 
with 200uL HyHEL9 hybridoma supernatant for 30 minutes on ice, washed with 2mL  
PBS with 2% albumin (PBA), and centrifuged at 1111 g for 5 minutes at 4qC without 
brakes, and further stained with anti-IgK biotin (1:100) on ice 20 min, then washed 
with 2mL PBA and centrifuged at 1111 g for 5 minutes at 4qC without brakes, and 
stained with streptavidin-FITC (1:1000) on ice 20 min, and washed with 2mL PBA Spin 
at 2300 rpm (1111 g) for 5 minutes at 4qC without brakes. The samples were then 
resuspended in 500uL PBA and analysed on BD Fortessa for change in GFP 
fluorescence to confirm successful conjugation. 
Preparation of cell extracts, western blot analysis: 
Total protein extracts from unsorted cells, Fucci cells sorted on BD Influx for GFP+ or 
mKO2+, or 3T3 G1 restricted mKO2+ transduced cells were prepared by suspending 
cell pellets 2x107 cells /mL in Laemmli sample buffer and incubated for 30min at 20°C 
with 50U Benzonase (Novagen) per sample. Extracts were electrophoresed on 4-12% 
Bolt Bis-Tris (+MES buffer) polyacrylamide gels (Invitrogen) and transferred to 
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nitrocellulose membranes in Bjerrum Schafer-Nielsen buffer on Novex Semi dry 
blotter (Invitrogen). Membranes were stained with Memcode total protein stain 
(Invitrogen) as per manufacturer’s protocol and imaged using a ChemiDoc MP (Bio-
Rad). Membranes were blocked with 5% (w/v) skim milk powder dissolved in TBST 
were incubated overnight at 4°C with mouse anti-SAMHD1 [1A1] antibody (Abcam), 
goat anti R2 antibody (e-16) (Santa Cruz Biotechnology), or rabbit anti-RRM1 
[epr8483] (ab137114) (Abcam) in 5% skim milk TBST. Washed membranes were 
incubated with appropriate secondary antibody conjugated to horseradish peroxidase 
(Santa Cruz Biotechnology) for 1h at 20°C, then washed again and incubated with 
Supersignal West Pico Chemiluminescent Substrate (Thermo Fisher Scientific) and 
luminescence recorded using a ChemiDoc MP (Bio-Rad). 
Retroviral and lentiviral transduction test 
Samhd1 ko and control mouse spleens were harvested and splenocytes isolated as per 
adoptive transfer, but cultured in B cell medium with anti-CD40 HM40-3 (BD 
Biosciences) at 5Pg/mL and IL-4 (BD Biosciences) at 20ng/mL for 24 hours then 
transduced with pMiG retroviral supernatant method as per adoptive transfer at 5-
fold dilutions and analysed for GFP+ by flow cytometry. 
 
C57/BL6 mice were harvested, splenocytes isolated and cultured as per above method 
and transduced with R2-IRES-GFP and GFP retroviruses for 48 hours then further 
transduced with mKO2 retrovirus at 5-fold dilutions and analysed 24 hours later for 
GFP+ and mKO2+ by flow cytometry.  
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Creation and validation of shRNA against SAMHD1 
The target for designing shRNAs against mouse Samhd1 was obtained from 
ensemble.org (mouse SAMHD1 cDNA ENSMUST000000057725). Potential 21-mer 
shRNA constructs against SAMHD1 mRNA were created as per protocol described in 
(Dow et al., 2012). Identification of potential candidates used a three-step process. An 
online siRNA prediction tool ‘Designer of Small Interfering RNAs-DSIR’ (Vert et al., 
2006) identified potential sequences. These sequences were then cross checked 
against the BLAST database to exclude sequences matching against off-target genes. 
Sequences were then filtered again through a series of seven Sensor exclusion criteria 
(Dow et al., 2012). In total 11 shRNA sequences made by this method and 4 
commercial shRNA sequences available from Sigma were selected (TRCN0000099800, 
TRCN0000099801, TRCN0000099803, TRCN0000099804).  
 
97-mer templates were then created from these sequences and synthesized by 
Integrated DNA Technologies (Coralville, Iowa, USA).  
 
shRNA sequences were then amplified using Phusion HF (Finnzymes) using miR30 5’ 
EcoR1 and 3’ Xho1 oligonucleotide adaptors (ACTTAGAAGAATTCCGAGGCAGTAGG 
and TACAATACTCGAGAAGGTATATTGCTG respectively) in the following PCR reaction 
in a 200PL well: 
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Reagent PL  
TDW 32.5 
5xPhusion HF buffer 10 
10mM dNTPs 1 
10pmol/PL miR30 5’ EcoR1 oligonucleotide 2.5 
10pmol/PL miR30 3’ Xho1 oligonucleotide 2.5 
0.02ng/PL 97-mer template  1 
Phusion HF 0.5 
Total 50 
 
The PCR reaction was: 
1x: 
98 degrees Celcius - 0:30 
 
35x: 
98 - 0:10 
54 - 0:30 
72 - 0:15 
 
1x: 
72 - 5:00 
 
PCR products were confirmed on 3% agarose gel. 
                                     
These products were cloned into a mIR30 site of LMP 1066 (Zhou et al., 2008) 
(Addgene) vector co-expressing using EcoR1 and Xho1 restriction sites. LMP 1066 is a 
MSCV based retroviral vector which expresses shRNAmir, with a puromycin resistance 
cassette and GFP as a marker for retroviral integration. 
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1. These products were then digested with EcoR1 and Xho1 at 37 degrees Celcius 
for 1 hour: 
Reagent PL  
TDW 2 
10X Cutsmart buffer 2 
EcoRI HF 0.5 
Xho I 0.5 
PCR product 15 
Total 20 
Products were purified using Promega PCR purification kit as per instructions and 
eluted into 25PL of T10E0.1 
 
2. Digestion of pLMP vector containing mIR30 site at 37 degrees Celsius for 1 
hour: 
Reagent PL  
TDW 80 
10X Cutsmart buffer 10 
EcoRI HF 2.5 
Xho I 2.5 
pLMP vector containing mIR30 site (300ng/PL) 5 
Total 100 
Products were run on 1% Agarose gel,  
 
7880bp band cut and purified using Promega PCR purification kit as per instructions 
and eluted into 50PL of T10E0.1.  
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3. Ligation of digested PCR product and backbone at RT for 1 hour: 
Reagent PL  
10x T4 ligase buffer 1 
T4 DNA ligase 1 
PCR product 7 
Backbone 1 
Total 10 
 
Products were then transformed into Top10 competent E.coli by putting on ice for 5 
minutes, followed by 5PL ligation product added to 50PL vial of Top10 competent 
E.coli and incubating on ice for 30 minutes. E.coli were transformed by putting into 42 
degree Celcius water bath for 40 seconds, then transferring on to ice for 5 minutes. 
1mL LB medium was then added to vial and put into 37-degree Celcius shaker at 
250rpm for one hour. After this, the vial was centrifuged for 3 minutes at 1000g at RT, 
aspirating 950uL of supernatant and resuspending the pellet in the rest. This 
suspension was plated onto LB agar with ampicillin, incubated at 37 degrees Celsius 
overnight. Positive colonies were purified using Promega Miniprep kit (Promega, 
Madison WI).  
 
Sequences were verified by sequencing of mIR30 containing the shRNA cassette by 
Macrogen Inc. (Seoul, Korea).  
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Out of 15 constructs, 14 were successfully cloned into the mIR30 vector. One 
luciferase control (CJ171) and control (ET06) were also created by the above cloning 
method. 
 
Ecotropic retroviral supernatants were produced as per Methods: Production of 
retroviral supernatants.  
 
3T3 cells at 50% confluence in 12 well plates were transduced with 8μL of viral 
supernatant with 4μg of polybrene in a total volume of 500μL and incubated for 48 
hours. Transduction efficiency was 1-2% ensuring single copy transduction. 
 
Cell cultures were then selected with puromycin at a concentration of 1 μg/mL for 48 
hours. Dead cells were then washed off and remaining cells re-plated into T25 flasks 
without puromycin and grown to confluence. 
Class switching experiment 
Mouse spleens were harvested from C02 euthanased mice into 5mL B cell medium, 
passed through 70Pm sieve and washed with a further 5mL B cell medium. Samples 
were centrifuged, the supernatant was aspirated, and the cells were resuspended in 
4mL B cell medium. Splenocytes were isolated from red blood cells by using 
Histopaque 1083. Cells were then suspended in B cell medium with anti-CD40 HM40-
3 (BD Biosciences) at 5Pg/mL and IL-4 (BD Biosciences) at 20ng/mL for 24 hours and 
then transduced by centrifugation with viral supernatant with 16Pg/mL polybrene 
(1100g, 60min, 32 °C). Splenocytes were then washed and incubated for 48 hours. 
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Cells were then fixed, permeabilised and stained for IgG by the following technique 
applicable to 5x106 cell samples, incubations performed in the dark: Cultures were 
transferred to 15mL centrifuge tube and then centrifuged at 500g for 5 minutes at RT. 
The supernatant was aspirated. Cells were then resuspended in 500PL of 10% formalin 
for 10 minutes at RT. 1500PL PBA was then added and cells spun at conditions above. 
Cells were then resuspended in 100PL BD Cytofix/Cytoperm (BD Biosciences) for 30 
minutes on ice. 1mL of BD Perm/Wash buffer was then added and the sample was 
centifuged. The supernatant was aspirated and the cells were then resuspended in 
100PL Cytoperm Plus for 10 minutes on ice and 1mL of BD Perm/Wash buffer was 
then added and the samples were centrifuged. The supernatant was aspirated and the 
cells were then resuspended in100PL BD Cytofix/Cytoperm for 5 minutes on ice. 1mL 
of BD Perm/Wash buffer was then added. 10% of the sample was set aside for 
unstained controls, the main sample centrifuged. To stain, cells were resuspended in 
100PL rat anti-mouse IgG1-Biotin conjugate (BD Pharmingen) at 2.5 µg/ml in 
Perm/Wash buffer for 30 minutes, 1mL of BD Perm/Wash buffer was then added then 
centrifuged. The supernatant was aspirated and the cells were then resuspended in 
100PL Streptavidin-APC conjugate at 0.2 µg/ml (BD Pharmingen) in Perm/Wash buffer 
for 30 minutes on ice, 1mL of BD Perm/Wash buffer was then added then centrifuged. 
The supernatant was aspirated and the cells were then resuspended in 500PL PBA and 
analysed on BD-Fortessa. 
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Preparation of samples for dNTP assay 
Mouse splenocytes were used for dNTP analysis by pelleting at 500g for 5 min at 4 
degrees Celsius. Samples were washed with cold PBS thrice with pelleting at 500g for 
5 min at 4 degrees Celsius. Samples were then resuspended in ice cold 60% methanol 
at 107 cells per mL. cells were then heated at 95 degrees Celsius for 3 minutes, and 
then sonicated for 30 seconds at 70% maximum amplitude.  
 
Samples were then dried in vacuum centrifuge at 60 degrees Celsius, 500g, 0.001 bar 
until dry.   
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ABSTRACT
AID deaminates C to U in either strand of Ig genes,
exclusively producing C:G/G:C to T:A/A:T transition
mutations if U is left unrepaired. Error-prone process-
ing by UNG2 or mismatch repair diversifies muta-
tion, predominantly at C:G or A:T base pairs, respec-
tively. Here, we show that transversions at C:G base
pairs occur by two distinct processing pathways that
are dictated by sequence context. Within and near
AGCT mutation hotspots, transversion mutation at
C:G was driven by UNG2 without requirement for
mismatch repair. Deaminations in AGCT were refrac-
tive both to processing by UNG2 and to high-fidelity
base excision repair (BER) downstream of UNG2,
regardless of mismatch repair activity. We propose
that AGCT sequences resist faithful BER because
they bind BER-inhibitory protein(s) and/or because
hemi-deaminated AGCT motifs innately form a BER-
resistant DNA structure. Distal to AGCT sequences,
transversions at G were largely co-dependent on
UNG2 and mismatch repair. We propose that AGCT-
distal transversions are produced when apyrimidinic
sites are exposed in mismatch excision patches, be-
cause completion of mismatch repair would require
bypass of these sites.
INTRODUCTION
During adaptive immune responses, the affinity of antigen-
specific antibodies increases over a time frame of a few days
to weeks. Mutations are introduced into the Ig genes of ac-
tivated B cells proliferating in germinal centres (1) by the
DNA editing enzyme AID (activation-induced deaminase,
geneAicda) (2,3). AID deaminates C toU in targeted genes,
producing a U:G mismatch founder mutation (4). AID has
a preference to deaminate C within 5′-WRCH-3′, on either
DNA strand (4,5). Ig genes concentrate this motif in the hy-
pervariable regions of Ig V gene segments, and have under-
gone selection against it in most of the framework regions.
As a consequence, mutation hotspots are concentrated in
the hypervariable regions (6). A palindromic iteration of
WRCH: AGCT, is the most favoured hotspot and AGCT
motifs are highly abundant in Ig S regions (7–11).
If deaminations are not repaired, one daughter cell will
inherit a U:A base pair in place of the original C:G base
pair (a phase 1A mutation) and the other daughter will be
un-mutated. DNA repair enzymes can correct U:G mis-
matches, but error-prone processing also diversifies muta-
tion (reviewed in (12)). Specifically, the U can be excised
by the uracil-specific enzyme UNG2 (uracil N-glycosylase),
creating an apyrimidinic (AP) site (12). Conventionally, AP-
endonucleases (APE1 or 2) can nick 5’ to AP sites to facil-
itate repair synthesis by polymerase !, restoring the orig-
inal base pair (13). Loss of UNG2 activity reduces the
frequency of transversion mutations at C:G base pairs by
>80% (14,15). It is frequently proposed that some AP-sites
produced by the sequential action of AID and UNG2 are
replicated before they are processed further by BER en-
zymes, requiring bypass of the AP sites by translesion DNA
polymerases (phase 1B mutation) (12,16–19). Alternatively,
the AP-lyase activity of the MRN complex may induce
error-prone BER (20). Loss of UNG2 activity can also in-
crease the frequency of C:G to T:A transition mutations,
presumably as a result of increased uracil replication. This
suggests that high fidelity uracil BER does occur in hyper-
mutating B cells (9,11,19,21).
U:G mismatches are recognized by the mismatch bind-
ing protein MutS": a heterodimer of MSH2 and MSH6.
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MutS!-deficiency substantially reduces the frequency of Ig
mutations at A:T base pairs and also reduces transversion
mutations at C:G base pairs. This has produced a consen-
sus view that mismatch repair (MMR) plays a dominant
role in AID-induced mutation at A:T base pairs, and a mi-
nor role in generating transversion mutations at C:G base
pairs (12,16). Canonical MMR occurs post-replication: the
binding of MutS! to a mismatch induces MutS! translo-
cation, the formation of a MutS!/MutL! complex, and
the recruitment of Exonuclease I (ExoI). Exo I excises a
large single strand patch, starting from the nearest avail-
able 3′-end (22,23). The excision patch is then in-filled by
DNA polymerases " or # (24). In contrast, Ig A:T muta-
tion exhibits little or no dependence on MutL! (see (12)),
but still requires Exo I (25). It additionally requires PCNA
capable of ubiquitination at K164 (26,27) and the transle-
sion DNA polymerase $ (pol $, (28)). K164Ub-PCNA/pol
$ is presumed to introduce mutations within Exo I excision
patches and preferentially at A:T base pairs (phase II mu-
tation, (16)), perhaps as a consequence of pol $’s inherent
infidelity (29), and/or as a consequence of low dNTP lev-
els in G1-phase cells (30,31). It’s not clear how nicks are
created to enable Exo I entry during AID-induced MMR.
UNG2 and SMUG1 induce at least some of the nicks via
APE, but are semi-redundant with other nick generators;
perhaps TDG, MBD4, MutL! or OGG1 (32–36).
Genetic ablation ofMutS! did not increase the frequency
of C:G to T:A transitionmutations in hypermutating B cells
in several studies (37–39), leading to the suggestion that
faithful mismatch repair is poorly recruited toAID-induced
founder mutations (21). However, it’s possible that faithful
MMR has been under-estimated because the most prolifer-
ated germinal center B cells are preferentially lost inMMR-
deficient mice (37,38). Ablation of both UNG2 andMutS!
results in a mutation spectrum consisting entirely of C:G
to T:A transitions, on both strands. (9,19,40–41). This sug-
gests that although SMUG1 and MBD4 do excise AID-
induced uracils in MMR-competent cells (32,36,42), pro-
cessing by these N-glycosylases does not occur in the ab-
sence of MutS!, or is non-mutagenic in V-regions when it
does occur.
Thousands of AP sites are produced daily in nor-
mal cells independently of AID (43), but do not cause
wholesale point mutation. The factors rendering AID-
induced uracil excision mutagenic remain unclear. Here,
we exploit mutation datasets collated using the SWHEL
transduction/adoptive transfer model (see (30)) to anal-
yse hypermutation at day 6 in a model immune response,
prior to the narrowing of the response to a limited num-
ber of B cell dynasties. We find that both UNG2 and
MMR repair many AID-induced uracils, especially in the
top strand. Excluding C:G base pairs within and near
AGCT hotspots––wherein UNG2 is mutagenic regardless
of MMR activity––we find that interaction between UNG2
andMMR is required for up to 90% of transversions at C:G
base pairs. Our data demonstrate that UNG2-mediated
mutation occurs by distinct MMR-independent or MMR-
dependent pathways, which are dictated by local sequence
context.
MATERIALS AND METHODS
Mice
Male C57Bl/6 host mice were purchased from Animal
Resources Centre (Canning Vale, Western Australia) and
were used in experiments when 8–16 weeks old. SWHEL,
Msh2ko/ko and Rag1ko/ko mice––all C57Bl/6 background
(30,44) were interbred and maintained under SPF condi-
tions in the Centenary Institute Animal Facility. Mouse ex-
periments were approved and monitored by the University
of Sydney Animal Ethics committee in accordance with the
New South Wales Animal Research Act (1985 No. 123).
Retroviral transduction and adoptive transfer
pMiG-based retroviruses expressing EGFP and ugi-EGFP
fusion protein have been described (19). cDNAs encod-
ing mouse UNG2 (CCDS19560) or SMUG1 (CCDS27898)
were cloned immediately 5′ to the internal ribosome entry
site (IRES) of the pMiG retroviral vector (45). cDNAs en-
coding UNG2-EGFP or SMUG1-EGFP fusion proteins
were cloned in place of the IRES and EGFP sequences in
the pMiG vector. Retroviral supernatants were produced
using calcium phosphate-mediated transient transfection of
Plat-E packaging cells (46). Primary SWHEL splenocytes
were purified by density gradient separation on Histopaque
1083 (Sigma-Aldrich) and activated overnight by culture
with recombinant CD40L as described (30), transduced
by ‘spinfection’ (1100 g, 45 min, 20◦C) with retrovirus su-
pernatants in the presence of 4 %g/ml Polybrene, washed,
then incubated for a further 2 days in activating medium.
GFP+ve cells were purified by flow cytometric sorting (BD
FACSAria IIU or Influx sorter), mixed with freshly HEL-
conjugated sheep red blood cells (prepared as described
(30)) and injected via a tail vein into 8–12 week old male
C57Bl/6 hosts that had been primed i.p. with 108 non-
conjugated SRBC in PBS seven days earlier. Each host re-
ceived ≤104 GFP+ve cells, along with 108 HEL-SRBC in a
bolus of 0.25 ml culture medium. Retroviral experiments
were performed in accordance with a permit from the Office
of the Gene Technology Regulator (Australia), overseen by
the Royal Prince Alfred Hospital Institute Biosafety Com-
mittee (Sydney).
Measurement of SWHEL VDJ-mutation in single cells
Six days after adoptive transfer, individual transduced
SWHEL B cells were recovered from the spleens of host
mice into 96-well PCR plates (Bio-Rad) as GFP+ve cells
that bound HEL conjugated to Alexa Fluor 647 (30). Fol-
lowing cell lysis and protein digestion, the VDJH-region
of the single SWHEL allele present in each well was am-
plified by nested PCR, as described (30). PCR products
from ≤60 wells per host in which amplification was suc-
cessful were Sanger sequenced by Macrogen (South Ko-
rea).Mutationswhere secondary peaks formed<30%of the
signal were confirmed using Sequencher software (version
5.1, Gene Codes Corporation). Processed sequences were
sorted into phylogenetic trees (using neighbor joining and
uncorrected ‘p’) with MacVector software (version 12.7.5
MacVector Inc) to check for clonal dynasties, then collated
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for a window spanning nucleotides 17–539 (counting from
the translation start ATG codon as bases 1–3) using custom
Microsoft Excel spreadsheets (version 15.23 for Mac, Mi-
crosoft Corporation). Statistical analyses of mutation data
exported from Excel were performed using Prism software
(version 7.0a for Mac, GraphPad Software).
RESULTS
Production of large datasets using the SWHEL adoptive trans-
fer model
SWHEL mice carry the HyHEL10 VDJH3-rearrangement
targeted to the IgH locus plus the HyHEL10 Igk as a
low copy number randomly-integrated transgene, in the
C57BL/6 strain. This enforces high affinity for hen egg
lysozyme (HEL) upon B cells––as long as receptor editing
has not occurred at the IgH locus (47). Editing is blocked
inRag1ko/ko SWHEL mice, so all B cells are specific for HEL
in this line (44). We blocked UNG2 activity in Rag1ko/ko
SWHEL (hereon simply called SWHEL) B cells via retroviral
expression of the uracil glycosylase inhibitor (ugi) protein
from phage (tagged with GFP), which blocks 98% of UNG
activity (48). Retroviral expression of GFP alone served as
a control. MutS!-deficient B cells were created by cross-
ing Msh2ko alleles (49) into SWHEL mice, and Msh2ko/ko
SWHEL cells were transduced to express either GFP or
ugi-GFP (19). We used our established procedure (30) to
analyse hypermutation in transduced adoptive SWHEL cells
(Figure 1). Briefly, C57BL/6 host mice were primed i.p.
with 108 sheep red blood cells (SRBC) on day −7, to ac-
tivate SRBC-specific T-cell help. On day −3, naı¨ve donor
SWHEL splenocytes were placed into culture with recom-
binant soluble CD40L. On day −2, these cells were trans-
duced with retroviruses derived from pMiG (45). On day
0, GFP+ cells were purified and ≤104 GFP+ cells plus 108
HEL-conjugated SRBC were injected i.v. into each SRBC-
primed host. By day +6, almost all adoptive SWHEL cells
are in germinal centres (50) and comprise 0.1–0.5% of total
splenocytes (data not shown). On day +6, individual HEL-
binding GFP+ cells were recovered from host spleens into
96-well PCR plates, and the SWHEL VDJH allele present in
each well was amplified by nested single cell PCR from ge-
nomic DNA, usually with ∼70% efficiency (30).
Most of the mutations we collate are in exons (Supple-
mentary Figure S1A), and subject therefore toAg-selection,
which has potential to bias the mutation spectrum towards
rare mutations that favour antigen-binding. However, the
HyHEL10 mAb from which SWHEL mice were derived has
very high affinity forHEL (51), soAg-selection is likely only
to be against deleterious mutations, rather than for affinity
enhancing mutations, especially given that adoptive SWHEL
cells enter germinal centers only three days prior to our har-
vesting of SHM data (50). In support of this assertion, the
distribution of mutations across all twelve possible point
mutations in the adoptive SWHEL model is comparable to
non-selected datasets derived from JH–CH intron sequences
and from passenger Ig transgenes (based on comparison of
Tables in (19) and (12)). Furthermore, as long as no more
than fifty sequences are collated per host mouse, clonal dy-
nasties are rare (30).
From now on, we will refer to cells expressing ugi-GFP
or GFP as ‘UNG–’ or ‘UNG+’ cells, respectively, and re-
fer toMsh2ko/ko orMsh2wt/wt cells as ‘M–’ or ‘M+’ cells, re-
spectively. We collated mutations in UNG+M+, UNG–M+,
UNG+M– or UNG–M– SWHEL cells, 6 days after antigen
encounter, using 10 or 11 host mice per dataset (Supple-
mentary Figure S1A, Table 1, Supplementary Table S1). As
indicated in Table 1 (column s), sub-sets of the data collated
here have been published for other purposes (19). Mutation
frequencies were acceptably reproducible between indepen-
dent hosts (Figure 2). The same hotspots were preferentially
targeted in multiple mice within each dataset (Supplemen-
tary Figure S1B), demonstrating that hotspots arose as a
result of repeat targeting, and were not an artifact of clonal
dynasties. This indicated that our model could be used to
quantitatively analyze antibody hypermutation.
Deficiency for UNG2 orMMR increases transition mutation
at C:G base pairs
Deficiency for UNG2 activity (in UNG–M+ cells) or for
Muts! (in UNG+M– cells) increased transitions at C:G 2.3-
fold or 1.6-fold, respectively, relative to UNG+M+ cells (Ta-
ble 1). Reduced UNG activity increased transitions at C
(p = 0.002) and at G (p < 0.0001) almost equally, while
Msh2-knockout significantly increased transitions at C (p
= 0.019), but not at G (Figure 2A). In double-deficient
UNG–M– cells, transitions at C:G were increased 5-fold
overall, relative to UNG+M+ cells (Table 1), with mutations
at C increasing 2.3-fold more than mutations at G (Fig-
ure 2A). These transition increases in UNG–M– cells were
highly significant, even in comparison to the UNG–M+ and
UNG+M– datasets (Figure 2A). The data are consistent
with MMR and UNG2 (especially UNG2) driving more
faithful than mutagenic repair at deamination sites, but it
is also possible that MMR and/or UNG2 curtail ongoing
deamination by AID, such that deficiency for UNG2 or
MMR gives AID greater leeway to deaminate cytosines in
the first place. In other studies, mutation at C was also in-
creasedmore than atG by double-deficiency forUNG2 and
MutS!, but in two of those studies (9,40) the bias towards
increasedmutation at Cwas not as high as in this or another
study (41). This may simply reflect experimental variability,
which is better controlled in our study (because n ≥ 10 in
each of our datasets) than in previous studies, or it may be
due to differences in compensatory mechanisms induced by
Ung-knockout versus ugi over-expression.
UNG2 and MMR semi-redundantly excise uracils
Transversion mutation at C:G (mostly phase 1B mutations
(12)) and mutations at A:T (phase II mutations (12)) were
almost eliminated in UNG–M– cells (Figure 2B and C,
Table 1, Supplementary Table S1, Supplementary Figure
S1A), as expected (40). The residual non-phase 1A muta-
tions (16/999 mutations from 368 cells, Table 1) could be
be due to a combination of PCR error (3 mutations per
375 cells––see Table 1), residual UNG2 activity (excess ugi
leaves 2% of UNG activity intact (48)), and possibly the
activity of other N-glycosylases such as SMUG1, TDG or
MBD4. Thus, transition mutation at C:G in UNG–M– cells
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Figure 1. Timeline for SWHEL transduction/adoptive transfer experiments.
Figure 2. Mutations in the top strand of the SWHEL VDJH sequence window were averaged per host mouse (dots), with the overall mean of hosts (± 95%
confidence interval) indicated by histograms. Significant differences (according to Tukey’s ordinary one-way ANOVA) compared to (‘cf.’) the UNG+M+
or UNG–M– datasets are indicated: ****p < 0.0001; ***p < 0.001; **p < 0.01; *p < 0.05; n.s., not significant. Mutations are divided into three classes:
(A) transition mutations at C or G; (B) transversion mutations at C or G; (C) any mutation at A or T.
Table 1. Summary of datasets and estimates of uracil processing as indicated by drops in transitionmutations at C orG relative to theUNG−M– ‘baseline’,
plus estimates of the relative contributions of UNG2 and MMR to other point mutations
a b c d e f g h i j k l m n o p q r s
Mutations per 523bp sequence window: Processing of baseline U
No. of G C drop in baseline Ts
U converted
to Tv
contribution
to:
Transduced cells
Transduced
protein Shorthand Hosts Seq’s Mut’ns Tv Ts Tv Ts A T G C G C A T
published
hosts (19)
Msh2ko/koSWHEL ugi-GFP UNG–M– 10 368 999 0.02 0.97 0.008 1.70 0.005 0.008 double-deficient baseline 3
Msh2ko/koSWHEL GFP UNG+M– 11 514 527 0.12 0.35 0.027 0.50 0.03 0.00 64% 71% 10% 1.1% 4% -2% 3
SWHEL ugi-GFP UNG–M+ 11 478 948 0.03 0.68 0.015 0.56 0.54 0.16 30% 67% 0.3% 0.4% 86% 75% 4
SWHEL GFP UNG+M+ 11 539 867 0.15 0.31 0.082 0.23 0.62 0.21 68% 86% 14% 4.3% 100% 100% 6
PCR backgrounda no AID 2 375 3 0 0.005 0 0.003 0 0 1
aPCR background from sequencing CD4+B220–SWHELRag1+/+ cells.
can be presumed to closely approximate the baseline deam-
ination signature of AID in the absence of significant muta-
genic uracil processing (52), and the residual phase 1B and
phase II mutations we detected in UNG–M– cells can be
considered little more than background noise.
We estimated the fraction of deaminations processed by
UNG2 or MutS! by comparing C:G transition mutation
in single-deficient UNG+M– cells or UNG–M+ cells to
double-deficient UNG–M– cells. In UNG+M– cells, tran-
sitions were reduced by 71% at C and by 64% at G, rela-
tive to the UNG–M– baseline (Table 1). This suggests that
UNG2 excises about two-thirds of deaminations in the ab-
sence of MMR, with 1.1-fold bias toward the non-template
(upper) strand. Of course, dATPmight be incorporated op-
posite deamination sites––indeed, dATP preferentially in-
corporates opposite AP sites in vitro (53,54). We presume,
therefore, we have estimated a minimum amount of MMR-
independent processing byUNG2. InUNG−M+ cells, tran-
sitions were reduced by 67% at C and by 30% at G, rela-
tive to the UNG–M– baseline (Table 1). Presumably this is
also a minimum estimate of UNG2-independent process-
ing by MMR in the absence of UNG2 activity, because
Exo I excision of the G-bearing strand instead of the U-
bearing strand of deamination sites would be indistinguish-
able from ignorant replication. MMR thus appeared to be
much more biased towards excising upper strand deamina-
tions than UNG2.
In UNG+M+ cells, transitions were reduced by 86% at C
and by 68% at G, relative to the UNG–M– baseline; both
of which are only a little greater than the uracil excision
rate apparent in UNG+M–cells (Table 1). This result is con-
sistent with incomplete redundancy between UNG2 and
MMR for access to AID-induced uracils.
Collaboration between UNG2 and MMR to diversify muta-
tion
As expected from the Neuberger model (12), transver-
sion mutation at C:G was largely UNG2-dependent (be-
cause it was reduced by 85% in UNG−M+ cells, relative to
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UNG+M+ cells) and mutation at A:T was largely MSH2-
dependent (because it was reduced by 96% in UNG+M–
cells, relative to UNG+M+ cells; Table 1, Figure 2B-C, Sup-
plementary Figure S1A). Some groups reported a similarly
high dependence of A/T mutation on MMR (38,55), while
others reported dependencies nearer 50% (37,39). The rea-
son for this variability remains unknown, but it is unlikely
to be due to variations in antigen selection, and might be
due to variation between mouse strains.
Transversion mutation at C was substantially co-
dependent on UNG and MMR. It was reduced by 84%
in UNG–M+ cells (p < 0.0001) and by 68% in UNG+M–
cells, relative to UNG+M+ cells (p < 0.0001, Figure
2B). Transversion mutation at G was reduced by 85% in
UNG–M+ cells (p< 0.0001), but only by 25% in UNG+M–
cells (p = 0.25, Figure 2B), so it was much less depen-
dent on MMR. Mutation at A:T base pairs also appeared
to be somewhat UNG2/MMR co-dependent, because the
frequencies of A and T mutations in UNG+M– cells and
UNG–M+ cells summed to values lower than their frequen-
cies in UNG+M+ cells (see columns q-r in Table 1). Co-
dependence of some phase 1B and phase II mutations on
MMRandBER is alreadywell recognised (12,32–33,35,56–
57).
Processing of U:G base pairs by MMR or UNG2 appears to
be dictated by local sequence context
We were particularly interested to know whether local se-
quence context influenced the processing of deaminations.
MMR-deficiency increases focusing of mutation on AID
hotspots (25,37–39,55,58–59), but whether this occurs by
altered AID-targeting (59) and/or by uneven uracil repair
downstream of AID (28,33) is unclear. We wanted to quan-
tify focusing in an unbiased manner. First, we sorted C or
Gmutation sites in each dataset frommost to least mutated
sites (Supplementary Figure S1B). We then calculated cu-
mulative mutation at C or at G accordingly. The UNG+M–
dataset produced outlying cumulative mutation plots for
both C and G (Figure 3A). In the UNG+M– dataset, five
C mutation sites or four G mutation sites (numbered in
Figure 3B) accounted for ≥50% of mutation at C or at
G, respectively (see 50% intercepts marked in Figure 3A).
This was about half the number of mutation sites required
in the other datasets. Seven of these nine most prominent
UNG+M– hotspots occurred within AGCT or AGCA mo-
tifs (AGCW motifs, Figure 3B), in which the C on both
strands conforms to theWRCHhotspot consensus. In other
words, mutation focusing at C and at G in UNG+M– cells
was about 2-fold greater than in the other treatment groups,
and focussed towards palindromic hotspots (AGCT) or
hotspots that are ‘quasi-palindromic’ fromAID’s viewpoint
(AGCA). A direct role forMSH6 inAID-targeting (59)may
contribute to mutation focusing in UNG+M– cells, but it is
difficult for this role to explain the relaxed focusing evident
in UNG–M– cells (see Figure 3A). Interference fromMMR
influences the fidelity of UNG2-mediated repair in vitro
(33). This supports the proposal of Delbos et al. that muta-
tion focusses to motifs that become hyper-resistant to faith-
ful UNG2-mediated repair in MMR-deficient cells (28).
To test the proposal of Delbos et al., we measured
changes in C or G transition frequency on a per-site ba-
sis in UNG–M+ cells and UNG+M– cells, compared to
the UNG–M– baseline. This approach was based on the
presumption that most C or G transitions are phase 1A
mutations. To exclude rarely deaminated sites, only sites
where >7 mutations were present in the UNG–M– dataset
were considered. This arbitrary cut-off still encompassed
75% or 74% of mutation at C or G, respectively, in the
UNG–M– dataset. Both MMR or UNG2 reduced base-
line C and G transition at all sites considered, except for
G531, G239 and G273 in the UNG–M+ dataset (Figure
4A). G239 and G273 were also noticeable outliers in the
UNG+M+ dataset (Figure 4A). These outliers might be
sites where MSH6 enhances AID-targeting, as proposed by
Scharff’s group (59). In MMR-competent UNG–M+ and
UNG+M+ cells, baseline transitions were reduced outside
and within AGCW sites almost equally (Figure 4A). How-
ever, in UNG+M– cells baseline transitions were reduced at
sites outsideAGCWalmost twice as much as withinAGCW
motifs (p = 0.0016, Figure 4A). To confirm that these find-
ings were consistent across replicate hosts, we plotted C:G
transition frequencies outside or within AGCW motifs, for
each host of UNG+M+ or UNG+M– cells (Figure 4B). This
confirmed that C:G transition frequencies outside AGCW
sites were comparable between UNG+M+ and UNG+M–
cells, but within AGCW motifs were significantly higher in
UNG+M– cells than in UNG+M+ cells (p = 0.014).
Thus, the AGCW sites upon which hypermutation be-
came most focused in UNG+M– cells were sites that ap-
peared to be especially resistant to MMR-independent pro-
cessing by UNG2, as proposed by the groups of Weill and
Ramiro (11,28). Nonetheless, the site-dependent changes in
C:G transition mutations revealed in Figure 4A could be
due to changes in targeting by AID, rather than changes in
uracil-processing. If this were so, then the ratio betweenmu-
tagenic and repair outcomes at AGCW versus non-AGCW
deamination sites would not be expected to vary. We there-
fore determined if the frequency of mutagenic outcomes
from deamination within AGCW versus outside AGCW
varied.
Outside AGCW motifs, transversion mutation at C:G base
pairs requires interaction between UNG2 and MMR
In the mutation skyline of UNG+M– cells shown in Fig-
ure 3B, transversion mutations at C/G were rare outside
hotspots. We therefore calculated the percentage of mu-
tations that were transversions at each C or G mutation
site for the UNG+M– and UNG+M+ datasets (Figure 3D).
Analysis was restricted to sites that acquired >7 mutations
in the UNG–M– dataset. The percentages of mutations at
C:G that were transversions were comparable within versus
outside AGCW sites in UNG+M+ cells (p = 0.82, Figure
3D bottom). In contrast, they formed a reduced propor-
tion of mutations at C:G outside AGCW sites, compared
to inside AGCW sites in UNG+M– cells (p = 0.023, Fig-
ure 3D top). To confirm consistency across biological repli-
cates, we plotted the frequencies of transversion mutations
at C:G that lay outside or inside AGCW motifs, for each
host of UNG+M+ orUNG+M– cells (Figure 4C). Transver-
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Figure 3. Mutation focusing. (A) Mean mutations per mutation site ranked from most to least mutated (see Supplementary Figure S1B) were transformed
into plots for cumulative mutation at C (blue, left) or at G (black, right) in the top strand. The x-axis indicates rank position (leftmost rank=most mutated
C or G site), while the y-axis indicates cumulative mutation at C or at G. 50% intercepts indicate the least number of mutation sites required to account for
≥50% of all mutation at C or at G for each dataset. (B and C) Skylines of (above the x-axis) total transition or (below the x-axis, with a different y-scale)
transversion mutations at (blue) C or (black) G in (B) UNG+M– cells or (C) UNG+M+ cells. Mutations were not collated in the most 5′ region shaded
brown. Grey stripes identify AGCW motifs. Beige and gray boxes at bottom indicate exons and CDRs (according to http://www.imgt.org), respectively.
Top-ranked mutation sites that together accounted for ≥50% mutation at C or at G are indicated by integers above or below the x-axes, respectively. (D)
Percentage of mutations that were transversions at each C or G site in the (top) UNG+M– or (bottom) UNG+M+ datasets, restricted to sites that acquired
>7 mutations in the UNG–M– dataset, and partitioned into those lying (open symbols) outside or (closed symbols) inside an AGCWmotif. Medians and
interquartile ranges are indicated in red. p-values from Mann–Whitney tests are indicated.
sion mutation at C:G outside AGCW sites was markedly
reduced in UNG+M– compared to UNG+M+ cells (p =
0.007), but this was not the case within AGCW motifs
(Figure 4C). This suggested that MMR was dispensable
for UNG2-dependent mutation within AGCW motifs. Ev-
erywhere else, UNG2-dependent mutation was largely co-
dependent on MMR.We noticed that most of the transver-
sion mutations that remained outside AGCT motifs in our
UNG+M– dataset were close to anAGCT site, including the
transversions at AGCA (examine Figure 3B). This raised
the possibility that proximity specifically to AGCT motifs,
rather than AGCW motifs, might be the major factor gov-
erning transversion rate in UNG+M– cells. To normalize
confounding influences, we plotted the ratio of transver-
sion mutation in UNG+M– cells versus UNG+M+ cells as a
function of absolute distance (i.e. 5′ or 3′) from the nearest
AGCT motif. We only performed this analysis for transver-
sions at G, because transversions at C were rare in all data
sets (see Table 1). The plot produced was a good fit to ex-
ponential decay of MMR-independent G transversion mu-
tation with distance from the nearest AGCT motif (Fig-
ure 4D; R square = 0.88; absolute sum of squares = 0.98),
with a half-life of 5.3 bases (95% confidence interval= 3.1–
8.3 bases), towards an asymptote of ∼0.1. In other words,
repair by UNG2 was ∼90% error-free in M– cells, except
within a roughly five base window either side of AGCTmo-
tifs. Within this window, MMR was redundant for UNG2-
dependent mutagenesis.
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Figure 4. Processing of deaminations outside versus within AGCW motifs. (A) The change in transition mutation in the top strand at (blue) C or (black)
G in each dataset, relative to the baseline UNG–M– dataset, for every site that was mutated more than seven times in the UNG–M– dataset. Medians
and interquartile ranges are indicated in red. Significant differences between (solid symbols) AGCW and (open symbols) non-AGCW sites are indicated
by Kruskal-Wallis p-values. (B and C) Mean frequencies per sequence of (B) transition mutations or (C) transversion mutations at C:G base pairs lying
(open symbols) outside or (closed symbols) inside AGCW sites, for individual hosts of (M+) UNG+M+ or (M–) UNG+M– cells. Bars indicate medians
and inter-quartile ranges of hosts means. Significant differences between UNG+M+ cells and UNG+M– cells are indicated by Kruskall-Wallis p-values.
(D) The MMR-dependence of normalised transversion mutation at G (y-axis) upon distance from ‘G’ in the nearest AGCTmotif (x-axis). The best-fitting
exponential decay curve (Prism software) is overlaid.
UNG2 over-expression suppresses phase 1A and phase II mu-
tations, but has little effect on phase 1B mutation
As a direct test for resistance of deaminated AGCWmotifs
to faithful processing by uracil N-glycosylases, we used the
adoptive SWHEL model to over-express SMUG1 or UNG2
inMMR-proficient B cells andmeasured the impact onmu-
tation within and outside AGCW hotspots. SMUG1 over-
expression substantially suppressed mutation at A:T base
pairs (p= 0.006, Figure 5A). Outside AGCWmotifs, it also
suppressed C/G transition mutation (p = 0.0017, Figure
5B) and almost ablated C/G transversion mutation (p =
0.0024, Figure 5C). However, SMUG1 over-expression had
no significant impact on C/Gmutation within AGCWmo-
tifs (Figure 5B and C). This suggested that SMUG1 was
largely unable to process deaminations within AGCW mo-
tifs, while outside AGCW motifs, SMUG1 induced non-
mutagenic BER almost exclusively or prevented deamina-
tion outside AGCW in the first place. The overall reduc-
tion in hypermutation induced by SMUG1 over-expression
(Figure 5 and Supplementary Figure S2) is consistent with a
previous report using human SMUG1-transgenicmice (42).
Like SMUG1, ectopic UNG2 substantially suppressed mu-
tation at A:T and C/G transition mutation outside AGCW
motifs (p < 0.0001, Figure 5A and B), and had no impact
upon C/G transversion mutation within AGCW motifs
(Figure 5C). In addition, UNG2 over-expression slightly re-
duced transition mutation within AGCWmotifs (p = 0.04,
Figure 5B) and slightly reduced transversion mutation out-
side AGCWmotifs (p = 0.04, Figure 5C).
Regardless of any impact SMUG1 or UNG2 over-
expression may have on deamination rates, Figure 5 indi-
cates firstly that most Ig C and G transitions arise from
replication of unrepaired uracils, and secondly that deam-
inations within AGCW sites are resistant to faithful re-
pair by UNG2 or SMUG1, even when theseN-glycosylases
are over-expressed. Furthermore, the virtual absence of
transversion mutations at C:G outside AGCW motifs in
SMUG1over-expressing cells (Figure 5C) suggests that, un-
likeUNG2, SMUG1 cannot collaborate withMMR to pro-
duce AGCT-distal phase 1B mutations.
DISCUSSION
Incomplete redundancy between UNG2 andMMR to process
AID-induced uracils
In contrast to early studies using memory or Peyer’s patch
B cells, loss of either UNG2 or MutS! activity increased
V-region transition mutation at C:G bases in our day 6
germinal center B cells, especially at C (Figure 2A). The
increases could be due to increased ignorance of deam-
inations, and/or to these factors curtailing deamination
by AID. In theory, excision of template strand uracils by
UNG2 could curtail iterative deamination, because AP-
sites block transcription in yeast (60) and might there-
fore be expected to alter recruitment of AID by transcrip-
tion complexes. This could explain why C and G muta-
tion in UNG–M– cells were less focused than in wild-type
UNG+M+ cells (Figure 3A). Nonetheless, we suspect the
presence of AP sites does not have a major effect on AID-
recruitment, firstly because mutation focusing in UNG–M–
cells was only slightly more relaxed than in UNG+M+ cells
(Figure 3A), and secondly because transversion mutation
at C:G was only marginally reduced in cells over-expressing
UNG2 (Figure 5C).
If we accept that UNG2 or MutS! induce only mi-
nor curtailment of deamination, Table 1 presents evidence
that Muts! is largely, but not completely redundant to
UNG2 for excision of AID-induced uracils. Furthermore,
the ability of ectopic UNG2 and SMUG1 to suppress
MMR-dependent mutation (Figure 5A) suggests that ex-
cess uracil N-glycosylase activity out-competes MMR to
process U:G base pairs. Recent data collated from day 8
anti-NP cells implied that MMR is completely redundant
to UNG2 for processing U:G base pairs, because UNG2,
MMR or combined UNG2/MMR activities reduced tran-
sitions at C:G by 81%, 64% or 78%, respectively, relative to
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Figure 5. Uracil N-glycosylase over-expression suppresses mutation outside AGCW motifs. Mean frequencies of (A) mutations at A:T, (B) transitions at
C:G or (C) transversions at C:G per sequence for each host mouse that received adoptive SWHEL B cells transduced with (SMUG) SMUG1-expressing
vector, (UNG) UNG2-expressing vector or (EV) empty pMiG vector. Open symbols: co-expression of native protein and GFP. Closed symbols: expression
of SMUG1-GFP or UNG2-GFP fusion proteins. Bars indicate median ± inter-quartile range of the host means. Holm–Sidak’s p-values are shown.
Ung−/−Msh2−/− cells (our calculations from Supplemen-
tal Data in (9)). The deviations from our MMR data might
be explained by target sequence composition, which has a
profound impact on both AID-recruitment and processing
downstream of AID ((8–9,11), this paper), or by the higher
risk of sampling error in the NP study (due to fewer repli-
cates per genotype) compared to this study, which has used
the highest number of biological replicates per dataset to
date. It is also possible that DNA repair-deficiency in TFH
cells impinges upon B cell hypermutation when Ung−/− or
Msh2−/−mice are immunised. This complicationwould not
occur in our datasets, because only the adoptive B cells car-
ried DNA repair defects.
A role for uracil BER in phase II mutations?
Despite the ability of elevated uracil N-glysolysase activ-
ity to inhibit MMR-induced mutation (Figure 5A), loss
of UNG2 activity did not increase MMR’s ability to pro-
duce mutations at A:T base pairs in our study (see Table
1), nor in any other studies. Some have concluded from
this that UNG2 and MMR do not compete to process
deaminations (61). However, it is also consistent with a
fraction of phase II mutation being UNG2 and MMR
co-dependent. Any potential co-dependence cannot be ex-
plained by recruitment of MMR to AP sites, because
MutS! does not recognize BER intermediates (62). How-
ever, entry by Exo I at BER-induced nicks (32–35) does
provide a plausible collaboration mechanism. Suppression
of A:T mutation by ectopic uracil N-glycosylases (Figure
5A) might seem to rule this idea out. However, excess uracil
N-glycosylase probably deprives MutS! of U:G substrate,
suppressing activation of MMR. UNG/SMUG1-double
knockout and UNG/APE2-double knockout significantly
reduced mutation at A:T base pairs (32,35). This is strong
evidence of a major role for uracil BER in A:T mutation.
UNG2/SMUG1-double knockout, but not UNG/APE2-
double knockout, also reduced the strand bias of A:T mu-
tation (32,35). AID and UNG2 seem to have 1.75-fold and
1.1-fold bias, respectively, towards activity in the top strand
in our datasets (see Table 1). The reduction in transitions we
induced with ectopic SMUG1 was 1.2-fold biased towards
C over G (data not shown). Assuming that AP sites can
be accessed by AP-endonucleases in each strand equally,
we calculate that combined UNG2 and SMUG1 activity
should produce 1.9 to 2.2-fold more nicks in the top strand
than in the template strand of mutating SWHEL alleles.
This could bias Exo I entry into the top strand, should a
nearby deamination site recruit MMR. Alternatively, AP-
endonucleases may simply have better access to AP sites in
the non-transcribed DNA strand. Either way, much of the
strand bias ofMMR-mediated uracil processing and of A:T
mutation (see Table 1 and Figure 6) can be explained if BER
is a major mediator of Exo I entry during AID-induced
MMR. Semi-redundant nick generation by uracil BER and
MutL!, and perhaps oxidation-induced BER (34) poten-
tially explain why MutL!-knockout has only marginal im-
pact on antibody hypermutation (57). Nick generation via
MutL!might account for the markedly reduced strand bias
of A:T mutation in Ung−/−Smug1−/− mice (32), because
there is no reason to assume that MutL! can distinguish
between the non-deaminated and deaminated strands of hy-
permutating Ig genes.
Two distinct pathways for generating phase 1B mutations,
dictated by proximity to AGCT motifs
Deaminations in AGCW motifs appeared more resistant
to excision by UNG2 than deaminations at other sites
(Figure 4A). In fact, the increase in C:G transition mu-
tation induced by Msh2-knockout (relative to wild-type)
was confined to these sites (Figure 4B). A similar phe-
nomenon was noted in sequences 3′ to JH4 (28). It’s possi-
ble that targeting of AGCWmotifs by AID increases when
MMR is lost from UNG-competent cells because MSH6
can directly influence targeting by AID (see (59)). How-
ever, increased mutation-focusing in UNG+M– cells can-
not be fully explained by abilities of MSH6 or MMR to
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Figure 6. A revised hypermutation model based on (12,16,19–20). Dashed boxes enclose refinements added by this paper. The class of mutation (phase
1A, phase 1B or phase II) produced by each pathway is indicated by orange boxes. (•) AP site; (AP-E) AP-endonuclease; (AP-L) AP-lyase; (Pol !) DNA
polymerase !; (tls pol) translesion polymerases; (Phase 1A) transition at C or G; (Phase 1B) transition or transversion at C or G; (Phase II) mutation at A
or T.
influence AID targeting, because mutation was not simi-
larly focussed in our UNG–M–cells (Figure 3A). Relaxed
targeting was also apparent in Ung−/−Msh2−/− cells (see
(28,40)). Mutagenic processing was particularly focused to
AGCW sites in UNG+M– cells (Figure 3D). Thus, AGCW
sites in UNG+M– cells were resistant both to processing
by UNG2 and to conventional BER steps downstream of
UNG2, diverting to mutagenic outcomes at a higher rate
than other sites in UNG+M– cells. Even when UNG2 was
over-expressed, C:G mutation rates within AGCW motifs
were barely affected (Figure 5B and C). A similar phe-
nomenon was observed in synthetic target genes in 3T3
cells expressing ectopic AID (11). Taken together, our re-
sults suggest that mutation-focusing previously described
in UNG2-competent Msh2−/−, Msh6−/−, and Exo1−/−
B cells (25,37–39,55,58) is more a consequence of al-
tered uracil processing by UNG2 than of altered uracil
production by AID.
We uncovered a mathematical relationship between dis-
tance from AGCT motifs and the MMR-dependence of
transversion mutation at C:G (Figure 4D). We can predict
from Figure 4D that the dependence of transversion mu-
tation on MMR should decrease as the density of AGCT
sequences in a target sequence increases. We can use the
data of Chen et al.––who compared hypermutation in a
conventional VDJH knock-in allele with hypermutation
in an AGCT-rich knock-in allele (9)––to test this predic-
tion. Ung-knockout reduced C:G transversion mutation by
85% and 89% (relative to Ung+/+Msh2+/+ cells) in Chen
et al.’s conventional and AGCT-rich target alleles, respec-
tively. These reductions compare to the 85% drop observed
in our UNG–M+ SWHEL cells. Msh2-knockout decreased
C:G transversion mutation (relative to wild-type cells) in
their conventional allele and our SWHEL allele by 44% and
40%, respectively. These reductions are also comparable,
but contrast with the 29% reductionMsh2-knockout caused
in Chen et al.’s AGCT-rich allele (our calculations, using
Supplemental Data in (9)). This contrast is what we would
predict from Figure 4D.
Based on our findings, we propose a refinement of the
Neuberger hypermutation model (Figure 6), wherein AID-
induced phase 1B mutation occurs by two distinct mecha-
nisms: (1) In the near vicinity of AGCT motifs, phase 1B
mutation depends on UNG2 and does not require MMR;
(2) distal to AGCT motifs, phase 1B mutation is ∼90% co-
dependent on UNG2 and MutS". We propose that these
distal mutations involve exposure of AP sites in Exo I exci-
sion patches. Critical to our model is the point that MMR
could recruit ExoI to excise either the U-bearing or the G-
bearing strand of U:G base pairs (albeit with a bias ap-
parently towards ExoI entry into the top strand; see Dis-
cussion earlier), regardless of which strand was deaminated
in the U:G base pair actually bound by MutS". This cre-
ates the potential for uracils or AP-sites to be exposed in
single-stranded MMR excision patches. If ExoI exposed
AP-sites created by UNG2, or if UNG2 excised uracils
after their exposure in ExoI excision patches, nicking by
an AP-endonuclease or AP- lyase (20,35) would create a
problematic double-strand break – likely leading to a dele-
tion and/or cell death if nicking occurred in G1-phase (see
Figure 6). AP-sites exposed within G1-phase ExoI exci-
sion patches would therefore require lesion bypass using
a translesion polymerase to be resolved, potentially caus-
ing a phase 1B mutation (Figure 6). In the absence of
MMR, or when MMR’s access to U:G base pairs is over-
whelmed by uracil N-glycosylase over-expression, AGCT-
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distal uracils appear to be processed efficiently by UNG2,
leading almost exclusively to faithful BER. We noticed that
SMUG1 over-expression almost ablated transversions at
C:G outside AGCW sites (Figure 5C). SMUG1 has been
reported to bind the AP sites it creates more persistently
thanUNG2 (63). Bearing this in mind, Figure 6 can explain
why excess SMUG1 prevents phase 1B mutation distal to
AGCT motifs: if SMUG1, rather than UNG2, created an
AP site within an ExoI excision patch, persistent binding of
SMUG1 to its product AP site would block excision patch
in-fill and force the creation of a double-strand break once
an AP-endonuclease or AP-lyase was recruited.
Deaminations within AGCT sequences appeared to be
more resistant to processing by UNG2 and were also re-
sistant to faithful BER steps downstream of UNG2 re-
gardless of MMR activity (see Figures 3D and 4). Since
transversion mutation at C:G depends on G1-phase UNG2
regardless of proximity to AGCT motifs (19), we propose
that slow G1-phase BER within and near AGCT motifs
leads to the persistence of G1-phase AP sites into S-phase,
where their entry into replication forks induces mutagenic
lesion bypass (Figure 6), as we proposed before (19), and/or
induces mutagenic processing by the MRN complex (20).
In contrast, bypass of AP-sites exposed in Exo I excision
patches is likely to occur entirely within G1-phase – with-
out any need for AP sites to persist into S-phase (Figure
6). It’s possible, therefore, that MMR-independent versus
MMR-dependent phase 1B mutation occur in distinct cell
cycle phases. Our model (Figure 6) posits that the same
fraction of deaminations within AGCTmotifs will undergo
BER-induced lesion bypass regardless of MMR activity; in
MMR-competent cells they will undergo lesion bypass by
either of the phase 1B pathways shown in Figure 6, while
in MMR-deficient cells, they will undergo lesion bypass via
the classic Neuberger pathway (i.e. ‘slow BER’) only.
Why are deaminated AGCT motifs resistant to uracil-BER?
Why do deaminated AGCT motifs appear to be resistant
to uracil BER? Option A: In vivo, deaminated AGCT se-
quences might innately form a structure inaccessible to
UNG2 and other BER enzymes. Option B: AID or co-
factors (e.g. 14-3-3 proteins, Spt5, RPA or RNA pol II)
might preferentially accumulate at AGCT sites in hypermu-
tating B cells (7,28,64–68), thus reducing access by UNG2
and subsequently by AP-endonucleases or AP-lyases. Since
AGCT sites form an AID hotspot in both strands, it’s con-
ceivable that AID or co-factors continue to be recruited to
the opposite strand even after one strand has been deami-
nated or processed by UNG2. This would enhance the like-
lihood that deaminations or AP sites created in AGCTmo-
tifs in G1-phase persisted into S-phase. Deaminated AGCT
motifs were not more resistant to processing byMMR than
other deamination sites (Figure 4A). This can be explained
by the potential for ExoI to excise uracil(s) distal to the
site of initial MutS!-binding, regardless of whether MutS!
ever bound to the uracil(s) excised by ExoI. Figure 4D im-
plies that the foot-print of BER-resistance at AGCT sites
is about 10.6 bases (i.e. 2X the Figure 4D half-life, which
represents one half of a bell curve footprint). This is con-
sistent with the size of the DNA binding grooves in AID
homologues APOBEC2 (69) and APOBEC3G (70) (Xiao-
jiang Chen, personal communication). However, it is also
consistent with the size of the single-stranded DNA bubble
formed by RNA pol II (∼11 bases), which may be particu-
larly prone to stalling at AGCT motifs in Ig genes indepen-
dently of AID (64,68)].
CONCLUSION
In this study, we have refined the Neuberger model of anti-
body hypermutation, having provided evidence thatUNG2-
induced phase 1B mutation distal to AGCT hot-spots is
MMR-dependent. Furthermore, our refined model poten-
tially explains the previously enigmatic strand bias of phase
II mutation. Our refinements are necessary to encompass
the remarkable complexity of antibody hypermutation that
has emerged since the Neuberger DNA deamination model
was first developed.
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Supplementary	Figure	1	(previous	page)	 	
Supplementary to Figure 2. (A) Histograms of mutation frequencies at each base in the sequenced 
window of 523bp. Transitions at C (blue) or G (black) are shown above the x-axis. Transversions at 
C (blue) or G (black) and mutations at A (green) or T (red) are shown below the x-axis. The brown 
stripe indicates a 5’ region in which mutations were not collated because it over-lapped a secondary 
PCR primer. Grey dashed lines identify the four AGCW motifs present in the starting sequence (see 
Results and Discussion). Beige boxes at bottom indicate the L and VJ exons, while grey boxes 
indicate the three CDRs, according to IMGT (IMGT®, the international ImMunoGeneTics 
information system® http://www.imgt.org (founder and director: Marie-Paule Lefranc, Montpellier, 
France)). (B) Reproducibility of hotspot-targeting in the datasets. C (top, blue) or G (bottom, black) 
mutation sites were sorted as most to least mutated site (i.e. decendingly ranked) in each dataset. The 
variation between hosts in mean mutation at each sorted site is indicated by the error bars, which 
depict s.e.m.  
 
Supplementary	Figure	2	(below)	
Supplementary to Figure 5. Mutation skylines for cells over-expressing (A) UNG2 or UNG2-GFP, 
or (B) SMUG1 or SMUG1-GFP. Data are presented as in Supplementary Figure 1A.  
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4.1 R2 overexpression reduces AID-induced 
mutations and increases retroviral and 
lentiviral transduction 
Introduction 
The current model of somatic hypermutation describes a multistep mutagenic 
process, initiated by AID deaminating cytosine residues to uracil (Frieder et al., 2009), 
which if left unrepaired, leads to transition mutations at C:G bases after replication. 
The majority of C deaminations are repaired faithfully by BER and MMR pathways 
(Thientosapol et al., 2017). However, error-prone BER of uracils that have been 
converted into apyrimidinic sites introduces transversion and transition mutations at 
deamination sites with assistance from error prone MMR (Krijger et al., 2009; 
Thientosapol et al., 2017). Error-prone MMR of U:G mismatches can also introduce 
mutations at A and T bases in proximity to the initial deamination site (Frieder et al., 
2009). 
 
In its usual role, during post replication repair, MMR repairs mismatches in an error-
free manner, but is highly mutagenic during somatic mutation. Mutagenesis involves 
polymerase K, because Polh inactivation almost ablates mutations at A:T bases 
(Delbos et al., 2005; Zeng et al., 2004). Polymerase K is a translesional DNA 
polymerase that is able to bypass certain DNA lesions that stall replication forks, in an 
error-prone manner (reviewed in (Weill & Reynaud, 2008)). PCNA ubiquitination at 
lysine 164 is also involved in MMR-induced mutation, because PcnaK164R/K164R mice, 
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which are completely resistant to ubiquitination at lysine 164, have substantially 
decreased mutations at A:T bases (Langerak et al., 2005; Roa et al., 2008). PCNA 
becomes mono-ubiquitinated at K164 during replication fork stalling, which increases 
PCNA’s affinity for polymerase K.  
 
Why PCNA mono-ubiquitination occurs during AID-induced MMR, to then recruit DNA 
polymerase K, has not been revealed. It is probable that mutagenic MMR occurs in 
G1, for the following reasons. (1) Nuclear AID activity is restricted to G1 by nuclear-
cytoplasmic shuttling (Wang et al., 2017). (2) The components of MMR known to be 
required for A:T mutation are also present in G1-phase B cells (Pena-Diaz et al., 2012; 
Pena-Diaz & Jiricny, 2012; Schrader et al., 2007). (3) Both UNG2-dependent and 
UNG2/MMR co-dependent mutations require UNG2 activity in G1-phase (Sharbeen et 
al., 2012). (4) In S-phase, when genome replication occurs, dNTP pools are in the range 
of 10-100pmoles for each dNTP per x106 cells; in G0/G1, dNTP pools are about 10-fold 
lower (Rampazzo et al., 2015). An optimal concentration of dNTPs is crucial for the 
fidelity of DNA synthesis during replication and post replication repair (Rampazzo et 
al., 2015), while depletion of dNTP pools causes S-phase replication fork stalling 
(Petermann et al., 2010). For these reasons, we hypothesised that dNTP paucity drives 
the stalling of the canonical MMR polymerase, polymerase G, if AID-induced MMR 
occurs in G1-phase, and that it is this stalling that induces PCNA mono-ubiquitination 
and the recruitment of error-prone polymerase K  (Sharbeen et al., 2010).  
 
dNTP pools are regulated by an interplay of synthesis and degradation (Rampazzo et 
al., 2010). The rate limiting step in de-novo dNTP biosynthesis is catalyzed by the 
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enzyme ribonucleotide reductase (RNR) (Xu et al., 2008). Ribonucleotide reductase 
catalyzes the synthesis of dNTPs (Ayinde et al., 2012), by substitution of the 2’hydroxyl 
group of a ribonucleoside diphosphate (NDP) with hydrogen, resulting in a 
deoxynucleoside diphosphate (dNDP) (Nordlund & Reichard, 2006). RNR is a cytosolic 
enzyme maximally active in S-phase cells and consists of the R1 (90kDa) and R2 
(45kDa) subunits (Niida et al., 2010). The R1 subunit is present throughout the cell 
cycle. However, the R2 subunit is undetectable during G1-phase (Bjorklund et al., 
1990; Engstrom et al., 1985; Mann et al., 1988). This chapter describes experiments 
performed to determine whether the cell cycle regulation of the R2 subunit of RNR 
contributes to error-prone DNA repair downstream of AID in B cells. 
Results 
Experiments initiated by Daniel Bosnjak, an Honours student in our laboratory, used 
B cell transduction/adoptive transfer experiments to show that retroviral R2 
overexpression in adoptive B cells significantly decreased Ig mutation at A:T base pairs 
(unpublished data). Three isoforms of ribonucleotide reductase R2 subunit (R2) were 
cloned for retroviral expression by Daniel. These were the canonical form (R2) 
encoded by mouse gene Rrm2, a cell cycle dysregulated R2 mutant (called R2AAN), and 
a p53-inducible R2 paralog that is induced by DNA damage in a manner dependent on 
p53 (R2b, encoded by mouse gene Rrm2b) (Chabes et al., 2004; Tanaka et al., 2000). 
These R2 variants were co-expressed with GFP via an internal ribosome entry site 
(IRES) using the pMiG retroviral vector (Parijs et al., 1999).  
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A summary of mutation data collected by Daniel Bosnjak, then extended by this 
author, is shown in Figure 4.1. All three R2 isoforms significantly inhibited mutation at 
A:T bases, with normal R2, R2AAN and R2b decreasing mutation at A:T by 67% 
(p=0.0005), 74% (p=0.0003) and 48% (p=0.0023) respectively. The R2 constructs did 
not inhibit mutation at C:G. Rather, wild-type R2 significantly increased transitions at 
C:G by 51% (p=0.0473); the other isoforms did not increase these transitions 
significantly. There were no significant changes in frequencies of transversion 
mutations at C:G induced by any R2 isoform (Figure 4.1).  
 
The R2-induced phenotype of increased transition mutation at C:G and reduced 
mutation at A:T base pairs is a somewhat similar phenotype to mismatch repair 
inhibition, because a 96% loss of hypermutation at A:T base pairs in adoptive Msh2ko/ko 
SWHEL B cells is accompanied by a 58% increase in transitions at C:G base pairs (see 
(Thientosapol et al., 2017)), but also by a 39% drop in C:G transversions, which did not 
occur with R2 overexpression. A key “signature” of MMR inhibition in UNG-proficient 
B cells is hyper-focusing of AID-induced C:G transitions on AGCW hotspots (Delbos et 
al., 2007; Rada et al., 1998; Thientosapol et al., 2017). This occurs because the fidelity 
of uracil BER is markedly increased in the absence of MMR, except at AGCW motifs, 
which appear inherently resistant to faithful uracil BER regardless of MMR-
proficiency. Using the analytical approach developed in the previous chapter 
(Thientosapol et al., 2017), we found that R2 over-expression did not produce this 
signature. In UNG-competent cells, mismatch repair deficiency significantly increased 
C:G mutation within, but not outside AGCW hotspots, as observed by others. On the 
other hand, R2-overexpression significantly increased C:G mutation outside, but not 
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within AGCW motifs in wild-type cells (see Figure 4.2). This analysis indicated that R2 
over-expression suppressed MMR-induced mutation at A:T base pairs, without 
suppressing MMR itself. 
Western blot data confirms R2 expression during G1 of primary 
splenocytes that have been transduced with R2-expressing 
constructs  
Western blot was performed to investigate cell cycle regulation of RNR sub-units in B 
cells and to confirm over-expression of R2 in transduced cells. “Fucci” mouse B cells 
were cultured in 20 µg/mL S. typhosa LPS (Sigma-Aldrich) plus 20ng/mL mouse IL-4 
(BD Biosciences) for 3 days to induce robust B cell proliferation and were sorted into 
a G1-phase fraction (mKO2+mAG-) and an S/G2/M-phase fraction (mKO2-mAG+) by 
flow cytometry. Fucci mice (Sakaue-Sawano et al., 2008) carry two separate 
transgenes for an orange or a green fluorescent protein that accumulates in a cell 
cycle-dependent manner as a result of fusion to “degrons”, which are sequences 
encoding E3 ubiquitin ligase substrates. The “fucci-red” transgene encodes the mKO2 
orange fluorescent protein fused to a degron from the human CDT1 protein (amino 
acids 30-120); mKO2 accumulates in G0 and G1-phases and very early S-phase and is 
actively degraded in other phases. The “fucci-green” transgene encodes the green 
fluorescent protein mAG fused to a degron from the human geminin protein (the last 
100 amino acids); mAG accumulates in S, G2 and M-phases and is actively degraded 
in G0 and G1-phases. Western blot for R1 and R2 sub-units extracted from sorted cells 
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is shown in Figure 4.3. R2 levels were beneath detection in G1-phase B cells, but 
readily detectable in S/G2/M-phase cells. 
 
To evaluate the expression of R2 in mouse B cells transduced with pMiG/R2, I 
harvested Fucci-red transgenic B cells from mice spleens and transduced these cells 
with pMiG/R2 or pMiG vector control retrovirus, and left cells to proliferate in culture 
for three days. GFP+mKO2+ and GFP+mKO2- populations were then purified by flow 
cytometry. Note that I used mice that carried the fucci-red transgenes, but did not 
carry the fucci-green transgene. 
                                                                                                     
The results in Figure 4.4 show that in G1-phase cells transduced with pMiG vector, R2 
levels remained undetectable, but in G1-phase cells transduced with pMiG/R2 R2 was 
readily detectable. Transduction of B cells with pMiG/R2 retrovirus therefore 
increased R2 expression in G1-phase cells substantially – to levels that approximated 
R2 levels in S/G2/M-phase cells transduced with vector alone. In mKO2- cells (i.e. 
predominantly S/G2/M-phase cells, contaminated with some early G1-phase cells), 
transduction with pMiG/R2 retrovirus increased R2 expression substantially further, 
compared to vector-transduced controls. R1 levels across the cell cycle varied far less 
in B cells than R2 levels, and that over-expression of R2 did not appear to alter the 
levels of R1. The data indicated that retrovirally expressed R2 remained subject to 
post-transcriptional cell cycle regulation, but was able to enhance G1-phase R2 
accumulation to levels approximating S-phase cells.  
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Retroviral R2 over-expression increases susceptibility to 
retroviral and lentiviral transduction 
As increased dNTP pools are associated with increased retroviral transduction 
efficiency (Ravot et al., 2002; H. Zhang et al., 1995), we examined the transduction 
efficacy of R2 over-expressing cells when secondarily transduced with other 
retroviruses or lentiviruses. 
 
Splenic B cells were transduced with either pMiG/R2 or empty pMiG vector, then 
secondarily transduced 48 hours later with retrovirus expressing mKO2. I then 
measured the fraction of GFP+ cells (i.e. transduced in the first round of transduction) 
that were mKO+ by flow cytometry. Primary R2 transduction significantly enhanced 
secondary retroviral transduction efficiency (2–way ANOVA p=0.027) (see Figure 4.5). 
R2 over-expression also enhanced secondary lentiviral transduction. NIH/3T3 cells 
were transduced with either pMiG/R2 or empty pMiG vector and sorted to greater 
than 90% GFP positivity, then secondarily transduced after expansion in culture with 
lentivirus expressing mCherry under confluent and pre-confluent conditions. R2 over-
expression enhanced lentiviral transduction in confluent cells 2.5x better than in pre-
confluent cells (that is, concurrent cells seeded at 2x lower concentration), (Figure 4.6, 
2-way ANOVA p<0.0001). 
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R2 overexpression reduces MMR-independent A:T mutation in 
Msh2-/- B cells 
Somatic mutation at Ig A:T base pairs is largely, but not entirely, dependent on 
mismatch repair. A small minority of A:T mutations are generated independently of 
mismatch repair; in adoptive SWHEL cells this minority represents about 5% of A:T 
mutations (Thientosapol et al., 2017). They require UNG2 and Pol η and are 
therefore proposed to arise via Pol η-mediated mis-incorporation during LP-BER of 
deamination sites initiated by UNG2 (Delbos et al., 2007). To test whether MMR-
independent A:T mutation could also be reduced by R2-overexpression, we used the 
SWHEL transduction/adoptive transfer model (Sharbeen et al., 2010; Sharbeen et al., 
2012) to measure the influence of R2-overexpression on Ig hypermutation on Msh2-
/- B cells. SWHEL mice carry a gene-targeted VDJH-rearrangement and a transgenic 
IgK rearrangement, which together confer B cell and Ig specificity for hen egg 
lysozyme (HEL) (Cook et al., 2003; Phan et al., 2003). Loss of RAG-recombinase 
activity in SWHEL Rag1-/- mice prevents V(D)J receptor editing, ensuring that all B 
cells express identical HEL-specific receptors (Cook et al., 2003). Msh2-/- SWHEL 
Rag1-/- splenocytes were transiently activated via CD40 and transduced with pMiG 
vectors ex-vivo. FACS-purified GFP+ cells were then co-injected with antigen (HEL-
conjugated sheep red blood cells, HEL-SRBC) into multiple C57BL/6 congenic hosts 
that had been primed with non-conjugated SRBC seven days earlier. This induces an 
immune response to HEL dominated by the adoptive SWHEL B cells in the B cell 
compartment (see (Sharbeen et al., 2010)). Six days after adoptive transfer, GFP+ 
HEL-binding cells were recovered from host spleens and sorted one cell per well into 
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96-well PCR plates. The single SWHEL VDJH allele (and 3’-intronic sequences) present 
in each well were then amplified by nested PCR. Single cell PCR products were then 
sequenced by automatic 96-well Sanger sequencing (Macrogen Inc, Korea) and 
mutations collated. Background mutation using this model is about one mutation 
per 94 sequences (Sharbeen et al., 2010). The sequencing primer used produced a 
data collection window of 560bp per sequence (Thientosapol et al., 2017).   
 
Results from nine hosts bearing pMiG/R2-overexpressing Msh2-/- cells were 
compared to ten hosts bearing Msh2-/- cells transduced with empty vector (see 
Figure 4.7). The level of Igh mutation at T for day 6 adoptive Msh2-/- SWhel B cells is 
indistinguishable from the PCR background in  our assay, whereas mutation at A 
remains significantly above background (Sharbeen et al., 2012) (see Figure 4.7). R2 
overexpression produced a statistically significant decrease in mutation at A bases, 
and no significant change in mutation at T bases. R2 overexpression also produced 
no significant change in overall transition or transversion mutation at C or G (see 
Figure 4.7), which indicated that the increase in C:G transition mutations that R2 
overexpression induces in Msh2+/+ (see Figure 4.1) occured via mismatch repair. 
 
It was previously demonstrated in wild-type cells that R2 overexpression significantly 
increased C:G mutation outside, but not within AGCW motifs, while mismatch repair 
deficiency significantly increased C:G mutations within, but not outside AGCW 
hotspots (see Figure 4.2). Analysis of R2 overexpression in Msh2-/- germinal centre B 
cells showed that Msh2-/- decreased C:G mutation outside AGCW motifs and increased 
C:G mutation within AGCW motifs regardless of R2 overexpression (see Figure 4.8). 
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Further analysis of these C:G mutations showed that Msh2-/- decreased C:G 
transversions outside AGCW and increased C:G transitions within AGCW regardless of 
R2 overexpression (see Figure 4.8). Also, R2 overexpression suppressed C:G 
transversions still further in Msh2-/- cells, but only outside AGCW motifs. 
Discussion 
The experiments presented in this chapter showed that R2 levels are cell cycle-
regulated in activated B cells; R2 levels were substantially lower in G1-phase B cells 
than in S/G2/M-phase B cells. R1 levels varied far less across the cell cycle. When 
splenocytes were transduced with pMiG/R2 retrovirus, R2 was detected in G1, while 
vector control splenocytes transduced with pMiG had an absence of detectable R2 in 
G1. Transduction with pMiG/R2 also substantially increased R2 protein in post G1-
phase compared to vector control. R1 protein levels were unchanged in G1-phase and 
post G1-phase in cells transduced with R2 compared to vector controls. Therefore, 
overexpression of R2 presumably increased RNR levels in G1-phase cells. It’s possible 
that pMiG/R2 also increased RNR levels outside G1-phase, but only if endogenous R1 
exists in excess to endogenous R2 in S/G2/M-phase B cells, which seems unlikely. 
 
It has been shown previously that retroviral and lentiviral transduction improves with 
an increased availability of dNTPs (Ravot et al., 2002; H. Zhang et al., 1995). We used 
retroviral and lentiviral transduction susceptibility therefore as a proxy to measure 
dNTP biological availability in cells overexpressing R2. Our experiments indicated that 
R2 over-expression enhanced retroviral/lentiviral transduction, and that this effect 
was greater in confluent than in non-confluent cell cultures. Given the known function 
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of R2 as a subunit of RNR, it is likely therefore that R2 over-expression increased the 
availability of dNTPs to retroviral/lentiviral reverse transcriptases and DNA 
polymerases in primary mouse B cells, especially in G0/G1-phase. However, we cannot 
rule out the possibility that R2 overexpression enhances transduction by some other 
mechanism. 
 
R2 over-expression significantly reduced mutation at A in Msh2ko/ko SWHEL B cells 
(p=0.036), but we were unable to measure an impact on mutation at T, which is 
already extremely low in Msh2ko/ko SWHEL B cells, because of background noise. The 
data suggests that dNTP paucity drives mis-incorporation during UNG-induced LP-BER, 
producing a small number of UNG2-dependent mutations at A:T base pairs and also 
at C:G base pairs outside AGCW motifs, in addition to strongly influencing mis-
incorporation at both A:T and C:G base pairs during AID-induced MMR. Combined with 
previous data produced by Daniel Bosnjak (see Figure 4.2) and analysis of mutation 
within versus outside AGCW hotspots (Figure 4.8), these data suggest that the 
mechanism by which R2 over-expression suppresses mutation at A:T base pairs is not 
by direct inhibition of MMR. As R2 over-expression did not increase C:G transition 
mutation in Msh2ko/ko cells, it is unlikely that R2 over-expression inhibits uracil BER, 
because inhibition of uracil BER substantially increases the frequency of C:G to T:A 
transition mutation in Ig genes (Thientosapol et al., 2017).  
 
In total, our data indicate, but do not prove that reduced production of dNTPs in G1-
phase drives much of the error-prone synthesis at A:T base pairs, and to a lesser extent 
at C:G base pairs in germinal centre B cells, whether mutation is via nan-canonical 
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MMR or long patch BER. 
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4.2 shRNAs against SAMHD1 decrease Ig 
mutation at A and T bases in vivo 
 
If over-expression of R2 influenced Ig hypermutation via an increase in dNTP supply, 
as proposed in the previous chapter, then treatments that reduce dNTP degradation 
should have a similar impact. dNTPs are actively degraded in vertebrate cells by the 
dNTP triphosphate hydrolase SAMHD1 (Goldstone et al., 2011; Powell et al., 2011). 
The restriction of dNTP supply by SAMHD1 is potently anti-viral, although SAMHD1 
also possesses an exonuclease activity that additionally may be important in 
restricting viruses (Beloglazova et al., 2013; Ryoo et al., 2014). SAMHD1 has also been 
found to be associated with the RNA exosome (Lim et al., 2015) and participates in 
HR-mediated DNA repair (Daddacha et al., 2017). Although SAMHD1 is not degraded 
in a cell cycle-dependent manner akin to R2, it’s activity is nonetheless cell-cycle 
regulated by post-translational modification (Pauls et al., 2014c).   
 
To generate preliminary data on the role of SAMHD1 in Ig mutation, we chose to 
retrovirally express shRNAs targeting mouse Samhd1 in adoptive SWHEL B cells, as a 
means to generate data directly comparable to our data on the influence of R2 on Ig 
mutation. Samhd1-knockout mice were published after this shRNA project 
commenced (Rehwinkel et al., 2013). Using these mice would have required 
importation, rederivation and crossing with SWHEL mice to produce data directly 
comparable to our existing hypermutation data. 
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SAMHD1 is present in primary B lymphocytes 
SAMHD1 expression was confirmed in primary B cells. Splenocytes from Fucci mice  
(Sakaue-Sawano et al., 2008) were cultured in-vitro in the presence of bacterial LPS. 
G1-phase fraction (mKO2+mAG-) and S/G2/M-phase fractions (mKO2-mAG+) were 
obtained by flow cytometric sorting and western blotting for SAMHD1 expression (see 
Methods: Preparation of cell extracts, western blot analysis). Using the same blot that 
was used for R1 and R2 western blot (Figures 4.3), SAMHD1 was readily detectable in 
both G1 and post G1 cell cycle phases (Figure 4.9).  
Selection of potent shRNAs targeting Samhd1 in NIH/3T3 cell 
lines 
Potential 21-mer shRNA constructs targeting SAMHD1 mRNA (Ensemble cDNA 
ENSMUST000000057725) were designed using the protocol described in (Dow et al., 
2012). Identification of potential candidates used a three-step process. An online 
siRNA prediction tool ‘Designer of Small Interfering RNAs-DSIR’ (Vert et al., 2006) 
identified potential sequences. These sequences were then cross-checked against the 
BLAST database to exclude sequences matching off-target genes. Sequences were 
then filtered again through a series of seven Sensor exclusion criteria (Dow et al., 
2012). 
 
11 Samhd1 shRNA sequences were synthesized as DNA gene blocks (Integrated DNA 
Technologies) and cloned into context of natural miRNA mIR30 in the retroviral 
expression plasmid pLMP (Zhou et al., 2008), along with an additional four commercial 
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shRNA sequences targeting mouse Samhd1 and two control sequences (Table 4.1) 
(see Methods: Creation and validation of shRNA against SAMHD1). Retroviral 
supernatants were created from these LMP vectors and used to transduce NIH/3T3 
cells (see Methods: Creation and validation of shRNA against SAMHD1).  
 
Semi-quantitative western blot analysis for SAMHD1 was performed using extracts 
from LMP-transduced NIH/3T3 cells (see Methods: Preparation of cell extracts, 
western blot analysis). Total protein blotting was measured using Memcode protein 
stain; anti-SAMHD1 signal was then normalized to Memcode signal using Imagelab 
analysis software (Bio-Rad). Estimated percentage knockdowns of Samhd1 
knockdown is listed in Table 4.1. Knockdown ranged between 8-98% based on this 
analysis. (see Figure 4.10). 
 
Using these data, western blot was repeated for the most potent shRNAs (#1,2,8 and 
the commercial shRNA TRCN0000099803) and for a low potency shRNA (#4). This 
time, closer approximation of equal protein loading was performed, as confirmed by 
Memcode staining (see Figure 4.10). Percentage knockdowns were similar to the first-
round results. From this, the candidates selected for in vivo experiments were Samhd1 
shRNA 1 (96-98% knockdown) and TRCN0000099800 (91-93% knockdown).  
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ID Samhd1 shRNA sequence DSIR score 
(Higher is better) 
Knockdown (%) Knockdown 
(Repeat) (%) 
1 CACGAGAUAGUGUCUAACAAGA 98.2 98 96 
2 CUCGUGUUCACUUCUAUUGUAA 95 93 86 
3 ACCAUAAGGUCAUAUAAUUCAA 93.3 78  
4 CUCACUUCUAUUGUAAGAGCAA 93.3 8 78 
5 AUGGAACUGUUUGAAAGGAUUA 92.7 47  
6 AGAAGAAGAUGAUAGAAUGUAU 92.7 89  
7 AACCAAUGACCUUUAUUUAGUA 91.9 83  
8 CCACAAUUAAGUUAGGAAAUAU 91.5 90 85 
9 AAAAGCGUGAGAAGAUUAGGAA 88.4 N/A  
10 CUCACAAUUAAGUUAGGAAAUA 88.1 86  
11 CUGAACUCAAACUUGUCAUGAA 88 95  
TRCN0
000099
803 
CAAGAAGCAUUAUCUGGUGUAU  73  
TRCN0
000099
804 
CAGAAGACAUUACCUUUAUCAA  31  
TRCN0
000099
800 
AUGGACAUCUUCAGAGACAAUA  91 93 
TRCN0
000099
801 
CGAGAAGAUUAGGAAGGAAGAA  75  
CJ171 ACAACAAGATGAAGAGCACCAA  Control  
ET06 ATCTCGCTTGGGCGAGAGTAAG  Control  
Table 4.1: 11 shRNA constructs (IDs 1-11) against Samhd1 were created as per protocol 
described in (Dow et al., 2012) and cloned into the mIR30 retroviral expression plasmid 
LMP1066, along with an additional four commercial shRNA sequences 
(TRCN0000099800,1,3,4) and two control sequences (CJ171, ET06) (construct 9 was not 
successfully cloned). Retroviral supernatants were created and used to transduce NIH/3T3 
cells. Western blot analyses for Samhd1 were performed from extracts of transduced 
NIH/3T3 cells cultured for 3 days in LPS. Samhd1 knockdown were calculated from western 
blot signal compared to controls (CJ171 and ET06).
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Knockdown of Samhd1 decreases mutations at A and T bases 
LMP-derived retroviruses producing Samhd1 shRNA1 and TRCN0000099800 shRNAs 
were used in the SWHEL transduction/adoptive transfer model. Two separate SWHEL 
transduction/adoptive transfer experiments were performed, consisting of three mice 
each for Samhd1 shRNA1 and TRCN0000099800 constructs, with a total of 134 and 
127 germinal centre SWHEL Igh sequences obtained, respectively. Three separate 
SWHEL transduction/adoptive transfer experiments consisting of four mice for each 
control shRNA (CJ171 and ET06) were performed and yielded a total of 176 and 162 
sequences respectively. 
 
Mutations at A and T bases, which mostly represent nucleotide substitutions due to 
MMR were decreased in cells expressing Samhd1 shRNA1 and TRCN0000099800, by 
23 and 15%, respectively, relative to the control sequences (see Figure 4.11). Using a 
non-parametric test (Mann-Whitney), these results were not statistically significant. 
On a per mouse basis, the Mann Whitney test shows a two-tailed p value of 0.0546. 
The remaining nucleotide substitutions were also analysed. There was no difference 
in transition mutations at C:G or transversion mutations at C:G between cells 
expressing Samhd1 shRNAs versus control shRNAs. 
Discussion  
In previously published experiments, SAMHD1 expression was detected by western 
blot in resting phase human fibroblasts only and was not detected in proliferating 
human fibroblasts (Franzolin et al., 2013). In a later paper, SAMHD1 was detected in 
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both G1 and S-phases in human lymphocytes (Yan et al., 2015). In agreement with the 
latter report, we found that SAMHD1 is expressed consistently throughout the cell 
cycle in mouse B cells. 
 
T592 phosphorylation of SAMHD1 occurs in S-phase human lymphocytes (Yan et al., 
2015); this inhibits SAMHD1 dNTPase activity by preventing the formation of SAMHD1 
tetramers. We did not measure SAMHD1 T592 phosphorylation. An antibody specific 
for T592 phosphorylated human SAMHD1 exists (White et al., 2013b), but it’s use on 
western blots would not have quantified non-phosphorylated dNTPase-active 
SAMHD1.   
 
Samhd1 knockdown produced a modest decrease in mutation at A:T that was not 
statistically significant. There were no significant changes in transitions at C:G or 
tranversions at C:G. These results were modest compared to the results from R2 
overexpression, which showed a much more pronounced decrease in mutations at A:T 
and a significant increase in transitions at C:G. These results suggested that analysis 
of hypermutation in Samhd1-knockout B cells would be worthwhile nonetheless, 
because the likelihood that incomplete silencing of Samhd1 produces a strongly 
“leaky” phenotype. Even low levels of Samhd1 are able to change dNTP pools (Arnold 
et al., 2015; Hansen et al., 2014), so the residual SAMHD1 we detected in silenced cells 
may still cleave dNTPs sufficiently to drive high levels of Igh A:T mutation. The negative 
correlation between Samhd1 shRNA efficacy and levels of A:T mutation in adoptive B 
cells (see Figure 4.11) also indicated that investigation of Ig hypermutation in Samhd1-
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frameshift deletions in Samhd1 in SWHEL embryos in collaboration with Professor 
Robert Brink.
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Figure 4.1: Day 6 Igh hypermutation in adoptive SWHEL germinal centre B cells !
retrovirally over-expressing one of three distinct ribonucleotide reductase R2 !
isoforms compared to pMiG vector controls. Mutations are divided into !
mutations at A/T, transition mutations (ts) at C/G and transversion mutations !
(tv) at C/G. Each circle represents the mean mutation (+/- SEM) per sequence !
for one mouse. Histograms represent the means (+/- SEM) of mouse means: !
**P<0.01,***P<0.001.
.
96
wt/wt
virus
Msh2
vector R2
*
m
ea
n 
m
ut
at
io
ns
 p
er
 s
eq
ue
nc
e
0
0.5
1.0
1.5
ko/ko
vectorR2AAN
C or G in AGCW
C or G outside AGCW
Figure 4.2: Mutation focussing to AGCW hotspots in Igh in germinal !
centre B cells over-expressing R2 or R2AAN in Msh2+/+ (wt) !
mice compared to vector transduced Msh2-/- (ko) B cells. Each circle !
represents the mean mutation (+/- SEM) per sequence for one mouse. !
Histograms represent the means for mice: *P<0.05.
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Figure 4.3: Western blot for the R1 (90kda) and R2 (45kda) subunits of !
ribonucleotide reductase extracted from Fucci splenic B cells cultured for 3 !
days in the presence of bacterial LPS. Cells were sorted for mKO+mAG- (G1-phase)  !
and mKO-mAG+ (S/G2/M-phase) populations. R1, anti-R1 signal; R2, anti-R2 signal; !
Memcode total protein stain (10-20kda bands).
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Figure 4.4: Western blot for the R1 (90kda) and R2 (45kda) subunits of ribonucleotide !
reductase extracted from Fucci-red splenic B cells transduced with retrovirus !
co-expressing GFP and R2 subunit or GFP reporter only virus and cultured for 3 !
days in the presence of bacterial LPS. Cells were sorted into GFP+mKO- and GFP+mKO+ !
populations. R1, anti-R1 signal; R2, anti-R2 signal; Memcode total protein stain (10-20kda !
bands).  
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Figure 4.5: Retroviral transducibility conferred by R2 overexpression. Primary !
mouse splenocytes were transduced with retrovirus with pMiG/R2 or MiG vector to !
express R2 plus GFP or GFP alone, respectively, then secondarily transduced 48 hours !
later with serially diluted retrovirus to express mKO. Plots show the frequency of mKO+ !
cells amongst GFP+ cells 48h after secondary transduction, as determined by flow !
cytometry:(*P=0.027 two-way ANOVA, error bars = 95%CI).
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Figure 4.6: Lentiviral transducibility conferred by R2 overexpression in confluent !
and pre-confluent NIH/3T3 cells. NIH/3T3 cells were transduced with retrovirus to co-
express GFP and R2 or GFP alone and flow-cytometry sorted to be >90% GFP+. After 
expansion in duplicate cultures at 2-fold different starting concentrations, they were 
secondarily transduced with serially diluted lentivirus expressing mCherry; lentiviral 
transduction occurred at the point of confluence for one culture (“100% confluence”) and 
prior to confluence for the other (“50% confluence”). Plots show the frequency of 
mCherry+ cells amongst GFP+ cells 48h after secondary transduction, as determined 
by flow cytometry. R2 over-expression increased the frequency of subsequent lentiviral 
transduction (i.e. frequency of mCherry+ cells) to a 2.5x greater extent in confluent cells 
than in pre-confluent cells (two-way ANOVA P<0.0001).
Figure 4.7: Day 6 Igh hypermutation in adoptive SWHEL Msh2-/- germinal centre !
B cells transduced with retrovirus to overexpress R2 subunit of ribonucleotide!
reductase or transduced with empty vector. Results are divided into mutations at !
A, mutations at T, transition mutations (ts) at C/G and transversion mutations (tv) at !
C/G. Each circle represents the mean mutation (+/-SEM) for sequences for one mouse. !
Histograms represent the means (+/-SEM) of mouse means: *P<0.05.
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Figure 4.8: Focusing of C/G mutation to AGCW motifs in adoptive SWHELMsh2-/- !
germinal centre B cells transduced to express the R2 subunit of ribonucleotide 
reductase or with empty vector. The top figure shows all forms of mutation at C:G 
within or outside AGCW motifs. Each circle represents the mean mutation per sequence 
for one mouse. Histograms represent the means (±s.e.m.) of mouse means: *P<0.05, 
**P<0.01. The bottom figure shows the same data simplified in a 2D plot. x-axes: 
Transition (Ts) mutations at C/G outside (left) or within (right) AGCW motifs. y-axes: 
Transversion (Tv) mutations at C/G outside (left) or within (right) AGCW motifs. 
Significant differences to the vector-transduced Msh2+/+ means are indicated with "
asterisks (one-way ANOVA, Holm–Sidak’s post hoc tests): vertical and black for C/G "
transitions; horizontal and gray for C/G transversions. All means lying to the right of the "
vertical dotted line represent significantly elevated C/G transition frequencies relative to "
the Msh2+/+ data. Data from cells overexpressing R2 or R2AAN were pooled. ***P<0.001, 
****P<0.0001. 
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Figure 4.9: Western blot for SAMHD1 (76kda) extracted from Fucci splenic !
B cells cultured for 3 days in the presence of bacterial LPS. Cells were sorted !
for mKO+mAG- (G1-phase)  and mKO-mAG+ (S/G2/M-phase) populations. SamHD1,!
anti-SAMHD1 signal; Memcode total protein stain (10-20kda bands).
104
Figure 4.10 (A) Western blot for Samhd1 (76kda) extracted from NIH/3T3 cells "
transduced with LMP retrovirus expressing shRNAs against Samhd1. NIH/3T3 
cells were cultured for 3 days after transduction. The shRNAs expressed by vectors 
1-11 were designed in our laboratory, TRCN 00009980-4 were designed by the shRNA 
consortium and published by Sigma-Aldrich. Memcode staining (10-30kda window) 
represents protein loading. (B) Repeat Western blot with better approximation of 
equal protein loading using selected samples. 
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Figure 4.11: Day6 Igh hypermutation in adoptive SWHEL germinal centre B cells !
transduced with retrovirus expressing shRNAs against Samhd1. Results are divided !
into mutations at A/T, transition mutations (ts) at C/G and transversion mutations (tv) at 
C/G. Each circle represents the mean mutation for sequences for one mouse. 
Histograms represent the means (+/-SEM) of means for all mice (control 1, non-
sliencing shRNA; control 2, luciferase control). 
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Activation-induced deaminase (AID) initiates hypermutation of Ig
genes in activated B cells by converting C:G into U:G base pairs. G1-
phase variants of uracil base excision repair (BER) and mismatch
repair (MMR) then deploy translesion polymerases including REV1
and Pol η, which exacerbates mutation. dNTP paucity may contrib-
ute to hypermutation, because dNTP levels are reduced in G1
phase to inhibit viral replication. To derestrict G1-phase dNTP sup-
ply, we CRISPR-inactivated SAMHD1 (which degrades dNTPs) in
germinal center B cells. Samhd1 inactivation increased B cell virus
susceptibility, increased transition mutations at C:G base pairs, and
substantially decreased transversion mutations at A:T and C:G
base pairs in both strands. We conclude that SAMHD1’s restriction
of dNTP supply enhances AID’s mutagenicity and that the evolu-
tion of Ig hypermutation included the repurposing of antiviral
mechanisms based on dNTP starvation.
B cells | mutation | DNA repair | dNTPs | deamination
Somatic hypermutation, in combination with clonal selection,creates high-affinity antibodies (Ig) in response to viral and
bacterial infection. Activation-induced deaminase (AID, gene
Aicda) initiates mutation by deaminating genomic cytosines, in ei-
ther strand of Ig V(D)J-regions, which creates a U:G mismatch in
the DNA (Fig. S1). If replication proceeds without uracil excision,
this produces a C:G to T:A transition mutation in one daughter
cell, because A is incorporated opposite U (reviewed in ref. 1).
Most deaminations are excised by the base excision repair
(BER) enzyme UNG2, a uracil-specific enzyme that converts U
into an apyrimidinic (AP) site (Fig. S1). The enzymes SMUG1
and TDG can substitute for UNG2, but in UNG2-proficient
cells, their contribution to Ig hypermutation is probably minor
(2–5). Mismatch repair (MMR) is also recruited (Fig. S1), pre-
sumably by the U:G mismatches deamination induces. Processing
via BER or MMR predominantly restores C in place of U (6–9)
but is also error-prone. Error-prone BER converts deamination
sites into transition or transversion mutations at C/G and occa-
sionally produces mutations at bases flanking deamination sites,
including A/T bases (1). Mutation does not require the canonical
BER polymerase, Pol β (10); instead, C/G to G/C transversion
mutation requires the translesion polymerases REV1 and Pol η
(11, 12). Bypass of persistent AP sites using translesion polymer-
ases is therefore thought to be the main mechanism of UNG2-
dependent Ig hypermutation (12, 13).
Mutation at Ig A:T base pairs is substantially reduced by in-
activation of the MMR genes Msh2, Msh6, or Exo1, inactivation
of Polh, or by mutation of the K164 ubiquitination site in mouse
PCNA (14–19). This has led to a model in which A/T mutations
are introduced by translesion Pol η, predominantly recruited by
noncanonical MMR (1, 20), with minor recruitment during
UNG2-driven long patch (LP) BER (21). In this model (Fig. S1),
activated MutSα recruits ExoI to create excision patches. Mon-
oubiquitinated PCNA then recruits error-prone Pol η during
excision patch in-fill, which introduces mutations biased toward
A:T base pairs. Until recently, it was unknown how the DNA was
nicked to allow ExoI entry, but it is now clear that APE1, APE2,
and MutLα produce nicks semiredundantly (4, 5, 22) (Fig. S1).
A major question raised by this model is why PCNA becomes
ubiquitinated to recruit Pol η during AID-induced MMR. Only
G1-phase activities of AID or UNG2 are mutagenic in mouse B
cells (5, 6, 23). Strong evidence for mutagenic interaction between
BER and MMR implies that mutagenic MMR also occurs in G1
phase (2, 3, 8, 9, 12, 21). dNTP levels were reported to be lowest in
G1 phase, especially in the nucleus (24). We proposed, therefore,
that dNTP pools may be inadequate to support long-patch DNA
synthesis by conventional DNA polymerases during G1-phase
MMR; polymerase stalling could then induce PCNA ubiquitina-
tion (ref. 25; also see ref. 20). The rate-limiting enzyme for dNTP
production is ribonucleotide reductase (RNR), which is down-
regulated in G1-phase cells via turnover of the R2 subunit (26).
However, the major regulator of dNTP levels is not in fact RNR
activity, but the deoxynucleotide triphosphohydrolase SAMHD1;
dNTPs increase more than 10-fold in resting and proliferating
Samhd1−/− cells (27, 28). SAMHD1 is a potent restrictor of virus
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replication (27, 28), and its activity is highest in G1 phase (29). We
quantified Ig hypermutation in mouse germinal center B cells
lacking SAMHD1. We observed an increase in transitions at C/G
and major decreases in transversions at A/T and C/G, which
suggests that SAMHD1-induced dNTP paucity contributes to
AID-induced mutagenesis via both MMR and uracil BER.
Results
RNR and SAMHD1 Expression in Mouse B Cells. Ribonucleotide re-
ductase (RNR) consists of R1 and R2 subunits, which form a
catalytic site at R1/R2 interfaces (reviewed in ref. 30). Consistent
with reports for other cell types (30), R2 levels were substantially
lower in G1-phase B cells [i.e., in mKO2+vemAG−ve (orange)
Fucci-transgenic B cells; ref. 31] than in the rest of the cell cycle
[i.e., in mKO2−vemAG+ve (green) Fucci- transgenic B cells; Fig. 1A],
implying that B cells carry out far less de novo deoxynucleotide
synthesis in G1 phase than in S phase. SAMHD1 levels were not
obviously cell cycle regulated in mouse B cells (Fig. 1A), which was
consistent with posttranslational modification being the principal
regulator of SAMHD1 activity (29).
Samhd1 Inactivation Substantially Decreased Transversions in Ig
Genes. We CRISPR-targeted Samhd1 exon 1 in C57BL/6 mouse
embryos. Samhd1 alleles carrying 25- or 41-bp frame-shift deletions
(“Δ”) in exon 1 (Fig. S2) appeared to be knockout alleles (Fig. 1A).
CRISPR mutation of Samhd1 enhanced retroviral transduction
(P = 0.0042; Fig. 1B) and substantially increased the levels of
dNTPs in resting and blasting B cells (P < 0.0001, P = 0.0003, re-
spectively) and in G1-phase cells (Fig. 1C). Purines (dATP and
dGTP) were increased more than pyrimidines (dTTP and dCTP;
Fig. 1C). These transduction and dNTP data closely reproduced
data generated using conventional Samhd1−/− mice (28, 32, 33).
We four times back-crossed Samhd1Δ alleles to Ig-transgenic
“SWHEL” mice, which have a C57BL/6 background, then bred
Samhd1Δ25/Δ25SWHEL mice (and later, Samhd1Δ41/Δ41SWHEL
mice). To quantify Ig hypermutation, we ex vivo transduced SWHEL
B cells, which are specific for hen egg lysozyme (HEL), to express
the PSB2 uracil glycosylase inhibitor and/or GFP then adoptively
transferred GFP-positive cells into congenic hosts and immunized
with HEL conjugated to SRBC, as outlined in Fig. 2A and de-
scribed previously (6, 9, 25). Adoptive cells are T-dependent and
concentrate in germinal centers soon after transfer (25, 34). Igh
mutations were collated in a 560-bp window from ≤47 single HEL-
binding GFP+ve cells per host, sorted from spleens 6 d after
adoptive transfer, using a minimum of three donors and hosts per
treatment (Methods). This procedure results in reproducible
hypermutation with minimal impact on the mutation spectrum by
antigen selection, because the BCR analyzed starts with high af-
finity for HEL and the duration of hypermutation (i.e., 6 d) is short
(9). Our model predicted that loss of SAMHD1 would decrease
mutation at A:T base pairs, and we indeed found this to be the
case (P < 0.0001 for mutation at A; P = 0.029 for mutation at T;
Fig. S3A). Specifically, Samhd1 inactivation reduced the frequency
of transversion mutations at A:T base pairs (hereon called “A/T
transversions”), relative to wild-type cells (P < 0.0001; Fig. 2 B, i),
but barely changed the frequency of A/T transitions (Fig. 2 B, ii).
Samhd1 inactivation also substantially reduced C/G transversions
(P < 0.0001; Fig. 2 B, iii) and nearly doubled C/G transitions (P =
0.0041; Fig. 2 B, iv). This increase in C/G transitions partly com-
pensated for the loss of A/T and C/G transversion mutations; total
Ig mutation in Samhd1Δ/Δ B cells was lower than in wild-type cells
(Table 1), but not significantly so (P = 0.07 by one-way ANOVA).
See Table 1 and Figs. S3 and S4 for overviews of the mutation
data. Samhd1 inactivation reduced all classes of C/G transversions.
That is C/G to G/C transversions, which are introduced by
REV1 via BER and by Pol η via MMR (11, 12, 35), and C/G to A/
T transversions, which are introduced by a polymerase or poly-
merases currently unknown (Table 1 and Fig. S3A).
To test whether the impact of Samhd1 inactivation on Ig
hypermutation was an artifact of antigen selection, we quantified
mutation in intron sequences immediately 3′ to the VDJH exon
(Fig. S3B). Our 560-bp sequence window included the 5′ 101 bp
of the J-CH intron (Fig. S4); this region is analogous to that
commonly analyzed in Peyers patch B cells (5, 36)—albeit, with
the SWHEL intron carrying a deletion that tags gene-targeted
cells (34). Samhd1 inactivation caused significant reductions in
transversions at A/T (P = 0.0089) and at C/G (P = 0.0001) in the
J-CH intron and increased C/G transitions, albeit not significantly
(P = 0.065; Fig. S3B), relative to wild-type cells. We conclude
that the impact of Samhd1 inactivation on Ig hypermutation—in
particular, reduced transversion mutation—was not an artifact of
antigen selection.
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Fig. 1. (A) Western blot for RNR subunits (R1 = 90 kDa; R2 = 45 kDa) or SAMHD1 (76 kDa) extracted from splenic B cells after culture for 3 d in LPS. Fucci-red/
Fucci-green transgenic B cells were sorted into green (mAG+mKO2−) and orange (mAG−mKO2+) populations. Memcode staining (∼10- to 20-kDa region)
indicates protein loading and transfer. In Fucci cells, mKO2+ cells are in G1 phase and mAG
+ cells are in S, G2, and M phases (6, 60). (B) Transducibility of
Samhd1Δ/Δ B cells. Splenocytes were cultured with LPS for 1 d to activate B cells, then transduced in triplicates with serially diluted pMiG retrovirus. Fre-
quencies of GFP+ cells were determined by cytometry 2 d later. **P = 0.0042, two-way ANOVA. (C) dNTPs measured in whole-cell extracts. (C, i) dNTPs per 106
resting splenocytes, measured in three independent experiments. ****P < 0.0001, two-way ANOVA. (C, ii and iii) Splenocytes were activated with LPS, and
dNTPs were extracted from live cells purified by sedimentation over Histopaque 1083 2 d after activation (ii). The ratio of Samhd1Δ/Δ dNTPs to Samhd1w.t./Δ
dNTPs is shown for four independent experiments. ***P = 0.0003, two-way ANOVA. (C, iii) One day after LPS activation, cells were transduced to express
mKO2-cdt fusion protein, which tagged G0/1 cells with orange fluorescence (6). Blasting mKO2
+ cells were purified by flow cytometry 2 d later.
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Samhd1 Inactivation Does Not Phenocopy MMR Inhibition. Like
Samhd1 inactivation,Msh2 knockout decreases A/T mutations and C/
G transversions in SWHEL B cells (9) (Fig. 2, Table 1, and Fig. S3).
This raised the possibility that Samhd1 inactivation acted by partially
inhibiting AID-induced MMR. A hallmark feature of MMR knock-
out is the focusing of AID-induced mutation on hotspot motifs, es-
pecially AGCW motifs (see ref. 9 and Table S1). We therefore
examined our mutation data for hotspot focusing (Fig. 3) and
measured hypermutation in adoptive Msh2−/−Samhd1Δ25/Δ25
SWHEL B cells (Figs. 2B and 3, Table 1, and Figs. S3 and S4). In
summary, we found that Samhd1 inactivation did not focus AID-
induced mutation on AGCW hotspots, an outcome quite different
to loss of MMR (see overviews in Table S1).
The strand bias of mutation changes further distinguished
Samhd1Δ/Δ from Msh2−/− cells. As described before (e.g., ref. 9),
Msh2−/− altered mutations at C nearly twice as much as at G. In
contrast, Samhd1 inactivation altered mutation at C and at G to
comparable extents (Fig. S3A).
Samhd1 Inactivation Does Not Inhibit Uracil Repair via UNG2. Re-
duced C/G transversion in Samhd1Δ/Δ B cells raised the obvious
possibility that uracil excision by UNG2 might partially depend
on SAMHD1, via some unexpected mechanism. To measure
UNG2-mediated uracil repair, we blockaded UNG2 activity in
adoptive Samhd1Δ/Δ cells using retroviral expression of the uracil
glycosylase inhibitor (ugi) from bacteriophage PSB2 (37). Previous
blockades of UNG activity in wild-type SWHEL B cells with ugi in-
creased Igh C/G transitions 2.3-fold, in a strand-unbiased manner,
presumably by increasing “ignorant” replication opposite persistent
uracils (6, 9). In Samhd1Δ/Δ B cells, retroviral expression of ugi-GFP
increased C/G transitions by 1.9-fold (P < 0.0001), relative to expres-
sion of GFP alone (Fig. 2 B, iv), and this increase was strand-unbiased
(Table 1 and Fig. S3A). This demonstrated that UNG2 mediates re-
version of similar frequencies of U:G base pairs into C:G base pairs in
hypermutating Igh genes regardless of SAMHD1 activity, so it is un-
likely SAMHD1 alters uracil excision rates by UNG2.
Discussion
Samhd1 Inactivation Partially Phenocopies Genotypes That Block Pol
η Recruitment.We, and later others, proposed polymerase stalling
induced by dNTP imbalances as a G1-phase mechanism that
could explain PCNA ubiquitination, Pol η recruitment, and nu-
cleotide misincorporation during AID-induced MMR (20, 25).
Our finding here of reduced A/T mutation in Samhd1Δ/Δ cells
(Fig. S3A) was predicted by this model but does not prove it. The
unequal impact of Samhd1 inactivation on A/T transversions
versus A/T transitions (Fig. 2B and Fig. S3B) was not expected
but might be explained by the greater impact of Samhd1 in-
activation on purine dNTPs over pyrimidine dNTPs (see below
and Fig. 4). Samhd1-CRISPR also decreased C/G transversions
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Fig. 2. Igh hypermutation in transduced germinal center B cells. (A) Experiment design. (B) Each symbol represents the mean Igh mutations (in a 560-bp sequence
window) for ∼45 transduced cells sorted from one host mouse. Histograms represent the means (±SEM) of hosts. Mutations are divided into transversions at A:T (i),
transitions at A:T (ii), transversions at C:G (iii), and transitions at C:G (iv). Symbols: white, Samhd1wt (thin border) or Samhd1+/Δ25 (bold border); gray, Samhd1Δ25/Δ25;
black; Samhd1Δ41/Δ41; black dot, Msh2−/−. Transduced with: diamonds, pMiG; triangles, pM/ugi-GFP. Significant differences (one-way ANOVA with Holm-Sidak’s post
hoc tests) to the vector-transduced Samhd1Δ25/Δ25 means (i.e., the dashed line) are indicated: *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; ns, not significant.
Table 1. Raw mutation data
No. of mutations
No. of
From G
(124 bases)
to:
From C
(131 bases)
to:
From A
(135 bases)
to:
From T
(170 bases)
to: TOTAL
Cells Protein Hosts Sequences Deletions* Insertions* A C T T G A G T C C A G Per sequence
WT or Samhd1+/Δ GFP 13 565 9,2,1 0 190 74 35 142 26 27 125 170 87 64 44 28 1.79
Samhd1Δ/Δ GFP 8 354 1 1 191 12 4 144 10 2 60 15 7 32 11 8 1.40
Msh2−/−Samhd1Δ/Δ GFP 5 213 1,2,15,5,1 0 129 11 3 122 2 5 3 1 2 1 1 0 1.31
Msh2−/− GFP 10 446 10,3 0 183 40 18 210 5 7 5 5 3 2 2 0 1.08
Samhd1Δ/Δ ugi-GFP 5 218 0 0 235 0 1 163 0 1 61 20 12 34 6 8 2.48
*The size (bp) of all deletions or insertions observed is listed, separated by commas.
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and increased C/G transitions in a strand unbiased manner that
was not focused on AGCW hotspots (Figs. 2 and 3, Figs. S3 and
S4, and Table S1). We largely ruled out reduced uracil excision
via MMR or UNG2 as the cause of this. Reduced A/T mutations
decoupled from an increase in focus on AGCW hotspots was
observed previously in Polh−/− and PcnaK164R/K164R mice (21,
38), and contrasts with MMR deficiency, which couples these
two mutation characteristics, regardless of Samhd1, Pcna, or
Polh genotype (Fig. 3; see also phenotypes summarized in Table
S1). The contrast in hotspot focusing among Samhd1Δ/Δ, Polh−/−,
and PcnaK164R/K164R on the one hand, and Msh2−/−, Msh6−/−,
and Exo1−/− on the other, can be explained by the likelihood that
the former genetic manipulations do not prevent mismatch excision
and only impact excision patch in-fill, while the latter manipulations
prevent both. We interpret the similarities in the hypermuta-
tion phenotypes of Polh−/−, PcnaK164R/K164, and Samhd1Δ/Δ B
cells as consistent with Samhd1 inactivation reducing PCNA
ubiquitination and Pol η recruitment during AID-induced MMR,
without reducing the production of mismatch excision patches.
Nonetheless, our data do not prove this model. Differences in the
precise frequencies of mutation subclasses in Polh−/−, PcnaK164R/K164,
and Samhd1Δ/Δ B cells (summarized in Table S1) might be as-
cribed to differences in the polymerases recruited downstream of
AID, as well as the unique dNTP milieu in Samhd1Δ/Δ cells. For in-
stance, Pol δ and Pol κ are likely to be recruited to in-fill MMR excision
patches in PCNAK164R/K164R and Polh−/− B cells, respectively (18).
Unlike theMsh2−/−, PCNAK164R/K164R, and Polh−/− mutations,
Samhd1 inactivation did not suppress A/T transitions, although it
suppressed A/T transversions (Fig. 2B and Fig. S3B). This may
reflect the fact that Samhd1 inactivation skewed the dNTP pool
toward purines (Fig. 1C), which would increase bias toward in-
corporation of dA and dG, regardless of the polymerase used.
Since mismatch excision downstream of AID is heavily skewed to
the top strand (5, 9), this would result in bias toward incorporation
of dA and dG opposite bottom-strand dT during AID-induced
MMR (Fig. 4). Thus, the A/T mutation phenotype of Samhd1Δ/Δ
B cells can theoretically be explained by altered polymerase re-
cruitment, as a consequence of better dNTP supply, combined
with bias toward top-strand purine incorporation during MMR.
Would A/T mutation disappear altogether in a hypothetical sit-
uation where G1-phase dNTP pools perfectly mimicked S phase?
We doubt it: The corequirement for UNG2 and MMR for al-
most half of Ig C/G transversions implies that UNG2-derived AP
sites are encountered by polymerases during AID-induced MMR
(9, 39, 40). This could induce a baseline of polymerase stalling
and PCNA ubiquitination regardless of dNTP supply. The role of
Ub-PCNA in AID-induced MMR might therefore be explained
by a combination of both polymerase encounter with AP sites
and SAMHD1-induced dNTP paucity.
The hypermutation phenotypes of Ung−/−, Rev1−/−, and Polb−/−
B cells suggest that most C/G transversions are created by
translesion bypass of AP sites, with a minority (∼15%) created by
simple misincorporation at C/G during MMR, long-patch BER,
or single-nucleotide BER (10, 13, 35). We speculate that the sub-
stantially reduced C/G transversion and increased C/G transition
mutation in Samhd1Δ/Δ cells is again most simply explained by bias
toward purine misincorporation over pyrimidine misincorporation—
this time during UNG2-induced lesion bypass events, as illustrated
in Fig. 4. It is possible that SAMHD1’s exonuclease activity and/
or its capacity to recruit the endonuclease CtIP (41, 42) influences
Ig mutation, rather than its dNTPase activity. The production of
double-strand breaks (DSB) downstream of AID is critical for Ig class
switching (1), but DSB formation plays a minor role in V-region
hypermutation (43–45). In our experiments, insertions and de-
letions, which likely arise from DSB, were not discernably af-
fected by Samhd1 inactivation (Table 1) and clustered near
AGCW motifs regardless of Samhd1 genotype (Fig. S4).
An Entirely G1-Phase Model of Ig Hypermutation. We suggested
previously that MMR-independent lesion bypass might occur when
G1-phase AP sites persist into S phase and are replicated (6; see Fig.
S1). This model is not explicitly contradicted by the Samhd1Δ/Δ
phenotype we report here, because Samhd1 inactivation produced
supraoptimal dNTPs in all cell cycle phases. However, we recently
identified an∼20-bp footprint flanking AGCW sites within which C/G
transversions occurred independently of MMR (9). In remarkable
convergence with this footprint size, Woodrick et al. (46) showed
that LP-BER produces excision patches centered on the excised
AP site that are ≤20 nucleotides long; they further showed that
LP-BER predominates over single-nucleotide BER in living cells.
AGCW motifs are the only hotspots where AID can deaminate
either DNA strand with comparable efficiency in vivo (8, 9, 47).
This leads us to update the Ig hypermutation model and propose
that MMR-independent C/G transversions occur via simultaneous
G1-phase LP-BER of deaminations that have accumulated in
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Fig. 4. A completely G1-phase model of Ig hypermutation that incorporates
SAMHD1 and a major role for LP-BER. If both strands of an AGCW motif are
deaminated, then LP-BER in one strand can expose an AP site in the other,
whereas single-nucleotide BER cannot. At deamination sites >10 bases away
fromAGCWmotifs, the chance that excision during LP-BER will expose another
AP site in the opposite strand is much lower. Recruitment of ExoI via MutSα
produces much longer excision patches (>90 bases long; ref. 61) than LP-BER’s
20-base excision patch (46). In UNG2+ cells, these long excision patches have a
roughly equal chance of exposing an AP site in the opposite strand regardless of
where the deamination site that recruited MutSα lies. SAMHD1 activity determines
the dNTPmilieu, thus dictating themisincorporation spectrum for bothMMR and LP-
BER. This model explains (i) the hyperfocusing of Igmutation on AGCW motifs that
occurs only in UNG2+MMR-deficient B cells and not in UNG2/MMR double-deficient
cells (9, 21), (ii) the near completeMMR dependence of C/G transversion mutation at
sites >10 bases from AGCW motifs (9), (iii) increased C/G transitions, and (iv) sub-
stantially decreased A/T and C/G transversions in Samhd1Δ/Δ B cells (this work).
A B
Fig. 3. Occurrence of C/G transitions (x axes) or transversions (y axes) outside or
within AGCWmotifs. The mean (±SEM) number of C/G transitions or transversions
per 560-bp sequence were calculated on a per host basis, as in Fig. 2, for C/G lo-
cated outside AGCW motifs (A) or C/G located inside AGCW motifs (B). Significant
differences to the vector-transduced Samhd1+ means are indicated with asterisks
(one-way ANOVA, Holm–Sidak’s post hoc tests): vertical and black for C/G transi-
tions; horizontal and gray for C/G transversions. All means lying to the right of the
vertical dotted line represent significantly elevated C/G transition frequencies, and
all means lying below the gray dotted line represent significantly reduced C/G
transversion frequencies, relative to the Samhd1+Msh2+/+ data.
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opposite strands of AGCW sites, as illustrated in Fig. 4, without any
requirement for AP sites to persist into S phase. A key strength of
this model is its ability to explain why UNG2 is at its most error-
prone in regions where AGCW motifs are concentrated.
Similarities Between Ig Hypermutation and Intracellular Virus Restriction
Mechanisms. Cell cycle turnover of RNR and the dNTPase activity
of SAMHD1 are intracellular antiviral mechanisms that evolved
long before the appearance of adaptive immunity (48). The
APOBEC3 family of AID paralogues also restrict viral infection
by deaminating viral genomes; UNG2 and APE activities down-
stream of APOBEC3 can contribute to viral restriction (49, 50).
AID/APOBEC-like deaminases occur across metazoa, dictyosteliida,
and even algae, and may have evolved in an arms race with viruses
and retro elements (51). Here, we’ve shown that SAMHD1 is an-
other virus restriction factor that contributes to the mutagenicity of
AID—by promoting transversion mutation downstream of AID.
Transition mutation is the most common form of point mutation in
the genome. Codon degeneracy has evolved to accommodate this,
which means that transversion mutations are generally more muta-
genic than transition mutations (52), implying that Ig point
mutations likely to cause the greatest changes in antibody binding
characteristics are promoted by SAMHD1. For example, the gen-
eration of high-affinity anti-phenyloxazalone antibodies in BALB/c
mice predominantly involves H34N and Y36F mutation of VκOx1/Jκ5
rearrangements: a C to A transversion and an A to T transversion,
respectively (53). It’s conceivable that G1-phaseMMR can also act as
an antiviral mechanism, because repeated recruitment of ExoI to
viral genomes that misincorporated G1-phase dNTPs would inhibit
viral replication. Given that G1-phase nicking by MutLα in B cells
does not discriminate between mutated and nonmutated DNA
strands (5), it is further conceivable that G1-phase MMR evolved to
attack viral genomes and trigger apoptosis, rather than to repair
errors, and was then coopted by Ig hypermutation, along with
UNG2 and SAMHD1, as part of a preexisting suite of ancient
intracellular antivirus mechanisms.
Materials and Methods
Mice. Male C57BL/6 host mice were initially purchased from Animal Resources
Centre (CanningVale,WesternAustralia) and later fromAustralianBioResources
(Moss Vale, New SouthWales), andwere used in experimentswhen 8–16wk old.
Msh2ko, Rag1ko, Igh-knock-in/Igk-transgenic SWHEL, and Fucci-red/Fucci-green
mice (25, 31, 34, 54) were interbred and maintained on a C57BL/6 background
under SPF conditions in the Centenary Institute Animal Facility.
Samhd1Δ/Δ mice were produced by the Mouse Engineering Garvan/ABR
(MEGA) Facility (Moss Vale and Sydney, Australia) by CRISPR/Cas9 gene tar-
geting in C57BL/6J mouse embryos following established molecular and
animal husbandry techniques (55). To minimize off-target genome modifi-
cations, the double-nicking approach employing the single-strand cleaving
mutant of the Cas9 endonuclease (Asp10Ala = Cas9n) was employed (56).
For this purpose, paired single-guide RNAs (sgRNAs) were designed to target
within the first coding exon (Exon 1) of Samhd1. The sites used were
CTCCAAGGGTGCGCTCTGCATGG and GCTAAGCGACCCCGCTGCGATGG (pro-
tospacer-associated motifs = PAMs underlined).
To target Samhd1, a solution consisting of the two sgRNAs (15 ng/μL each) and
full-length, polyadenylated Cas9n mRNA (30 ng/μL) was prepared and micro-
injected into the nucleus and cytoplasm of SWHEL × C57BL/6 zygotes. Micro-
injected embryos were cultured overnight and introduced into pseudopregnant
foster mothers. Pups were screened by PCR across the two target sites and Sanger
sequencing to detect those with modifications to Samhd1. Independent founders
carrying 25- and 41-bp frame-shift deletions within Exon 1 were selected, back-
crossed to wild-type SWHEL (C57BL/6J) mice four times, and the progeny was
intercrossed to derive homozygous Samhd1Δ25/Δ25 and Samhd1Δ41/Δ41 lines.
All work was carried out with approval from and oversight by the Royal
Prince Alfred Hospital Animal Welfare and Biosafety Committees, in accor-
dance with NSW and Federal Australian legislation and the Australian Code
for the Care and Use of Animals for Scientific Purposes (57).
Plasmids and Retroviruses. pMiG-based retroviruses expressing mKO2-cdt
fusion protein (whose accumulation is restricted to G0/G1-phases by the
degron from human Cdt1), EGFP, or ugi-EGFP fusion protein have been
described (6). All cDNAs were cloned into the pMiG vector (58) using con-
ventional techniques and verified by Sanger sequencing (Macrogen Inc).
Ecotropic viral supernatants were produced by calcium phosphate transfection
of the Platinum-E retroviral packaging cell line (Cell Biolabs, Inc.) as described
(9). Culture medium (DMEM, 10% bovine calf serum, 1 mM sodium pyruvate,
2 mM L-alanyl-L-glutamine dipeptide, penicillin/streptomycin) was replaced at
12 h, then retroviral supernatants were harvested at 60 h, 0.45-μm filtered,
snap frozen in liquid nitrogen, and stored at −70 °C.
Transduction and Adoptive Transfer of SWHEL Splenocytes and Mutation
Analysis. Activation of mouse splenocytes with recombinant CD40L for 24 h,
followed by transduction in culture for a further 48 h has been described (9).
GFP+ cells were sorted using a BD FACS Aria II or BD influx sorter, mixed with
sheep red blood cells (SRBC; Applied Biological Products Management)
conjugated to hen egg lysozyme (HEL; Sigma-Aldrich) in B cell medium (54)
and injected into host tail veins as a bolus of ≤104 HEL-binding B cells plus
108 HEL-SRBC into 8- to 12-wk-old male hosts that had been primed i.p. 7 d
prior with 108 SRBC in PBS, as described (34). Six days after adoptive transfer,
host spleens were harvested, depleted of RBC using Histopaque 1083 frac-
tionation (Sigma-Aldrich), and GFP+ HEL-binding cells were sorted using a BD
FACS Aria II or BD influx, one cell per well into 96-well PCR plates (4titude)
containing 15 μL per well of ice-cold Mg-free 1× Taq DNA polymerase buffer
(Promega “Go-Taq” buffer) supplemented to include 0.1 mM EDTA, 1%
Tween-20 detergent (Astral Scientific) and 0.25 mg/mL proteinase K (Roche
Diagnostics). Single-cell nested PCR of the singular gene-targeted SWHEL
VDJH rearrangement present in each cell was performed as described (25).
Single allele mutation data were collected from up to 47 single cells using
direct Sanger sequencing (Macrogen) of single-cell PCR products, as de-
scribed (25), except that the sequencing primer (jol27: 5′-ACTC CACC AACA
CCAT CACA C-3′) was positioned further 3′ to the start codon than previously,
enlarging the sequence window from 523 bases to 560 bases. Each treatment
involved at least three individual donors and hosts. Mutation data were ana-
lyzed by one-way ANOVA and Holm–Sidak’s post hoc multiple comparisons tests
with Prism 7 for MacOS (GraphPad Software, Inc), using the mean mutation of
each hosts’ sampled cells as a single data point (9).
Western Blot Analysis. B cells from Fucci-red/Fucci-green double-transgenic
mice (31) were cultured in 20 μg/mL S. typhosa LPS (Sigma-Aldrich) plus
20 ng/mL mouse IL-4 (BD Biosciences) for 3 d to induce robust B cell pro-
liferation. B cells from Fucci mice express an orange fluorescent fusion
protein (“mKO2-cdt”) in G1 phase of the cell cycle or a green fluorescent
fusion protein (“mAG-gmnn”) in S, G2, and M phases (31). Transduced cells
were sorted into mKO2+mAG− (G1 phase) and mKO2
−mAG+ (S/G2/M phase)
fractions using a BD Influx sorter. Proteins were extracted from cells by
vortexing cell pellets at 2 × 107 cells per mL in Laemmli sample buffer (0.1%
2-mercaptoethanol, 2% SDS, 10% glycerol, 0.0005% bromophenol blue,
63 mM Tris·Cl, pH 6.8), then incubating for 30 min at 20 °C with 250 units/mL
Benzonase nuclease (Millipore). Extracts were electrophoresed using 4–12%
Bolt Bis-Tris Plus polyacrylamide gels (Invitrogen) and transferred to nitro-
cellulose membranes using a Novex semi-dry blotter (Invitrogen) according
to manufacturer protocols. Membranes were blocked for 1 h with 5% (wt/vol)
skim milk powder in TBST [0.9% (wt/vol) NaCl, 0.1% (vol/vol) Tween-20 and
10 mM Tris·HCl, pH 7.4] at room temperature, then incubated overnight at
4 °C with mouse anti-SAMHD1 IgG2b monoclonal OTI1A1 (Abcam), goat
anti-R2 IgG polyconal E-16 (Santa Cruz Biotechnology), or rabbit anti-R1
IgG monoclonal EPR8483 (Abcam) in skim milk/TBST. Washed membranes
were incubated with species-appropriate secondary antibodies conjugated
to horseradish peroxidase (Santa Cruz Biotechnology) for 1 h at 20 °C in
skim milk/TBST, then washed again and incubated with SuperSignal West Pico
Chemiluminescent Substrate (Thermo Fisher). Luminescence was recorded
using a ChemiDoc MP (Bio-Rad).
dNTP Quantitation. Samhd1Δ25/Δ25 or Samhd1+/Δ25 splenocytes were cultured
with LPS plus IL-4, for 24 h as above. Activated cells were then transduced
with fresh retroviral supernatants of pMiG-derived retroviruses that
expressed mKO2-cdt; cells expressing mKO2-cdt fluoresce red when they are in G1
phase (6, 31). Two days later, orange-fluorescent (i.e., G1-phase) cells were sorted
using a BD Influx sorter into ice-cold bovine serum. Total dNTPs were extracted
from PBS-washed sorted cells using ice-cold 60% aqueous methanol, as described
(59). Resting or nonfractionated proliferating Samhd1Δ25/Δ25 or Samhd1+/Δ25 sple-
nocytes depleted of RBC and dead cells using density gradient centrifugation over
Histopaque 1083 (Sigma-Aldrich) were also extracted. dNTPs were then quantified
using an HIV reverse transcriptase primer extension assay, as described (59).
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Fig. S3. (A) Mutation data from Fig. 2B and Table 1 broken down into mutations from A or T, transversions from C or G, and transitions from C or G, referring
to the top strand. Each symbol is the mean number of mutations per sequence within one host. Histograms are the mean of hosts (±SEM), with each histogram
segmented into mutations to G, A, C, or T (colors, without any variance indicated). (B) Hypermutation within the J-CH intron, analyzed exactly as in Fig. 2B.
Significant differences (one-way ANOVA, Holm–Sidak’s post hoc multiple comparisons tests) to the vector-transduced wild-type means (A) or the vector-
transduced Samhd1Δ/ΔMsh2+/+ means (B) are indicated: *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; ns, not significant.
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Table S1. Overview of mutation phenotypes discussed in this paper
C/G mutation A/T mutation Hotspot-focusing
Dataset %C mutations = Tv %G mutations = Tv %mutations at A:T %A/T mutations = Tv
% C/G mutations at
WGCW* or AGCW† Source
Peyer’s patch VDJH4-CH intron (495 bp) 1
Control 32 32 51 50 11*
Msh2−/− 18 24 10 64 48*
Polh−/− 41 40 16 81 26*
Polh−/−Msh2−/− 13 17 1 – 57*
Peyer’s patch VDJH4-CH intron (510 bp) 2
Control 37 45 55 54 19†,‡
PCNAK164R/K164R 26 42 5 73 16†,‡
Ung−/− 1 3 44 45 22†,‡
Msh2−/− 22 25 12 67 29†,‡
PCNAK164R/K164R Msh2−/− 11 27 2 67 32†,‡
SWHEL allele (560 bp) This paper
Control 27 36 51 64 32†
Msh2−/− 5 24 4 59 48†
Samhd1Δ/Δ 8 8 27 31 31†
Samhd1Δ/Δ, Msh2−/− 5 10 3 50 41†
ugi+ Samhd1Δ/Δ 1 0 26 33 11†
SWHEL VDJ-CH intron (101 bp) This paper
Control 32 52 52 65 19†
Msh2−/− 19 26 0 – 34†
Samhd1Δ/Δ 5 5 38 39 12†
Samhd1Δ/Δ, Msh2−/− 0 9 0 – 40†
ugi+ Samhd1Δ/Δ 0 0 36 30 10†
*Focusing to WGCW motifs.
†Focusing to AGCW motifs.
‡Focusing estimated using mutation skylines in figure 4 of ref. 2 and numbers in figure 2 of ref. 2.
1. Delbos F, Aoufouchi S, Faili A, Weill JC, Reynaud CA (2007) DNA polymerase eta is the sole contributor of A/T modifications during immunoglobulin gene hypermutation in the mouse. J
Exp Med 204:17–23.
2. Krijger PH, Langerak P, van den Berk PC, Jacobs H (2009) Dependence of nucleotide substitutions on Ung2, Msh2, and PCNA-Ub during somatic hypermutation. J Exp Med 206:
2603–2611.
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6. General Discussion 
In 2002, the laboratory of Michael Neuberger proposed the first comprehensive 
model of Ig somatic hypermutation (Di Noia & Neuberger, 2002; Petersen-Mahrt et 
al., 2002; Rada et al., 2002). This model incorporated the then recently discovered 
requirement for AID and the older discovery of a role for MMR in somatic 
hypermutation with new evidence that AID directly targeted DNA and that UNG2 
diversified transition mutations at C/G to transversions. Supporting data was originally 
produced from E. coli (Petersen-Mahrt et al., 2002), then from the DT40 chicken 
lymphoblast cell line (Di Noia & Neuberger, 2002) and later from mouse B cells (Rada 
et al., 2002). The Neuberger model has since become the paradigm (Maul & Gearhart, 
2014). While this model has been refined in the years since, this thesis attempts to 
answer some remaining important questions. Why do mutations hyper-focus on AID 
hotspots in MMR-deficient mouse B cells? Also, why are AID-induced deamination 
events not accurately repaired by DNA repair pathways, and are instead intensely 
mutagenic (Maul & Gearhart, 2014)? 
 
Our laboratory developed the mouse SWHEL  transduction/adoptive transfer system as 
a quantitative model that can bypass embryo transgenesis (Sharbeen et al., 2010; 
Sharbeen et al., 2012), and potentially embryo gene-knockout, to investigate why DNA 
repair pathways are mutagenic during B cell somatic hypermutation. The 
transduction/adoptive transfer system was first used, in 2010 (Sharbeen et al., 2010), 
to test and refute Neuberger’s “dUTP incorporation” model of AID-induced A:T 
mutation (Neuberger et al., 2005). Neubereger’s hypothesis proposed that during G1 
phase, when the dUTP/dTTP ratio rises as a result of depressed dUTPase enzyme 
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activity, dUTP becomes incorporated opposite A during re-synthesis of DNA in MMR 
generated excision patches. Incorporated uracils would then be excised by one of 
several redundant DNA glycosylases to generate AP sites. Polymerase η would then 
be recruited to bypass these AP sites in later rounds of AID-induced MMR, leading to 
permanent mutations opposite dA during in-fill of the MMR excision patches. In 2012, 
the SWHEL model was used to produce definitive evidence that processing of AID-
induced deaminations by UNG2 occurred predominantly in G1 and was both faithful 
and mutagenic in this cell cycle phase (Sharbeen et al., 2012). This thesis further 
develops the SWHEL transduction/adoptive transfer model to gain new insights into 
somatic hypermutation, focusing on the role of cell cycle in turnover of all dNTPs (as 
opposed to dUTP solely), and testing whether RNA-silencing in adoptive B cells can be 
used as a substitute for time-consuming embryonic gene-knockout to definitively 
determine the role of novel factors in antibody hypermutation. 
 
Using the largest number of biological replicates per dataset ever published, Chapter 
three quantifies the dependence of AID-induced hypermutation on UNG2 and MMR 
and mathematically models the focusing of mutations on AGCT/AGCA (AGCW) 
hotspots in Msh2 knockout mouse B cells. Various mechanisms have been proposed 
to explain this phenomenon of hotspot-focusing. Scharff’s group suggested that MMR 
was necessary to recruit AID to deaminate Cs outside of hotspot WRC motifs (Li et al., 
2006). They based this conclusion on analysis of Msh6+/+, Msh6ko/ko mice and mice with 
a Msh6 knock-in (Msh6TD/TD) that produced Msh6 protein, but ablated the ability of 
MMR to repair mismatches. They found that the Msh6TD/TD mice lacked A/T mutation, 
similar to the Msh6ko/ko mice. AID hotspot focusing was also present in Msh6TD/TD mice, 
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but displayed a different pattern of mutation at G:C compared to Msh6ko/ko and 
Msh6+/+ mice. They concluded that these differences meant that Msh6 recruited AID 
to motifs outside of WRC. They did not perform experiments incorporating the effects 
of UNG2 deficiency and used small datasets, with low statistical power. Given the 
finding in Chapter 3 that MMR and UNG2 double-deficiency produced abundant 
mutation outside hotspots, rather than focusing mutation on hotspots, plus our use 
of very large datasets, it is unlikely that AID targeting via MSH6 is the reason for 
mutation focusing on hotspots in MMR deficiency. Instead, in agreement with Delbos 
et al. (Delbos et al., 2007), our data were consistent with the notion that mutation 
focuses in MMR-deficient B cells to motifs that are most resistant to faithful UNG2-
mediated repair, and that it is this resistance to UNG2-mediated repair that explains 
hyper-focusing of mutation to hotspots in MMR-deficient cells. 
 
Chapter three also refines the Neuberger model by showing that transversion 
mutations at C:G, already known to be largely dependent on UNG2, arise 
independently of MMR if they are in or near AGCT and AGCA hotspots, but are 
increasingly dependent (mathematically described by an exponential decay equation) 
on UNG2 plus MMR as distance from AGCT hotspots increases. This result was 
consistent with independent data generated by Chen et al (Chen et al., 2016), which 
we partially re-analysed in Chapter 3. Their data measured mutations in a 
conventional VDJH knock-in allele (analogous to our SWHEL allele) and in an allele 
carrying a knocked-in AGCT-rich sequence. Chen et al.’s data revealed an 85% 
(conventional) and 89% (AGCT-rich) reduction in transversions at C:G with UNG2 
deficiency and a 44% (conventional) and 29% (AGCT-rich) reduction in transversions 
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at C:G with Msh2 knockout. These findings of a substantially lower reduction in MMR-
dependent transversions in the AGCT-rich allele compared to the conventional allele, 
are consistent with our conclusions. 
 
Chapters four and five investigate the role of dNTP paucity in G1 phase during somatic 
hypermutation. The original hypothesis that dNTP paucity (as opposed to dUTP/dTTP 
ratios) might contribute to somatic hypermutation was generated in our laboratory as 
a consequence of testing Neuberger’s dUTP-incorporation hypothesis. Our 
laboratory’s experiments showed that constitutive over-expression of mouse or EBV 
dUTPase in adoptive SWHEL B cells reduced dUTP levels (because these enzymes 
convert dUTP to dUMP), but did not decrease mutations at A/T. Indeed, the opposite 
occurred: a small increase in mutations at A/T. It was proposed that excess dUTPase 
may have perturbed the dNTP pool generally (because dTTP is synthesized via dUMP), 
and this may have led to increased mis-incorporation of dNTPs during infill of MMR 
excision patches. 
 
To test whether dNTP supply determines the frequencies of MMR-dependent Ig 
mutations, we have assessed the effect of constitutive R2 overexpression, and of 
Samhd1 silencing and CRISPR-knockout in adoptive SWHEL B cells. R2 overexpression 
and Samhd1 CRISPR both caused nearly 50% reductions in A/T mutations, which was 
consistent with our dNTP paucity hypothesis. R2 overexpression and Samhd1 CRISPR, 
however, also increased transition mutations at C/G by about 50%, and in Samhd1 
CRISPR-knockout cells there was a >70% decrease in C/G tranversion mutations. These 
additional findings were not initially predicted by our hypothesis. 
 112 
 
The recurrent combination of decreased mutation at A/T and increased transition at 
C/G in our manipulated cells appeared to partially phenocopy MMR inhibition. 
However, using the hotspot-focused mutation signature described for MMR-
deficiency in Chapter 3, we showed that Samhd1-inactivation and R2 overexpression 
did not induce hyper-focusing of mutation at AGCW motifs, unlike MMR deficiency. 
Therefore, it was unlikely that Samhd1 inactivation or R2 overexpression inhibited 
MMR activity. Polh-/- (Delbos et al., 2007) and PcnaK164R/K164R (Krijger et al., 2009) mice 
also lose A/T mutations without concomitant hyper-focusing of mutation on AGCW 
hotspots (Chapter 5 Discussion). These similarities between Samhd1 inactivation, R2 
over-expression, Polh-inactivation and PcnaK164R/K164R mutation are consistent with 
our initial hypothesis: loss of R2 expression and increased Samhd1 activity during G1 
phase lead to nucleotide paucity-driven recruitment of polymerase K during AID-
induced MMR, but do not prove it. 
 
In Samhd1∆/∆ B cells, increased C/G transition mutations combined with decreased 
C/G transversions can theoretically be explained by the greater increase in purine 
dNTPs relative to the pyrimidine dNTPs. To explicate: incorporation of purines 
opposite UNG2-induced AP sites by lesion bypass produces a transition mutation if dA 
is incorporated, or faithful bypass if dG is incorporated; incorporation of pyrimidines 
dC or dT produces a transversion mutation. Markedly increased bias towards 
transition mutation was also seen when analysing the A/T mutations remaining in 
Samhd1∆/∆ B cells. Because mismatch excision downstream of AID appears to be 
heavily skewed to the top strand (Girelli Zubani et al., 2017), favoured incorporation 
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of dA and dG opposite dT can theoretically explain the preferential loss of transversion 
mutations at A:T base pairs (Chapter 5).  
 
Although there was a similar and significant decrease in mutation at A/T induced by 
R2 overexpression and Samhd1 inactivation, neither produced a complete loss in 
mutation at A/T. It is unlikely that in our models we achieved an exact S-phase level 
of dNTPs. This may explain why we saw an incomplete loss of A/T mutation, although 
it is also probable that there are multiple drivers of polymerase η recruitment in 
hypermutating B cells. In Chapter three we noted that C/G transversion mutations 
distal to AGCW motifs were dependent on both UNG2 and MMR. This implied that 
UNG2-derived AP sites are encountered by polymerases during infill of MMR excision 
patches. Encounters with AP sites in the intact strand may cause polymerases to stall 
during MMR infill, providing an additional driver for polymerase η recruitment. 
  
In total, this thesis significantly refines the Neuberger model of somatic 
hypermutation, providing insights into how sequence context affects downstream 
processing by UNG2 and the BER pathway and also how G1-phase dNTP paucity could 
contribute to mutagenic DNA repair (see Figure 4 from Chapter 5). Combining these 
results with our laboratory’s previous results, showing that transversions at C/G 
depend on G1 phase UNG2 activity, we now show that mutagenic processing of AID 
deaminations by uracil BER to create C/G transversions (phase 1B mutation) and by 
MMR to create A/T mutations (phase 2 mutations) are both at least partly driven by 
G1 phase dNTP paucity, which evolved prior to the appearance of antibodies as an 
ancient intra-cellular anti-virus mechanism. 
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Future Directions 
Since writing this thesis, more recent journal articles have been published which raise 
different possibilities in which SAMHD1 may enhance immunoglobulin 
hypermutation.  
 
Recently, SAMHD1 has been shown to interact with the DNA repair protein MRE11 at 
stalled replication forks (Coquel et al., 2018). While MRE11 is involved in DNA double-
strand break repair (Paull, 2018), it has recently been found that initiation of somatic 
hypermutation and class switch recombination leads to the formation of a complex 
between many DNA repair proteins, including MRE11 (Kumar et al., 2018) and also 
proteins involved in somatic hypermutation, such as PCNA, MSH2, UNG, APE1 and 
polymerase η. SAMHD1 could possibly contribute to mutagenic DNA repair during 
somatic hypermutation by direct activity on the Igh locus or interactions with other 
DNA repair proteins, rather than its effect on G1 phase dNTP pools. 
 
To further investigate these possibilities, we will measure the changes in somatic 
hypermutation in murine B cells with Samhd1 mutants for either dNTPase activity or 
DNA repair protein binding ability. 
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